<?xml version="1.0" encoding="UTF-8"?>
<hmdb xmlns="http://www.hmdb.ca">
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-04-23 20:53:36 UTC</update_date>
      <accession>HMDB0000001</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00001</accession>
        <accession>HMDB0004935</accession>
        <accession>HMDB0006703</accession>
        <accession>HMDB0006704</accession>
        <accession>HMDB04935</accession>
        <accession>HMDB06703</accession>
        <accession>HMDB06704</accession>
      </secondary_accessions>
      <name>1-Methylhistidine</name>
      <description>1-Methylhistidine, also known as 1-MHis, belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from a reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Methylhistidine is derived mainly from the anserine of dietary flesh sources, especially poultry. The enzyme, carnosinase, splits anserine into beta-alanine and 1-MHis. High levels of 1-MHis tend to inhibit the enzyme carnosinase and increase anserine levels. Conversely, genetic variants with deficient carnosinase activity in plasma show increased 1-MHis excretions when they consume a high meat diet. Reduced serum carnosinase activity is also found in patients with Parkinson's disease and multiple sclerosis and patients following a cerebrovascular accident. Vitamin E deficiency can lead to 1-methylhistidinuria from increased oxidative effects in skeletal muscle. 1-Methylhistidine is a biomarker for the consumption of meat, especially red meat.</description>
      <synonyms>
        <synonym>(2S)-2-Amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</synonym>
        <synonym>Pi-methylhistidine</synonym>
        <synonym>(2S)-2-Amino-3-(1-methyl-1H-imidazol-4-yl)propanoate</synonym>
        <synonym>1 Methylhistidine</synonym>
        <synonym>1-Methyl histidine</synonym>
        <synonym>1-Methyl-histidine</synonym>
        <synonym>1-Methyl-L-histidine</synonym>
        <synonym>1-MHis</synonym>
        <synonym>1-N-Methyl-L-histidine</synonym>
        <synonym>L-1-Methylhistidine</synonym>
        <synonym>N1-Methyl-L-histidine</synonym>
        <synonym>1-Methylhistidine dihydrochloride</synonym>
        <synonym>1-Methylhistidine</synonym>
      </synonyms>
      <chemical_formula>C7H11N3O2</chemical_formula>
      <average_molecular_weight>169.1811</average_molecular_weight>
      <monisotopic_molecular_weight>169.085126611</monisotopic_molecular_weight>
      <iupac_name>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</iupac_name>
      <traditional_iupac>1 methylhistidine</traditional_iupac>
      <cas_registry_number>332-80-9</cas_registry_number>
      <smiles>CN1C=NC(C[C@H](N)C(O)=O)=C1</smiles>
      <inchi>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</inchi>
      <inchikey>BRMWTNUJHUMWMS-LURJTMIESA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as histidine and derivatives. Histidine and derivatives are compounds containing cysteine or a derivative thereof resulting from reaction of cysteine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
        <direct_parent>Histidine and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Carboxylic acids and derivatives</class>
        <sub_class>Amino acids, peptides, and analogues</sub_class>
        <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Amino acids</alternative_parent>
          <alternative_parent>Aralkylamines</alternative_parent>
          <alternative_parent>Azacyclic compounds</alternative_parent>
          <alternative_parent>Carbonyl compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Heteroaromatic compounds</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Imidazolyl carboxylic acids and derivatives</alternative_parent>
          <alternative_parent>L-alpha-amino acids</alternative_parent>
          <alternative_parent>Monoalkylamines</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>N-substituted imidazoles</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alpha-amino acid</substituent>
          <substituent>Amine</substituent>
          <substituent>Amino acid</substituent>
          <substituent>Aralkylamine</substituent>
          <substituent>Aromatic heteromonocyclic compound</substituent>
          <substituent>Azacycle</substituent>
          <substituent>Azole</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Heteroaromatic compound</substituent>
          <substituent>Histidine or derivatives</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Imidazole</substituent>
          <substituent>Imidazolyl carboxylic acid derivative</substituent>
          <substituent>L-alpha-amino acid</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>N-substituted imidazole</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organoheterocyclic compound</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Primary aliphatic amine</substituent>
          <substituent>Primary amine</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>L-histidine derivative</external_descriptor>
          <external_descriptor>non-proteinogenic L-alpha-amino acid</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Kidney disease</term>
                      <definition>A urinary system disease that is located in the kidney. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Renal disease</synonym>
                        <synonym>Nephropathy</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Diabetes mellitus type 2</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                        <synonym>Niddm</synonym>
                        <synonym>Adult-onset diabetes</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Metabolism and nutrition disorders</term>
                      <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Obesity</term>
                          <definition>A disorder characterized by having a high amount of body fat. (nci ctcae).</definition>
                          <parent_id>7708</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Muscle</term>
                      <definition>A fibrous soft tissue with the ability to contract to produce force and motion. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Skeletal muscle</term>
                      <definition>Striated muscles that are under voluntary control of the organism. they are connected at either or both ends to a bone and are utilized for locomotion and other movements. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Striated muscle</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Histidine Metabolism</term>
                          <definition> after reaching several years of age, humans begin to synthesize it (most likely in the intestinal micrflora) and it thus becomes a non-essential amino acid. humans can obtain histidine through the breakdown of carnosine (a dipeptide containing histidine and beta-alanine) via the action of carnosine dipeptidase.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>200 g/kg</value>
          <source>http://download.cappchem.com/data/Properties-of-Amino-Acids.pdf</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>249 °C</value>
          <source>http://download.cappchem.com/data/Properties-of-Amino-Acids.pdf</source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-2.95</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-1.39</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>6.93 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-3.1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>1.96</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>9.25</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>169.1811</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>169.085126611</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>CN1C=NC(C[C@H](N)C(O)=O)=C1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C7H11N3O2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>BRMWTNUJHUMWMS-LURJTMIESA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>81.14</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>42.39</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>17.11</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1022</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>915</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>3</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>255159</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>255160</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>255161</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>275100</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>275101</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>275102</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1469</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1755</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>7663</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30940</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30941</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37237</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Placenta</tissue>
          <tissue>Skeletal Muscle</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Histidine Metabolism</name>
            <smpdb_id>SMP00044</smpdb_id>
            <kegg_map_id>map00340</kegg_map_id>
          </pathway>
          <pathway>
            <name>Histidinemia</name>
            <smpdb_id>SMP00191</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>7.7 +/- 1.9</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
              <pubmed_id>7061274</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>14.4 +/- 2.3</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
              <pubmed_id>7061274</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>19.6 +/- 2.6</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
              <pubmed_id>7061274</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>12.7 +/- 2.9</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
              <pubmed_id>7061274</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>20.2 +/- 4.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
              <pubmed_id>7061274</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>9.1 +/- 7.2</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>4.0 +/- 8.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 85-97. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>4.0 +/- 1.74</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By CIL LC−MS </comment>
          <references>
            <reference>
              <reference_text>Xu W, Chen D, Wang N, Zhang T, Zhou R, Huan T, Lu Y, Su X, Xie Q, Li L, Li L: Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015 Jan 20;87(2):829-36. doi: 10.1021/ac503619q. Epub 2014 Dec 25.</reference_text>
              <pubmed_id>25486321</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>26.34</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
              <pubmed_id>1819935</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.15-162.32</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>10-17 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub  2012 Aug 31.</reference_text>
              <pubmed_id>22932811</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.36-175.22</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>17.74-153.77</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>David F. Putnam Composition and Concentrative Properties of Human Urine. NASA Contractor Report. July 1971</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>8.3 (2.4-28.4)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.60-151.46</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.9 +/- 19.5 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>46.0833 +/- 53.432</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.92-47.39</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>11-16 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>45.473 +/- 41.617</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Blacks - Omnivores. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.919 +/- 19.503</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>4.635</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Blacks - Vegetarians. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>33.624 +/- 36.360</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Whites - Omnivores. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>28.0954 +/- 31.826</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Whites - Omnivores. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.340 +/- 5.0764</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.334 +/- 2.759</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Whites - Vegetarians. From Exposome Explorer.</comment>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>30.0 +/- 43.0</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.036-184.27</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>4.6 +/- 2.7</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.3 +/- 5.1</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>46.1 +/- 53.5</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.9 +/- 19.5</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>28.1 +/- 31.8</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.3 +/- 2.76</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>45.5 +/- 41.6</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>33.6 +/- 36.4</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
              <pubmed_id>11052553</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>18.55-145.2</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>21.329 +/- 12.971</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>53.18(22.81-139.9)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>47.06(17.31-146.8)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.13-166.96</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Mayo Clinic: https://neurology.testcatalog.org/show/AAPD</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Under omnivorous diet</comment>
          <references>
            <reference>
              <reference_text>Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006 Oct;5(10):2780-8.</reference_text>
              <pubmed_id>17022649</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With fish (Salmon) consumption</comment>
          <references>
            <reference>
              <reference_text>Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J: Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br J Nutr. 2011 Sep;106(6):812-24. doi: 10.1017/S0007114511001164. Epub 2011 May  9.</reference_text>
              <pubmed_id>21736852</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Healthy condition not specified, assume it is healthy</comment>
          <references>
            <reference>
              <reference_text>Lloyd AJ, Beckmann M, Haldar S, Seal C, Brandt K, Draper J: Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure. Am J Clin Nutr. 2013 Feb;97(2):377-89. doi: 10.3945/ajcn.112.048033. Epub 2012 Dec 26.</reference_text>
              <pubmed_id>23269817</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>51.2 +/- 17.6 </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
          <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>43.4 +/- 22.3 </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>50.7 (12.9) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Early preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>50.0 (14.6) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>28.8 +/- 18.2</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Kidney disease</patient_information>
          <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with nocturnal hemodialysis for 8 h during the night, 6 times/week.</comment>
          <references>
            <reference>
              <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
              <pubmed_id>10838467</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>83.1 +/- 21.7</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Kidney disease</patient_information>
          <comment>Patients with chronic renal failure on maintenance hemodialysis. These subjects were treated with conventional hemodialysis for 4 h, 3 times/week.</comment>
          <references>
            <reference>
              <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
              <pubmed_id>10838467</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>70.3 (40.0) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Late-onset preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>38.9 (20.3) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>10.66 +/- 2.68</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Elderly (&gt;65 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Alzheimer's disease</patient_information>
          <comment>Probable Alzheimer's disease</comment>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>40.4 (12.3) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Down syndrome pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>32.7 (13.7) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>2.6 +/- 1.13</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Alzheimer's disease</patient_information>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>10.9 +/- 10.1</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Obesity</patient_information>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>17.5 +/- 25.7</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.7 +/- 4.04</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Alzheimer's disease </patient_information>
          <comment>Probable Alzheimer's disease</comment>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>18.299 +/- 16.521</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>40 +/- 2.6</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Propionic acidemia </patient_information>
          <references>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>31 +/- 11</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Maple syrup urine disease </patient_information>
          <references>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>50.3 +/- 9.9</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Aminoaciduria</patient_information>
          <references>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Kidney disease</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST: Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 2001 Jun;59(6):2267-72.</reference_text>
              <pubmed_id>11380830</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003 Jul;112(2):256-64.</reference_text>
              <pubmed_id>12865413</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P: Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991 Mar;44(3):243-5.</reference_text>
              <pubmed_id>2013627</pubmed_id>
            </reference>
            <reference>
              <reference_text>Niwa T, Takeda N, Yoshizumi H: RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Kidney Int. 1998 Jun;53(6):1801-6.</reference_text>
              <pubmed_id>9607216</pubmed_id>
            </reference>
            <reference>
              <reference_text>Takagi T, Chung TG, Saito A: Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography. J Chromatogr. 1983 Feb 11;272(2):279-85.</reference_text>
              <pubmed_id>6833425</pubmed_id>
            </reference>
            <reference>
              <reference_text>Burke RA, Moberly JB, Patel H, Shockley TR, Martis L: Maltose and isomaltose in uremic plasma following icodextrin administration. Adv Perit Dial. 1998;14:120-3.</reference_text>
              <pubmed_id>10649708</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fleck C, Schweitzer F, Karge E, Busch M, Stein G: Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta. 2003 Oct;336(1-2):1-12.</reference_text>
              <pubmed_id>14500028</pubmed_id>
            </reference>
            <reference>
              <reference_text>Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.</reference_text>
              <pubmed_id>10838467</pubmed_id>
            </reference>
            <reference>
              <reference_text>Liebich HM, Woll J: Volatile substances in blood serum: profile analysis and quantitative determination. J Chromatogr. 1977 Nov 11;142:505-16.</reference_text>
              <pubmed_id>914932</pubmed_id>
            </reference>
            <reference>
              <reference_text>Galley HF, Le Cras AE, Yassen K, Grant IS, Webster NR: Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth. 2001 Apr;86(4):578-80.</reference_text>
              <pubmed_id>11573638</pubmed_id>
            </reference>
            <reference>
              <reference_text>Paniagua R, Claure R, Amato D, Flores E, Perez A, Exaire E: Effects of oral administration of zinc and diiodohydroxyquinolein on plasma zinc levels of uremic patients. Nephron. 1995;69(2):147-50.</reference_text>
              <pubmed_id>7723896</pubmed_id>
            </reference>
            <reference>
              <reference_text>Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ: Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Clin Chim Acta. 2006 Feb;364(1-2):209-16. Epub 2005 Aug 8.</reference_text>
              <pubmed_id>16087168</pubmed_id>
            </reference>
            <reference>
              <reference_text>Butscheid M, Schafer C, Brenner S, Alscher D, Murdter T, Niwa T, Frischmann M, Pischetsrieder M, Klotz U: Unchanged serum levels of advanced glycation endproducts in patients with liver disease. Naunyn Schmiedebergs Arch Pharmacol. 2007 Aug;375(6):401-6. Epub 2007 Jun 15.</reference_text>
              <pubmed_id>17571253</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stenvinkel P, Rodriguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellstrom B, Heimburger O, Lindholm B, Alvestrand A: Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2006 Mar;1(2):281-7. Epub 2006 Feb 1.</reference_text>
              <pubmed_id>17699218</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bain MA, Faull R, Milne RW, Evans AM: Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006 Oct;7(7):811-6.</reference_text>
              <pubmed_id>17073580</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bain MA, Faull R, Fornasini G, Milne RW, Evans AM: Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006 May;21(5):1300-4. Epub 2006 Jan 9.</reference_text>
              <pubmed_id>16401621</pubmed_id>
            </reference>
            <reference>
              <reference_text>Teerlink T, Hennekes MW, Mulder C, Brulez HF: Determination of dimethylamine in biological samples by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):269-76.</reference_text>
              <pubmed_id>9174262</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T: Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transplant. 2002 Jun;17(6):1032-6.</reference_text>
              <pubmed_id>12032193</pubmed_id>
            </reference>
            <reference>
              <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
              <pubmed_id>17919531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nieren- und Hochdruckkrankheiten (1978), 7(2), 62-74 (translated from German Kidney and Hypertension). </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Early preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pregnancy</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
              <pubmed_id>3252730</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
              <pubmed_id>663967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
              <pubmed_id>12833386</pubmed_id>
            </reference>
            <reference>
              <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
              <pubmed_id>2994907</pubmed_id>
            </reference>
            <reference>
              <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
              <pubmed_id>17704099</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
              <pubmed_id>12698507</pubmed_id>
            </reference>
            <reference>
              <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
              <pubmed_id>17061063</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
              <pubmed_id>16925883</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
              <pubmed_id>22420377</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
              <pubmed_id>18059417</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
            <reference>
              <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Late-onset preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Alzheimer's disease</name>
          <omim_id>104300</omim_id>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
            <reference>
              <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
              <pubmed_id>11959400</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
              <pubmed_id>8595727</pubmed_id>
            </reference>
            <reference>
              <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
              <pubmed_id>15361288</pubmed_id>
            </reference>
            <reference>
              <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
              <pubmed_id>9693263</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
              <pubmed_id>15465626</pubmed_id>
            </reference>
            <reference>
              <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
              <pubmed_id>15061359</pubmed_id>
            </reference>
            <reference>
              <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
              <pubmed_id>10494443</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
              <pubmed_id>11255442</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
              <pubmed_id>12498967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
              <pubmed_id>16227558</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
              <pubmed_id>9720975</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
              <pubmed_id>12111441</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
              <pubmed_id>16244393</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
              <pubmed_id>8356878</pubmed_id>
            </reference>
            <reference>
              <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
              <pubmed_id>12391605</pubmed_id>
            </reference>
            <reference>
              <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
              <pubmed_id>8478958</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
              <pubmed_id>21292280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
              <pubmed_id>20858978</pubmed_id>
            </reference>
            <reference>
              <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
              <pubmed_id>21474939</pubmed_id>
            </reference>
            <reference>
              <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
              <pubmed_id>20523031</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
              <pubmed_id>11314776</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
              <pubmed_id>1716470</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Obesity</name>
          <omim_id>601665</omim_id>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
              <pubmed_id>16253646</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
              <pubmed_id>2401584</pubmed_id>
            </reference>
            <reference>
              <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
              <pubmed_id>17264178</pubmed_id>
            </reference>
            <reference>
              <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
              <pubmed_id>1783639</pubmed_id>
            </reference>
            <reference>
              <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
              <pubmed_id>26505825</pubmed_id>
            </reference>
            <reference>
              <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
              <pubmed_id>17408529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
              <pubmed_id>18997681</pubmed_id>
            </reference>
            <reference>
              <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
              <pubmed_id>24740590</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
              <pubmed_id>23108202</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
              <pubmed_id>26910390</pubmed_id>
            </reference>
            <reference>
              <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Diabetes mellitus type 2</name>
          <omim_id>125853</omim_id>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
              <pubmed_id>11887176</pubmed_id>
            </reference>
            <reference>
              <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
              <pubmed_id>16731998</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
              <pubmed_id>15982426</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
              <pubmed_id>6321058</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
              <pubmed_id>10431355</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
              <pubmed_id>6810706</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
              <pubmed_id>7758205</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
              <pubmed_id>9357814</pubmed_id>
            </reference>
            <reference>
              <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
              <pubmed_id>14512036</pubmed_id>
            </reference>
            <reference>
              <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
              <pubmed_id>12067838</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
              <pubmed_id>17161231</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
              <pubmed_id>11315839</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
              <pubmed_id>17659063</pubmed_id>
            </reference>
            <reference>
              <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
              <pubmed_id>17705693</pubmed_id>
            </reference>
            <reference>
              <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
              <pubmed_id>1456422</pubmed_id>
            </reference>
            <reference>
              <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
              <pubmed_id>484160</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
              <pubmed_id>8234346</pubmed_id>
            </reference>
            <reference>
              <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
              <pubmed_id>9591306</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
              <pubmed_id>16966827</pubmed_id>
            </reference>
            <reference>
              <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
              <pubmed_id>7096503</pubmed_id>
            </reference>
            <reference>
              <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
              <pubmed_id>2614280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
              <pubmed_id>18760976</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
              <pubmed_id>11815509</pubmed_id>
            </reference>
            <reference>
              <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
              <pubmed_id>10694785</pubmed_id>
            </reference>
            <reference>
              <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
              <pubmed_id>17919531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
              <pubmed_id>17190852</pubmed_id>
            </reference>
            <reference>
              <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
              <pubmed_id>22031514</pubmed_id>
            </reference>
            <reference>
              <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
              <pubmed_id>23637065</pubmed_id>
            </reference>
            <reference>
              <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Propionic acidemia</name>
          <omim_id>606054</omim_id>
          <references>
            <reference>
              <reference_text>Scholl-Burgi S, Haberlandt E, Gotwald T, Albrecht U, Baumgartner Sigl S, Rauchenzauner M, Rostasy K, Karall D: Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation. Neuropediatrics. 2009 Apr;40(2):76-81. doi: 10.1055/s-0029-1231065. Epub 2009 Oct 6.</reference_text>
              <pubmed_id>19809936</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
            <reference>
              <reference_text>Thompson GN, Chalmers RA, Walter JH, Bresson JL, Lyonnet SL, Reed PJ, Saudubray JM, Leonard JV, Halliday D: The use of metronidazole in management of methylmalonic and propionic acidaemias. Eur J Pediatr. 1990 Aug;149(11):792-6.</reference_text>
              <pubmed_id>2226555</pubmed_id>
            </reference>
            <reference>
              <reference_text>Riemersma M, Hazebroek MR, Helderman-van den Enden ATJM, Salomons GS, Ferdinandusse S, Brouwers MCGJ, van der Ploeg L, Heymans S, Glatz JFC, van den Wijngaard A, Krapels IPC, Bierau J, Brunner HG: Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017 Nov;25(11):1195-1201. doi: 10.1038/ejhg.2017.127. Epub 2017 Aug 30.</reference_text>
              <pubmed_id>28853722</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Maple syrup urine disease</name>
          <omim_id>248600</omim_id>
          <references>
            <reference>
              <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
              <pubmed_id>12101068</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40.</reference_text>
              <pubmed_id>10508118</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schadewaldt P, Hammen HW, Ott AC, Wendel U: Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis. 1999 Aug;22(6):706-22.</reference_text>
              <pubmed_id>10472531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
              <pubmed_id>11978597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Podebrad F, Heil M, Reichert S, Mosandl A, Sewell AC, Bohles H: 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease. J Inherit Metab Dis. 1999 Apr;22(2):107-14.</reference_text>
              <pubmed_id>10234605</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.</reference_text>
              <pubmed_id>6422161</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yunus ZM, Kamaludin DA, Mamat M, Choy YS, Ngu L: Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep. 2012;5:99-107. doi: 10.1007/8904_2011_105. Epub 2011 Dec 11.</reference_text>
              <pubmed_id>23430924</pubmed_id>
            </reference>
            <reference>
              <reference_text>Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR: Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008 Mar;41(4-5):317-24. Epub 2007 Dec 5.</reference_text>
              <pubmed_id>18088602</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C01152</kegg_id>
      <foodb_id>FDB093588</foodb_id>
      <chemspider_id>83153</chemspider_id>
      <drugbank_id>DB04151</drugbank_id>
      <pdb_id/>
      <chebi_id>50599</chebi_id>
      <pubchem_compound_id>92105</pubchem_compound_id>
      <biocyc_id/>
      <wikipedia_id>Methylhistidine</wikipedia_id>
      <knapsack_id/>
      <phenol_explorer_compound_id/>
      <bigg_id/>
      <metlin_id>3741</metlin_id>
      <vmh_id/>
      <fbonto_id/>
      <synthesis_reference>Jain, Rahul; Cohen, Louis A. Regiospecific alkylation of histidine and histamine at N-1 (t).Tetrahedron  (1996),  52(15),  5363-70.</synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Colombani PC, Kovacs E, Frey-Rindova P, Frey W, Langhans W, Arnold M, Wenk C: Metabolic effects of a protein-supplemented carbohydrate drink in marathon runners. Int J Sport Nutr. 1999 Jun;9(2):181-201.</reference_text>
          <pubmed_id>10362454</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811.</reference_text>
          <pubmed_id>7762816</pubmed_id>
        </reference>
        <reference>
          <reference_text>Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol. 2000 Oct 15;152(8):752-5.</reference_text>
          <pubmed_id>11052553</pubmed_id>
        </reference>
        <reference>
          <reference_text>Giesecke K, Magnusson I, Ahlberg M, Hagenfeldt L, Wahren J: Protein and amino acid metabolism during early starvation as reflected by excretion of urea and methylhistidines. Metabolism. 1989 Dec;38(12):1196-200.</reference_text>
          <pubmed_id>2593832</pubmed_id>
        </reference>
        <reference>
          <reference_text>Vranic L, Granic P, Rajic Z: Basic amino acid in the pathogenesis of caries. Acta Stomatol Croat. 1991;25(2):71-6.</reference_text>
          <pubmed_id>1819935</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sjolin J, Stjernstrom H, Henneberg S, Hambraeus L, Friman G: Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios. Am J Clin Nutr. 1989 Jan;49(1):62-70.</reference_text>
          <pubmed_id>2912013</pubmed_id>
        </reference>
        <reference>
          <reference_text>COCKS DH, DENNIS PO, NELSON TH: ISOLATION OF 3-METHYL HISTIDINE FROM WHALEMEAT EXTRACT AND THE PREPARATION OF SOME DERIVATIVES. Nature. 1964 Apr 11;202:184-5.</reference_text>
          <pubmed_id>14156296</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dohm GL, Williams RT, Kasperek GJ, van Rij AM: Increased excretion of urea and N tau -methylhistidine by rats and humans after a bout of exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jan;52(1):27-33.</reference_text>
          <pubmed_id>7061274</pubmed_id>
        </reference>
        <reference>
          <reference_text>Garlick PJ, McNurlan MA, Bark T, Lang CH, Gelato MC: Hormonal regulation of protein metabolism in relation to nutrition and disease. J Nutr. 1998 Feb;128(2 Suppl):356S-359S.</reference_text>
          <pubmed_id>9478024</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
          <pubmed_id>15899597</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dunnett M, Harris RC: High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):47-55.</reference_text>
          <pubmed_id>9029312</pubmed_id>
        </reference>
        <reference>
          <reference_text>Betto P, Ricciarello G, Pichini S, Dello Strologo L, Rizzoni G: High-performance liquid chromatography-electrochemical detection of 3-methylhistidine in human urine. J Chromatogr. 1992 Dec 23;584(2):256-60.</reference_text>
          <pubmed_id>1484110</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00473</protein_accession>
          <name>Beta-Ala-His dipeptidase</name>
          <uniprot_id>Q96KN2</uniprot_id>
          <gene_name>CNDP1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00474</protein_accession>
          <name>Protein arginine N-methyltransferase 3</name>
          <uniprot_id>O60678</uniprot_id>
          <gene_name>PRMT3</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000002</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00002</accession>
        <accession>HMDB0060172</accession>
        <accession>HMDB60172</accession>
      </secondary_accessions>
      <name>1,3-Diaminopropane</name>
      <description>1,3-Diaminopropane, also known as DAP or trimethylenediamine, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing a primary aliphatic amine group. 1,3-Diaminopropane is a stable, flammable, and highly hygroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled, or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1,3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway. 1,3-Diaminopropane has been detected, but not quantified in, several different foods, such as cassava, shiitakes, oyster mushrooms, muscadine grapes, and cinnamons. This could make 1,3-diaminopropane a potential biomarker for the consumption of these foods.</description>
      <synonyms>
        <synonym>1,3-Propanediamine</synonym>
        <synonym>1,3-Propylenediamine</synonym>
        <synonym>Propane-1,3-diamine</synonym>
        <synonym>tn</synonym>
        <synonym>Trimethylenediamine</synonym>
        <synonym>1,3-diamino-N-Propane</synonym>
        <synonym>1,3-Trimethylenediamine</synonym>
        <synonym>3-Aminopropylamine</synonym>
        <synonym>a,W-Propanediamine</synonym>
        <synonym>Trimethylenediamine hydrochloride</synonym>
        <synonym>Trimethylenediamine dihydrochloride</synonym>
        <synonym>1,3-Diaminepropane</synonym>
        <synonym>1,3-Diaminopropane</synonym>
      </synonyms>
      <chemical_formula>C3H10N2</chemical_formula>
      <average_molecular_weight>74.1249</average_molecular_weight>
      <monisotopic_molecular_weight>74.08439833</monisotopic_molecular_weight>
      <iupac_name>propane-1,3-diamine</iupac_name>
      <traditional_iupac>α,ω-propanediamine</traditional_iupac>
      <cas_registry_number>109-76-2</cas_registry_number>
      <smiles>NCCCN</smiles>
      <inchi>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</inchi>
      <inchikey>XFNJVJPLKCPIBV-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing an primary aliphatic amine group.</description>
        <direct_parent>Monoalkylamines</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic nitrogen compounds</super_class>
        <class>Organonitrogen compounds</class>
        <sub_class>Amines</sub_class>
        <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Aliphatic acyclic compound</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Primary aliphatic amine</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>a small molecule</external_descriptor>
          <external_descriptor>alkane-alpha,omega-diamine</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cancer</term>
                      <definition>A group of disorders characterized by the presense of malignant neoplasm.</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Leukemia</term>
                          <definition>A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells. (do).</definition>
                          <parent_id>7696</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Leukaemia</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fabaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Papilionoideae</synonym>
                            <synonym>Legume</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Glycine max</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Soy</synonym>
                            <synonym>Soya</synonym>
                            <synonym>Soybean</synonym>
                            <synonym>Soya bean</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Cucurbitaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Cucurbits</synonym>
                            <synonym>Gourds</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Beta-Alanine Metabolism</term>
                          <definition> these dipeptides are found in protein rich foods such as chicken, beef, pork and fish. beta-alanine can also be formed in the liver from the catabolism of pyrimidine nucleotides which are broken down into uracil and dihydrouracil and then metabolized into beta-alanine and beta-aminoisobutyrate.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Liquid</state>
      <experimental_properties>
        <property>
          <kind>logp</kind>
          <value>-1.43</value>
          <source>HANSCH,C ET AL. (1995)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>-12 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-1.41</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>0.77</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>437 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-1.4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>10.17</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>propane-1,3-diamine</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>74.1249</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>74.08439833</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>NCCCN</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C3H10N2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>XFNJVJPLKCPIBV-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>52.04</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>22.73</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>9.06</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1023</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>3789</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4048</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4740</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::EiMs</type>
          <spectrum_id>1533</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>916</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>934</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>272</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>273</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>274</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>275</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1311</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>3286</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>27666</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>28730</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>28772</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30163</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30249</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30410</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30742</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30942</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>32035</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>32036</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>4</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>5</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2508</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2509</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2510</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2511</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2512</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2513</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2514</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2515</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20192</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20193</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20194</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20441</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20442</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20443</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21743</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21744</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21745</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21992</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21993</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21994</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>445975</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>445976</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Beta-Alanine Metabolism</name>
            <smpdb_id>SMP00007</smpdb_id>
            <kegg_map_id>map00410</kegg_map_id>
          </pathway>
          <pathway>
            <name>Carnosinuria, carnosinemia</name>
            <smpdb_id>SMP00493</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>GABA-Transaminase Deficiency</name>
            <smpdb_id>SMP00351</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Ureidopropionase Deficiency</name>
            <smpdb_id>SMP00492</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.04 +/- 0.03</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Byun JA, Lee SH, Jung BH, Choi MH, Moon MH, Chung BC: Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2008 Jan;22(1):73-80.</reference_text>
              <pubmed_id>17668437</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.16 (0.02-0.69)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>van den Berg GA, Muskiet FA, Kingma AW, van der Slik W, Halie MR: Simultaneous gas-chromatographic determination of free and acetyl-conjugated polyamines in urine. Clin Chem. 1986 Oct;32(10):1930-7.</reference_text>
              <pubmed_id>3757213</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.55 (0.18-5.85)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia. Cancer Lett. 1998 Jan 9;122(1-2):1-8.</reference_text>
              <pubmed_id>9464484</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.015</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guo K, Li L: Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem. 2009 May 15;81(10):3919-32. doi: 10.1021/ac900166a.</reference_text>
              <pubmed_id>19309105</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.2</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.13 +/- 0.13</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Breast cancer </patient_information>
          <references>
            <reference>
              <reference_text>Byun JA, Lee SH, Jung BH, Choi MH, Moon MH, Chung BC: Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2008 Jan;22(1):73-80.</reference_text>
              <pubmed_id>17668437</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.96 (0.12-2.11)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Leukemia</patient_information>
          <comment>Initial stage of leukemia
    </comment>
          <references>
            <reference>
              <reference_text>Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia. Cancer Lett. 1998 Jan 9;122(1-2):1-8.</reference_text>
              <pubmed_id>9464484</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Perillyl alcohol administration for cancer treatment</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Byun JA, Lee SH, Jung BH, Choi MH, Moon MH, Chung BC: Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2008 Jan;22(1):73-80.</reference_text>
              <pubmed_id>17668437</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW: Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin Biochem. 2005 Jan;38(1):24-30.</reference_text>
              <pubmed_id>15607313</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR, Kuller LH: Estrogen metabolites and the risk of breast cancer in older women. Epidemiology. 2003 Nov;14(6):740-4.</reference_text>
              <pubmed_id>14569192</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang Z, Chen H, Chan KK, Budd T, Ganapathi R: Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma. J Chromatogr B Biomed Sci Appl. 1999 May 14;728(1):85-95.</reference_text>
              <pubmed_id>10379660</pubmed_id>
            </reference>
            <reference>
              <reference_text>Grace PB, Mistry NS, Carter MH, Leathem AJ, Teale P: High throughput quantification of phytoestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):138-46. Epub  2007 Mar 18.</reference_text>
              <pubmed_id>17403619</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec  22.</reference_text>
              <pubmed_id>22284503</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
              <pubmed_id>20300169</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lv W, Yang T: Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem. 2012 Jan;45(1-2):127-33. doi: 10.1016/j.clinbiochem.2011.10.011. Epub 2011 Oct 26.</reference_text>
              <pubmed_id>22061338</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
            <reference>
              <reference_text>Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC: Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta. 2009 Feb;400(1-2):63-9. doi: 10.1016/j.cca.2008.10.014. Epub 2008 Oct 30.</reference_text>
              <pubmed_id>19010317</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Leukemia</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia. Cancer Lett. 1998 Jan 9;122(1-2):1-8.</reference_text>
              <pubmed_id>9464484</pubmed_id>
            </reference>
            <reference>
              <reference_text>Curtius HC, Wolfensberger M, Redweik U, Leimbacher W, Maibach RA, Isler W: Mass fragmentography of 5-hydroxytryptophol and 5-methoxytryptophol in human cerebrospinal fluid. J Chromatogr. 1975 Oct 29;112:523-31.</reference_text>
              <pubmed_id>1184685</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.</reference_text>
              <pubmed_id>15911239</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silvennoinen R, Malminiemi K, Malminiemi O, Seppala E, Vilpo J: Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses. Pharmacol Toxicol. 2000 Nov;87(5):223-8.</reference_text>
              <pubmed_id>11129502</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00986</kegg_id>
      <foodb_id>FDB031131</foodb_id>
      <chemspider_id>415</chemspider_id>
      <drugbank_id/>
      <pdb_id/>
      <chebi_id>15725</chebi_id>
      <pubchem_compound_id>428</pubchem_compound_id>
      <biocyc_id>CPD-313</biocyc_id>
      <wikipedia_id>1,3-Diaminopropane</wikipedia_id>
      <knapsack_id>C00007404</knapsack_id>
      <phenol_explorer_compound_id/>
      <bigg_id/>
      <metlin_id/>
      <vmh_id/>
      <fbonto_id/>
      <synthesis_reference>Takayanagi, Yasuyuki; Oohinata, Takahiro.  Preparation of 1,3-diaminopropane from acrylonitrile and ammonia.    Jpn. Kokai Tokkyo Koho  (1994),     5 pp.</synthesis_reference>
      <general_references>
        <reference>
          <reference_text>van den Berg GA, Muskiet FA, Kingma AW, van der Slik W, Halie MR: Simultaneous gas-chromatographic determination of free and acetyl-conjugated polyamines in urine. Clin Chem. 1986 Oct;32(10):1930-7.</reference_text>
          <pubmed_id>3757213</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim KR, Paik MJ, Kim JH, Dong SW, Jeong DH: Rapid gas chromatographic profiling and screening of biologically active amines. J Pharm Biomed Anal. 1997 Jun;15(9-10):1309-18.</reference_text>
          <pubmed_id>9226558</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bremer HJ, Kohne E: The excretion of diamines in human urine. II. Cadaverine, putrescine, 1,3-diaminopropane, 2,2'-dithiobis(ethylamine) and spermidine in urine of patients with cystinuria and cystinlysinuria. Clin Chim Acta. 1971 May;32(3):407-18.</reference_text>
          <pubmed_id>5096953</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fleisher JH, Russell DH: Estimation of urinary diamines and polyamines by thin-layer chromatography. J Chromatogr. 1975 Jul 16;110(2):335-40.</reference_text>
          <pubmed_id>1150841</pubmed_id>
        </reference>
        <reference>
          <reference_text>Blackburn P, Peterson CM: Thiol-disulfide interchange between cystine and N-2-mercaptoethyl-1, 3-diaminopropane as a potential treatment for cystinuria. Anal Biochem. 1984 Jan;136(1):31-8.</reference_text>
          <pubmed_id>6324613</pubmed_id>
        </reference>
        <reference>
          <reference_text>Aigner-Held R, Campbell RA, Daves GD Jr: Polyamine-pyridoxal Schiff bases in urine. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6652-5.</reference_text>
          <pubmed_id>293750</pubmed_id>
        </reference>
        <reference>
          <reference_text>Somayaji VV, Guay V, Peng Z, Sykes TR, Noujaim AA: Synthesis and evaluation of a new bifunctional chelating agent for the preparation of radioimmunoconjugates. Q J Nucl Med. 1995 Dec;39(4):300-10.</reference_text>
          <pubmed_id>8624793</pubmed_id>
        </reference>
        <reference>
          <reference_text>van den Berg GA, Schaaf JM, Nagel GT, Teelken AW, Muskiet FA: Determination of polyamines and metabolites in cerebrospinal fluid by isotope dilution mass fragmentography, and a clinical application. Clin Chim Acta. 1987 Jun 15;165(2-3):147-54.</reference_text>
          <pubmed_id>3308180</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muskiet FA, van den Berg GA, Kingma AW, Fremouw-Ottevangers DC, Halie MR: Total polyamines and their non-alpha-amino acid metabolites simultaneously determined in urine by capillary gas chromatography, with nitrogen-phosphorus detector; and some clinical applications. Clin Chem. 1984 May;30(5):687-95.</reference_text>
          <pubmed_id>6713628</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee SH, Suh JW, Chung BC, Kim SO: Polyamine profiles in the urine of patients with leukemia. Cancer Lett. 1998 Jan 9;122(1-2):1-8.</reference_text>
          <pubmed_id>9464484</pubmed_id>
        </reference>
        <reference>
          <reference_text>Thiele I, Swainston N, Fleming RM, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD, Thorleifsson SG, Agren R, Bolling C, Bordel S, Chavali AK, Dobson P, Dunn WB, Endler L, Hala D, Hucka M, Hull D, Jameson D, Jamshidi N, Jonsson JJ, Juty N, Keating S, Nookaew I, Le Novere N, Malys N, Mazein A, Papin JA, Price ND, Selkov E Sr, Sigurdsson MI, Simeonidis E, Sonnenschein N, Smallbone K, Sorokin A, van Beek JH, Weichart D, Goryanin I, Nielsen J, Westerhoff HV, Kell DB, Mendes P, Palsson BO: A community-driven global reconstruction of human metabolism. Nat Biotechnol. 2013 May;31(5):419-25. doi: 10.1038/nbt.2488. Epub 2013 Mar 3.</reference_text>
          <pubmed_id>23455439</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00217</protein_accession>
          <name>Spermine synthase</name>
          <uniprot_id>P52788</uniprot_id>
          <gene_name>SMS</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00219</protein_accession>
          <name>Deoxyhypusine synthase</name>
          <uniprot_id>P49366</uniprot_id>
          <gene_name>DHPS</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00390</protein_accession>
          <name>Amiloride-sensitive amine oxidase [copper-containing]</name>
          <uniprot_id>P19801</uniprot_id>
          <gene_name>ABP1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00393</protein_accession>
          <name>Membrane primary amine oxidase</name>
          <uniprot_id>Q16853</uniprot_id>
          <gene_name>AOC3</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00394</protein_accession>
          <name>Retina-specific copper amine oxidase</name>
          <uniprot_id>O75106</uniprot_id>
          <gene_name>AOC2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00420</protein_accession>
          <name>S-adenosylmethionine decarboxylase proenzyme</name>
          <uniprot_id>P17707</uniprot_id>
          <gene_name>AMD1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01034</protein_accession>
          <name>Ornithine decarboxylase</name>
          <uniprot_id>P11926</uniprot_id>
          <gene_name>ODC1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-27 20:29:42 UTC</update_date>
      <accession>HMDB0000005</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00005</accession>
        <accession>HMDB0006544</accession>
        <accession>HMDB06544</accession>
      </secondary_accessions>
      <name>2-Ketobutyric acid</name>
      <description>2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine.</description>
      <synonyms>
        <synonym>2-Ketobutanoic acid</synonym>
        <synonym>2-Oxobutyric acid</synonym>
        <synonym>3-Methyl pyruvic acid</synonym>
        <synonym>alpha-Ketobutyrate</synonym>
        <synonym>alpha-Ketobutyric acid</synonym>
        <synonym>alpha-oxo-N-Butyric acid</synonym>
        <synonym>2-Oxobutyrate</synonym>
        <synonym>2-Oxobutanoic acid</synonym>
        <synonym>2-Ketobutanoate</synonym>
        <synonym>3-Methyl pyruvate</synonym>
        <synonym>a-Ketobutyrate</synonym>
        <synonym>a-Ketobutyric acid</synonym>
        <synonym>Α-ketobutyrate</synonym>
        <synonym>Α-ketobutyric acid</synonym>
        <synonym>a-oxo-N-Butyrate</synonym>
        <synonym>a-oxo-N-Butyric acid</synonym>
        <synonym>alpha-oxo-N-Butyrate</synonym>
        <synonym>Α-oxo-N-butyrate</synonym>
        <synonym>Α-oxo-N-butyric acid</synonym>
        <synonym>2-Oxobutanoate</synonym>
        <synonym>2-Ketobutyrate</synonym>
        <synonym>2-oxo-Butanoate</synonym>
        <synonym>2-oxo-Butanoic acid</synonym>
        <synonym>2-oxo-Butyrate</synonym>
        <synonym>2-oxo-Butyric acid</synonym>
        <synonym>2-oxo-N-Butyrate</synonym>
        <synonym>2-oxo-N-Butyric acid</synonym>
        <synonym>3-Methylpyruvate</synonym>
        <synonym>3-Methylpyruvic acid</synonym>
        <synonym>a-Keto-N-butyrate</synonym>
        <synonym>a-Keto-N-butyric acid</synonym>
        <synonym>a-Oxobutyrate</synonym>
        <synonym>a-Oxobutyric acid</synonym>
        <synonym>alpha-Keto-N-butyrate</synonym>
        <synonym>alpha-Keto-N-butyric acid</synonym>
        <synonym>alpha-Ketobutric acid</synonym>
        <synonym>alpha-Oxobutyrate</synonym>
        <synonym>alpha-Oxobutyric acid</synonym>
        <synonym>Methyl-pyruvate</synonym>
        <synonym>Methyl-pyruvic acid</synonym>
        <synonym>Propionyl-formate</synonym>
        <synonym>Propionyl-formic acid</synonym>
        <synonym>alpha-Ketobutyric acid, sodium salt</synonym>
        <synonym>2-Ketobutyric acid</synonym>
      </synonyms>
      <chemical_formula>C4H6O3</chemical_formula>
      <average_molecular_weight>102.0886</average_molecular_weight>
      <monisotopic_molecular_weight>102.031694058</monisotopic_molecular_weight>
      <iupac_name>2-oxobutanoic acid</iupac_name>
      <traditional_iupac>2-oxobutanoic acid</traditional_iupac>
      <cas_registry_number>600-18-0</cas_registry_number>
      <smiles>CCC(=O)C(O)=O</smiles>
      <inchi>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</inchi>
      <inchikey>TYEYBOSBBBHJIV-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms.</description>
        <direct_parent>Short-chain keto acids and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Keto acids and derivatives</class>
        <sub_class>Short-chain keto acids and derivatives</sub_class>
        <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Alpha-hydroxy ketones</alternative_parent>
          <alternative_parent>Alpha-keto acids and derivatives</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Aliphatic acyclic compound</substituent>
          <substituent>Alpha-hydroxy ketone</substituent>
          <substituent>Alpha-keto acid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Ketone</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Short-chain keto acid</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>2-oxo monocarboxylic acid</external_descriptor>
          <external_descriptor>Oxo fatty acids</external_descriptor>
          <external_descriptor>Oxo fatty acids</external_descriptor>
          <external_descriptor>short-chain fatty acid</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fabaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Papilionoideae</synonym>
                            <synonym>Legume</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Glycine max</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Soy</synonym>
                            <synonym>Soya</synonym>
                            <synonym>Soybean</synonym>
                            <synonym>Soya bean</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Cucurbitaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Cucurbits</synonym>
                            <synonym>Gourds</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Glycine and Serine Metabolism</term>
                          <definition> all of these compounds share common intermediates and almost all can be biosynthesized from one another. serine and glycine are not essential amino acids and can be synthesized from a number of routes.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Homocysteine Degradation</term>
                          <definition> in mammals, homocysteine is used to biosynthesize cysteine via the following pathway. first the enzyme cystathionine beta-synthetase irreversibly condenses homocysteine with l-serine, forming l-cystathionine.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Methionine Metabolism</term>
                          <definition> these pathways share 3 common reactions with both including the conversion of methionine to s-adenosylmethionine (sam),the utilization of sam in diverse transmethylation reactions yielding a methylated product plus s-adenosylhomocysteine, and the cleavage of s-adenosylhomocysteine to yield homocysteine and adenosine. the transulfuration reactions that produce cysteine from homocysteine and serine also produce α-ketobutyrate, the latter being converted first to propionyl-coa and then via a 3-step process to succinyl-coa.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Propanoate Metabolism</term>
                          <definition> alternatively, propionyl-coa results from the oxidative decarboxylation of 2-ketobutyric acid. this reaction is mediated by a large, multienzyme complex such as the branched-chain alpha-keto acid dehydrogenase complex.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Selenoamino Acid Metabolism</term>
                          <definition> these include selenocysteine, selenohomocysteine and selenomethionine. selenium and sulfur are chalcogen elements that share many chemical properties and so the substitution of normal (sulfur-containing) amino acids with selenoamino acids has little effect on protein structure and function.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Threonine and 2-Oxobutanoate Degradation</term>
                          <definition> in humans, threonine is converted to 2-oxobutanoate via serine dehydratase, and thereby enters the pathway leading to succinyl-coa. this is the major route for threonine degradation in humans.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>119 mg/mL</value>
          <source/>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>33 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>0.07</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-0.11</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>79.2 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>0.77</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>3.19</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-9.7</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>2-oxobutanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>102.0886</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>102.031694058</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>CCC(=O)C(O)=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C4H6O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>TYEYBOSBBBHJIV-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>54.37</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>22.62</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>9.2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>917</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1024</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4754</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4755</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>7</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>8</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>9</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2522</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20636</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20637</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20638</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>22187</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>22188</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>22189</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439247</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>276</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>277</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>936</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>937</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>943</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>3474</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30041</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30042</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30433</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30434</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30943</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30944</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30945</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>31982</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>31983</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37238</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>3-Phosphoglycerate dehydrogenase deficiency</name>
            <smpdb_id>SMP00721</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Cystathionine Beta-Synthase Deficiency</name>
            <smpdb_id>SMP00177</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dihydropyrimidine Dehydrogenase Deficiency (DHPD)</name>
            <smpdb_id>SMP00179</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dimethylglycine Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00242</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dimethylglycine Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00484</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Gamma-cystathionase deficiency (CTH)</name>
            <smpdb_id>SMP00514</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Glycine and Serine Metabolism</name>
            <smpdb_id>SMP00004</smpdb_id>
            <kegg_map_id>map00260</kegg_map_id>
          </pathway>
          <pathway>
            <name>Glycine N-methyltransferase Deficiency</name>
            <smpdb_id>SMP00222</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Homocysteine Degradation</name>
            <smpdb_id>SMP00455</smpdb_id>
            <kegg_map_id></kegg_map_id>
          </pathway>
          <pathway>
            <name>Homocystinuria, cystathionine beta-synthase deficiency</name>
            <smpdb_id>SMP00515</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type</name>
            <smpdb_id>SMP00570</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Hyperglycinemia, non-ketotic</name>
            <smpdb_id>SMP00485</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Hypermethioninemia</name>
            <smpdb_id>SMP00341</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Malonic Aciduria</name>
            <smpdb_id>SMP00198</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Malonyl-coa decarboxylase deficiency</name>
            <smpdb_id>SMP00502</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methionine Adenosyltransferase Deficiency</name>
            <smpdb_id>SMP00221</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methionine Metabolism</name>
            <smpdb_id>SMP00033</smpdb_id>
            <kegg_map_id>map00270</kegg_map_id>
          </pathway>
          <pathway>
            <name>Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)</name>
            <smpdb_id>SMP00340</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
            <smpdb_id>SMP00201</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Non Ketotic Hyperglycinemia</name>
            <smpdb_id>SMP00223</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Propanoate Metabolism</name>
            <smpdb_id>SMP00016</smpdb_id>
            <kegg_map_id>map00640</kegg_map_id>
          </pathway>
          <pathway>
            <name>S-Adenosylhomocysteine (SAH) Hydrolase Deficiency</name>
            <smpdb_id>SMP00214</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Sarcosinemia</name>
            <smpdb_id>SMP00244</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Selenoamino Acid Metabolism</name>
            <smpdb_id>SMP00029</smpdb_id>
            <kegg_map_id>map00450</kegg_map_id>
          </pathway>
          <pathway>
            <name>Threonine and 2-Oxobutanoate Degradation</name>
            <smpdb_id>SMP00452</smpdb_id>
            <kegg_map_id></kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>3.33 +/- 5.00</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Yang W, Roth KS: Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta. 1985 Jan 30;145(2):173-82.</reference_text>
              <pubmed_id>3918815</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>9.4 (3.4-15.4)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
              <pubmed_id>9869358</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>8.6 (6.0-11.2)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Rocchiccioli F, Leroux JP, Cartier PH: Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectrometry; application to pediatrics. Biomed Mass Spectrom. 1984 Jan;11(1):24-8.</reference_text>
              <pubmed_id>6704500</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>4.8 (3.4-6.2)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Rocchiccioli F, Leroux JP, Cartier PH: Microdetermination of 2-ketoglutaric acid in plasma and cerebrospinal fluid by capillary gas chromatography mass spectrometry; application to pediatrics. Biomed Mass Spectrom. 1984 Jan;11(1):24-8.</reference_text>
              <pubmed_id>6704500</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.0412 +/- 0.214</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=27)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>2.62 +/- 4.13</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI ≥ 21.00 kg/m2 (n=22)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>4.06 +/- 8.39</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=24)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>4.12 +/- 4.41</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI &lt; 21.00 kg/m2 (n=45)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.39 (0.05-2.2)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
              <pubmed_id>9869358</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.13 (0.04-0.51)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
              <pubmed_id>9869358</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Urine compound detected by GC-MS</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>9.476 +/- 6.626</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.9 (0.7-5.4)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.6 (1.1-4.1) </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ.  Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy.  Metabolomics.  2009</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-50</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
          <references>
            <reference>
              <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
              <pubmed_id>31506554</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>6.564 +/- 7.802</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00109</kegg_id>
      <foodb_id>FDB030356</foodb_id>
      <chemspider_id>57</chemspider_id>
      <drugbank_id>DB04553</drugbank_id>
      <pdb_id/>
      <chebi_id>30831</chebi_id>
      <pubchem_compound_id>58</pubchem_compound_id>
      <biocyc_id>2-OXOBUTANOATE</biocyc_id>
      <wikipedia_id>Alpha-Ketobutyric_acid</wikipedia_id>
      <knapsack_id>C00019675</knapsack_id>
      <phenol_explorer_compound_id/>
      <bigg_id>33889</bigg_id>
      <metlin_id/>
      <vmh_id>2OBUT</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Figge, Rainer; Lux, Fabien; Raynaud, Celine; Soucaille, Philippe. Production of a-ketobutyrate by engineered Escherichia coli.PCT Int. Appl.  (2006), 31pp.  </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Sprague CL, Elfarra AA: Detection of carboxylic acids and inhibition of hippuric acid formation in rats treated with 3-butene-1,2-diol, a major metabolite of 1,3-butadiene. Drug Metab Dispos. 2003 Aug;31(8):986-92.</reference_text>
          <pubmed_id>12867486</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yaegaki K, Sanada K: Biochemical and clinical factors influencing oral malodor in periodontal patients. J Periodontol. 1992 Sep;63(9):783-9.</reference_text>
          <pubmed_id>1474480</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yaegaki K, Sanada K: Effects of a two-phase oil-water mouthwash on halitosis. Clin Prev Dent. 1992 Jan-Feb;14(1):5-9.</reference_text>
          <pubmed_id>1499240</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yang W, Roth KS: Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta. 1985 Jan 30;145(2):173-82.</reference_text>
          <pubmed_id>3918815</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00012</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit beta, mitochondrial</name>
          <uniprot_id>P11177</uniprot_id>
          <gene_name>PDHB</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00046</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial</name>
          <uniprot_id>P08559</uniprot_id>
          <gene_name>PDHA1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00050</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial</name>
          <uniprot_id>P29803</uniprot_id>
          <gene_name>PDHA2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00299</protein_accession>
          <name>2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</name>
          <uniprot_id>P21953</uniprot_id>
          <gene_name>BCKDHB</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00300</protein_accession>
          <name>2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial</name>
          <uniprot_id>P12694</uniprot_id>
          <gene_name>BCKDHA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00439</protein_accession>
          <name>2-oxoglutarate dehydrogenase, mitochondrial</name>
          <uniprot_id>Q02218</uniprot_id>
          <gene_name>OGDH</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00538</protein_accession>
          <name>Cystathionine gamma-lyase</name>
          <uniprot_id>P32929</uniprot_id>
          <gene_name>CTH</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00671</protein_accession>
          <name>L-serine dehydratase/L-threonine deaminase</name>
          <uniprot_id>P20132</uniprot_id>
          <gene_name>SDS</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00893</protein_accession>
          <name>L-lactate dehydrogenase A-like 6A</name>
          <uniprot_id>Q6ZMR3</uniprot_id>
          <gene_name>LDHAL6A</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00914</protein_accession>
          <name>Urocanate hydratase</name>
          <uniprot_id>Q96N76</uniprot_id>
          <gene_name>UROC1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01493</protein_accession>
          <name>[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial</name>
          <uniprot_id>O14874</uniprot_id>
          <gene_name>BCKDK</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03577</protein_accession>
          <name>L-lactate dehydrogenase B chain</name>
          <uniprot_id>P07195</uniprot_id>
          <gene_name>LDHB</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03578</protein_accession>
          <name>L-lactate dehydrogenase C chain</name>
          <uniprot_id>P07864</uniprot_id>
          <gene_name>LDHC</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03579</protein_accession>
          <name>L-lactate dehydrogenase A chain</name>
          <uniprot_id>P00338</uniprot_id>
          <gene_name>LDHA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03581</protein_accession>
          <name>L-lactate dehydrogenase A-like 6B</name>
          <uniprot_id>Q9BYZ2</uniprot_id>
          <gene_name>LDHAL6B</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03654</protein_accession>
          <name>Trimethyllysine dioxygenase, mitochondrial</name>
          <uniprot_id>Q9NVH6</uniprot_id>
          <gene_name>TMLHE</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP08668</protein_accession>
          <name>Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2</name>
          <uniprot_id>Q6NS38</uniprot_id>
          <gene_name>ALKBH2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP08669</protein_accession>
          <name>Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3</name>
          <uniprot_id>Q96Q83</uniprot_id>
          <gene_name>ALKBH3</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP08972</protein_accession>
          <name>Serine dehydratase-like</name>
          <uniprot_id>Q96GA7</uniprot_id>
          <gene_name>SDSL</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09100</protein_accession>
          <name>2-oxoglutarate dehydrogenase-like, mitochondrial</name>
          <uniprot_id>Q9ULD0</uniprot_id>
          <gene_name>OGDHL</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09101</protein_accession>
          <name>2-oxoglutarate receptor 1</name>
          <uniprot_id>Q96P68</uniprot_id>
          <gene_name>OXGR1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-06-15 17:04:51 UTC</update_date>
      <accession>HMDB0000008</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00008</accession>
      </secondary_accessions>
      <name>2-Hydroxybutyric acid</name>
      <description>2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as "cerebral" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632).</description>
      <synonyms>
        <synonym>(S)-2-Hydroxybutanoic acid</synonym>
        <synonym>2-Hydroxybutyrate</synonym>
        <synonym>2-Hydroxybutyric acid</synonym>
        <synonym>L-2-Hydroxybutanoic acid</synonym>
        <synonym>L-2-Hydroxybutyric acid</synonym>
        <synonym>L-alpha-Hydroxybutanoic acid</synonym>
        <synonym>L-alpha-Hydroxybutyric acid</synonym>
        <synonym>(S)-2-Hydroxybutanoate</synonym>
        <synonym>L-2-Hydroxybutanoate</synonym>
        <synonym>L-2-Hydroxybutyrate</synonym>
        <synonym>L-a-Hydroxybutanoate</synonym>
        <synonym>L-a-Hydroxybutanoic acid</synonym>
        <synonym>L-alpha-Hydroxybutanoate</synonym>
        <synonym>L-Α-hydroxybutanoate</synonym>
        <synonym>L-Α-hydroxybutanoic acid</synonym>
        <synonym>L-a-Hydroxybutyrate</synonym>
        <synonym>L-a-Hydroxybutyric acid</synonym>
        <synonym>L-alpha-Hydroxybutyrate</synonym>
        <synonym>L-Α-hydroxybutyrate</synonym>
        <synonym>L-Α-hydroxybutyric acid</synonym>
        <synonym>(S)-2-Hydroxybutyrate</synonym>
        <synonym>2-Hydroxybutanoate</synonym>
        <synonym>(+)-2-Hydroxy-n-butyric acid</synonym>
        <synonym>(+)-2-Hydroxybutanoic acid</synonym>
        <synonym>(+)-2-Hydroxybutyric acid</synonym>
        <synonym>(+)-alpha-Hydroxybutyric acid</synonym>
        <synonym>(+)-α-Hydroxybutyric acid</synonym>
        <synonym>(2S)-2-Hydroxybutanoic acid</synonym>
        <synonym>(S)-(+)-2-Hydroxybutanoic acid</synonym>
        <synonym>(S)-2-Hydroxybutyric acid</synonym>
        <synonym>2-Hydroxybutanoic acid</synonym>
        <synonym>alpha-Hydroxy-n-butyric acid</synonym>
        <synonym>alpha-Hydroxybutanoic acid</synonym>
        <synonym>alpha-Hydroxybutyric acid</synonym>
        <synonym>α-Hydroxy-n-butyric acid</synonym>
        <synonym>α-Hydroxybutanoic acid</synonym>
        <synonym>α-Hydroxybutyric acid</synonym>
      </synonyms>
      <chemical_formula>C4H8O3</chemical_formula>
      <average_molecular_weight>104.105</average_molecular_weight>
      <monisotopic_molecular_weight>104.047344118</monisotopic_molecular_weight>
      <iupac_name>(2S)-2-hydroxybutanoic acid</iupac_name>
      <traditional_iupac>(S)-2-hydroxybutyric acid</traditional_iupac>
      <cas_registry_number>3347-90-8</cas_registry_number>
      <smiles>CC[C@H](O)C(O)=O</smiles>
      <inchi>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1</inchi>
      <inchikey>AFENDNXGAFYKQO-VKHMYHEASA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as alpha hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon.</description>
        <direct_parent>Alpha hydroxy acids and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Hydroxy acids and derivatives</class>
        <sub_class>Alpha hydroxy acids and derivatives</sub_class>
        <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Carbonyl compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Fatty acids and conjugates</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Secondary alcohols</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alcohol</substituent>
          <substituent>Aliphatic acyclic compound</substituent>
          <substituent>Alpha-hydroxy acid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Fatty acid</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Secondary alcohol</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>2-hydroxybutyric acid</external_descriptor>
          <external_descriptor>Hydroxy fatty acids</external_descriptor>
          <external_descriptor>Hydroxy fatty acids</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Schizophrenia</term>
                      <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Pyruvate dehydrogenase deficiency</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Pdh</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Prostate</term>
                      <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Prostate gland</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Sweat</term>
                      <definition>Secretion produced by a sweat gland.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Propanoate Metabolism</term>
                          <definition> alternatively, propionyl-coa results from the oxidative decarboxylation of 2-ketobutyric acid. this reaction is mediated by a large, multienzyme complex such as the branched-chain alpha-keto acid dehydrogenase complex.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Biological role</term>
              <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Metabolite</term>
                  <definition>A chemical substance produced during metabolism process, as an intermediate or end-product.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>melting_point</kind>
          <value>44.2 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-0.16</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>0.67</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>484 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>0.051</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>3.99</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-3.8</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(2S)-2-hydroxybutanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>104.105</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>104.047344118</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>CC[C@H](O)C(O)=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C4H8O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>AFENDNXGAFYKQO-VKHMYHEASA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>57.53</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>23.36</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>9.98</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>2063</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102797</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102798</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102799</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102800</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102801</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102802</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>102803</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1250182</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1250183</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1250184</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1365478</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1365479</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1365480</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448541</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448542</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448543</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448544</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448545</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1448546</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>5245</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>5246</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Extracellular</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Sweat</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Placenta</tissue>
          <tissue>Prostate</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Malonic Aciduria</name>
            <smpdb_id>SMP00198</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Malonyl-coa decarboxylase deficiency</name>
            <smpdb_id>SMP00502</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
            <smpdb_id>SMP00201</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Propanoate Metabolism</name>
            <smpdb_id>SMP00016</smpdb_id>
            <kegg_map_id>map00640</kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>8.00-80.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Molecular You: https://molecularyou.com</reference_text>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>26.9(32.92)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
              <pubmed_id>26010610</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>8.00-80.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With wine consumption. Female twins. Healthy condition not specified, assume it is healthy</comment>
          <references>
            <reference>
              <reference_text>Pallister T, Jennings A, Mohney RP, Yarand D, Mangino M, Cassidy A, MacGregor A, Spector TD, Menni C: Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins. PLoS One. 2016 Jun 29;11(6):e0158568. doi: 10.1371/journal.pone.0158568. eCollection 2016.</reference_text>
              <pubmed_id>27355821</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>54.0 (8.0-80.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>40.0 +/- 24.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
              <pubmed_id>18502700</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>85.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
              <pubmed_id>18502700</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>37 +/- 21 (10 - 76)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Seppel CK, Holmes B, Mitchell L, Christen HJ, Hanefeld F, Rating D, Nyhan WL: Quantitative organic acid analysis in cerebrospinal fluid and plasma: reference values in a pediatric population. J Chromatogr. 1993 Jul 23;617(1):1-10.</reference_text>
              <pubmed_id>8376520</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>35.0 +/- 24.0 </concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>10.42 +/- 9.20</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Sweat</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult </subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Delgado-Povedano MM, Calderon-Santiago M, Priego-Capote F, Luque de Castro MD: Development of a method for enhancing metabolomics coverage of human sweat by gas chromatography-mass spectrometry in high resolution mode. Anal Chim Acta. 2016 Jan 28;905:115-25. doi: 10.1016/j.aca.2015.11.048. Epub 2015 Dec 17.</reference_text>
              <pubmed_id>26755145</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.31-0.69 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.445 (0-4.89)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Landaas S, Pettersen JE: Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid. Scand J Clin Lab Invest. 1975 May;35(3):259-66.</reference_text>
              <pubmed_id>168632</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC/MS. Samples were collected from infants of 1-6 months old</comment>
          <references>
            <reference>
              <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
              <pubmed_id>31963255</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-6.0</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC/MS. Samples were collected from infants of 7-12 months old</comment>
          <references>
            <reference>
              <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
              <pubmed_id>31963255</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-6.1</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC/MS. Samples were collected from infants of 1-6 months old</comment>
          <references>
            <reference>
              <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
              <pubmed_id>31963255</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-9.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC/MS. Samples were collected from infants of 7-12 months old</comment>
          <references>
            <reference>
              <reference_text>Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, Dore S, Franconi F, Campesi I: Influence of Sex on Urinary Organic Acids: A Cross-Sectional Study in Children. Int J Mol Sci. 2020 Jan 16;21(2). pii: ijms21020582. doi: 10.3390/ijms21020582.</reference_text>
              <pubmed_id>31963255</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.29 +/- 3.529</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.8 (1.2-6.9)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.0 (0.0-10.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.26-0.53 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>26.96 +/- 13.11 </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
          <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>16.93 +/- 8.17</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>21.4 (5.6) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Early preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>19.5 (7.4) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <references>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>17.13 (7.48) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>16.69 (6.25) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>28.0 (14.4) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Late-onset preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>4.14(10.18)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Heart failure with reduced ejection fraction</patient_information>
          <references>
            <reference>
              <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
              <pubmed_id>26010610</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>21.2 (7.5) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>23.1 (14.1) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Down syndrome pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>15.0 (7.4) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>7.26 +/- 4.47</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Alzheimer's disease</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>7.30 +/- 1.32</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Frontotemporal lobe dementia</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>8.12 +/- 5.32</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Lewy body disease</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&gt;25.0</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Pyruvate dehydrogenase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>OMIM 238331</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>8.699 +/- 10.366</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>248.732</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Dihydrolipoamide Dehydrogenase Deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I: Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta. 1983 Sep 30;133(2):133-40.</reference_text>
              <pubmed_id>6688766</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal adenoma </patient_information>
          <comment>With shellfish consumption</comment>
          <references>
            <reference>
              <reference_text>Playdon MC, Sampson JN, Cross AJ, Sinha R, Guertin KA, Moy KA, Rothman N, Irwin ML, Mayne ST, Stolzenberg-Solomon R, Moore SC: Comparing metabolite profiles of habitual diet in serum and urine. Am J Clin Nutr. 2016 Sep;104(3):776-89. doi: 10.3945/ajcn.116.135301. Epub 2016 Aug 10.</reference_text>
              <pubmed_id>27510537</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Schizophrenia</name>
          <omim_id>181500</omim_id>
          <references>
            <reference>
              <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
              <pubmed_id>115032</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
            <reference>
              <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
              <pubmed_id>2480613</pubmed_id>
            </reference>
            <reference>
              <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
              <pubmed_id>17276036</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
              <pubmed_id>11877547</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
              <pubmed_id>12796220</pubmed_id>
            </reference>
            <reference>
              <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
              <pubmed_id>7595563</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
              <pubmed_id>20814316</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
              <pubmed_id>25004141</pubmed_id>
            </reference>
            <reference>
              <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
              <pubmed_id>24713860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
              <pubmed_id>23823132</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
              <pubmed_id>2415198</pubmed_id>
            </reference>
            <reference>
              <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
              <pubmed_id>1694425</pubmed_id>
            </reference>
            <reference>
              <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
              <pubmed_id>7711000</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
              <pubmed_id>19390223</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
            <reference>
              <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
              <pubmed_id>22007635</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
              <pubmed_id>21483431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
              <pubmed_id>3741918</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
              <pubmed_id>11979513</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
              <pubmed_id>20206656</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
              <pubmed_id>436860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19401681</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
              <pubmed_id>6184954</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
              <pubmed_id>26952797</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
              <pubmed_id>22800120</pubmed_id>
            </reference>
            <reference>
              <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
              <pubmed_id>24789758</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
              <pubmed_id>22944140</pubmed_id>
            </reference>
            <reference>
              <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
              <pubmed_id>22892715</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
              <pubmed_id>17440431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
              <pubmed_id>25729574</pubmed_id>
            </reference>
            <reference>
              <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
              <pubmed_id>22257447</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Early preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pregnancy</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
              <pubmed_id>3252730</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
              <pubmed_id>663967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
              <pubmed_id>12833386</pubmed_id>
            </reference>
            <reference>
              <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
              <pubmed_id>2994907</pubmed_id>
            </reference>
            <reference>
              <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
              <pubmed_id>17704099</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
              <pubmed_id>12698507</pubmed_id>
            </reference>
            <reference>
              <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
              <pubmed_id>17061063</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
              <pubmed_id>16925883</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
              <pubmed_id>22420377</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
              <pubmed_id>18059417</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
            <reference>
              <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Late-onset preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Alzheimer's disease</name>
          <omim_id>104300</omim_id>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
            <reference>
              <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
              <pubmed_id>11959400</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
              <pubmed_id>8595727</pubmed_id>
            </reference>
            <reference>
              <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
              <pubmed_id>15361288</pubmed_id>
            </reference>
            <reference>
              <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
              <pubmed_id>9693263</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
              <pubmed_id>15465626</pubmed_id>
            </reference>
            <reference>
              <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
              <pubmed_id>15061359</pubmed_id>
            </reference>
            <reference>
              <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
              <pubmed_id>10494443</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
              <pubmed_id>11255442</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
              <pubmed_id>12498967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
              <pubmed_id>16227558</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
              <pubmed_id>9720975</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
              <pubmed_id>12111441</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
              <pubmed_id>16244393</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
              <pubmed_id>8356878</pubmed_id>
            </reference>
            <reference>
              <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
              <pubmed_id>12391605</pubmed_id>
            </reference>
            <reference>
              <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
              <pubmed_id>8478958</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
              <pubmed_id>21292280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
              <pubmed_id>20858978</pubmed_id>
            </reference>
            <reference>
              <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
              <pubmed_id>21474939</pubmed_id>
            </reference>
            <reference>
              <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
              <pubmed_id>20523031</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
              <pubmed_id>11314776</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
              <pubmed_id>1716470</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Frontotemporal dementia</name>
          <omim_id>600274</omim_id>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Lewy body disease</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pyruvate dehydrogenase deficiency</name>
          <omim_id>312170</omim_id>
          <references>
            <reference>
              <reference_text>Patel KP, O'Brien TW, Subramony SH, Shuster J, Stacpoole PW: The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab. 2012 Jan;105(1):34-43. doi: 10.1016/j.ymgme.2011.09.032. Epub 2011 Oct 7.</reference_text>
              <pubmed_id>22079328</pubmed_id>
            </reference>
            <reference>
              <reference_text>OMIM 238331</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Dihydrolipoamide Dehydrogenase Deficiency</name>
          <omim_id>246900</omim_id>
          <references>
            <reference>
              <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
              <pubmed_id>11978597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I: Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta. 1983 Sep 30;133(2):133-40.</reference_text>
              <pubmed_id>6688766</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB021867</foodb_id>
      <kegg_id>C05984</kegg_id>
      <chemspider_id>389701</chemspider_id>
      <chebi_id>50613</chebi_id>
      <pubchem_compound_id>440864</pubchem_compound_id>
      <pdb_id/>
      <biocyc_id>CPD-3564</biocyc_id>
      <drugbank_id/>
      <phenol_explorer_compound_id/>
      <wikipedia_id>2-Hydroxybutyric_acid</wikipedia_id>
      <knapsack_id/>
      <bigg_id/>
      <metlin_id/>
      <vmh_id/>
      <synthesis_reference>Carlier, J. P.; Henry, C.; Lorin, V.; Rouffignat, K. Conversion of DL-threonine, D-threonine and 2-oxobutyrate into propionate and 2-hydroxybutyrate by Fusobacterium species. Letters in Applied Microbiology  (1997),  25(5),  371-374.  </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Sweatman BC, Farrant RD, Holmes E, Ghauri FY, Nicholson JK, Lindon JC: 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal. 1993 Aug;11(8):651-64.</reference_text>
          <pubmed_id>8257730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Landaas S, Pettersen JE: Clinical conditions associated with urinary excretion of 2-hydroxybutyric acid. Scand J Clin Lab Invest. 1975 May;35(3):259-66.</reference_text>
          <pubmed_id>168632</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
          <pubmed_id>19212411</pubmed_id>
        </reference>
        <reference>
          <reference_text>Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, Yu Y, Xu G: Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009 Feb 9;633(2):257-62. doi: 10.1016/j.aca.2008.11.058. Epub 2008 Dec 3.</reference_text>
          <pubmed_id>19166731</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E: alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010 May 28;5(5):e10883. doi: 10.1371/journal.pone.0010883.</reference_text>
          <pubmed_id>20526369</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
        <reference>
          <reference_text>Aldrich Library of FT-IR Spectra, 1st edn., 1985, 1, 548D</reference_text>
        </reference>
        <reference>
          <reference_text>Mori, K. et al., Tetrahedron, 1979, 35, 1601</reference_text>
        </reference>
        <reference>
          <reference_text>Levene, P.A. et al., J. Biol. Chem., 1941, 141, 391</reference_text>
        </reference>
        <reference>
          <reference_text>Duvillier, E., Ann. Chim. Phys., 1879, 17, 532</reference_text>
        </reference>
        <reference>
          <reference_text>Chenault, H.K. et al., J.O.C., 1987, 52, 2608</reference_text>
        </reference>
        <reference>
          <reference_text>Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 1, 854B</reference_text>
        </reference>
        <reference>
          <reference_text>Horn, D.H.S. et al., J.C.S., 1954, 1460</reference_text>
        </reference>
        <reference>
          <reference_text>Wong, C.H. et al., J.O.C., 1985, 50, 1992</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00054</protein_accession>
          <name>Dihydrolipoyl dehydrogenase, mitochondrial</name>
          <uniprot_id>P09622</uniprot_id>
          <gene_name>DLD</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00355</protein_accession>
          <name>Sulfotransferase family cytosolic 2B member 1</name>
          <uniprot_id>O00204</uniprot_id>
          <gene_name>SULT2B1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00483</protein_accession>
          <name>UDP-glucuronosyltransferase 1-1</name>
          <uniprot_id>P22309</uniprot_id>
          <gene_name>UGT1A1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00893</protein_accession>
          <name>L-lactate dehydrogenase A-like 6A</name>
          <uniprot_id>Q6ZMR3</uniprot_id>
          <gene_name>LDHAL6A</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03577</protein_accession>
          <name>L-lactate dehydrogenase B chain</name>
          <uniprot_id>P07195</uniprot_id>
          <gene_name>LDHB</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03578</protein_accession>
          <name>L-lactate dehydrogenase C chain</name>
          <uniprot_id>P07864</uniprot_id>
          <gene_name>LDHC</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03579</protein_accession>
          <name>L-lactate dehydrogenase A chain</name>
          <uniprot_id>P00338</uniprot_id>
          <gene_name>LDHA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03581</protein_accession>
          <name>L-lactate dehydrogenase A-like 6B</name>
          <uniprot_id>Q9BYZ2</uniprot_id>
          <gene_name>LDHAL6B</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000010</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00010</accession>
        <accession>HMDB0004990</accession>
        <accession>HMDB0004991</accession>
        <accession>HMDB04990</accession>
        <accession>HMDB04991</accession>
      </secondary_accessions>
      <name>2-Methoxyestrone</name>
      <description>2-Methoxyestrone belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid lipid molecule. 2-Methoxyestrone is a steroid derivative that is a byproduct of estrone and 2-hydroxyestrone metabolism. It is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone is 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17).</description>
      <synonyms>
        <synonym>2-(8S,9S,13S,14S)-3-Hydroxy-2-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one</synonym>
        <synonym>2-Hydroxyestrone 2-methyl ether</synonym>
        <synonym>2-Methoxy-17-oxoestra-1,3,5(10)-trien-3-ol</synonym>
        <synonym>2-Methoxy-3-hydroxyestra-1,3,5(10)-trien-17-one</synonym>
        <synonym>3-Hydroxy-2-methoxy-estra-1,3,5(10)-trien-17-one</synonym>
        <synonym>3-Hydroxy-2-methoxyestra-1,3,5(10)-trien-17-one</synonym>
        <synonym>Methoxy-estrone</synonym>
      </synonyms>
      <chemical_formula>C19H24O3</chemical_formula>
      <average_molecular_weight>300.3921</average_molecular_weight>
      <monisotopic_molecular_weight>300.172544634</monisotopic_molecular_weight>
      <iupac_name>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one</iupac_name>
      <traditional_iupac>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one</traditional_iupac>
      <cas_registry_number>362-08-3</cas_registry_number>
      <smiles>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3</smiles>
      <inchi>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1</inchi>
      <inchikey>WHEUWNKSCXYKBU-QPWUGHHJSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane.</description>
        <direct_parent>Estrogens and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Lipids and lipid-like molecules</super_class>
        <class>Steroids and steroid derivatives</class>
        <sub_class>Estrane steroids</sub_class>
        <molecular_framework>Aromatic homopolycyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>1-hydroxy-2-unsubstituted benzenoids</alternative_parent>
          <alternative_parent>17-oxosteroids</alternative_parent>
          <alternative_parent>3-hydroxysteroids</alternative_parent>
          <alternative_parent>Alkyl aryl ethers</alternative_parent>
          <alternative_parent>Anisoles</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Ketones</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Phenanthrenes and derivatives</alternative_parent>
          <alternative_parent>Tetralins</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
          <substituent>17-oxosteroid</substituent>
          <substituent>3-hydroxysteroid</substituent>
          <substituent>Alkyl aryl ether</substituent>
          <substituent>Anisole</substituent>
          <substituent>Aromatic homopolycyclic compound</substituent>
          <substituent>Benzenoid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Estrogen-skeleton</substituent>
          <substituent>Ether</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Hydroxysteroid</substituent>
          <substituent>Ketone</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Oxosteroid</substituent>
          <substituent>Phenanthrene</substituent>
          <substituent>Tetralin</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>17-oxo steroid</external_descriptor>
          <external_descriptor>3-hydroxy steroid</external_descriptor>
          <external_descriptor>C18 steroids (estrogens) and derivatives</external_descriptor>
          <external_descriptor>C18 steroids (estrogens) and derivatives</external_descriptor>
          <external_descriptor>alicyclic ketone</external_descriptor>
          <external_descriptor>phenols</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Prolactinoma</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Pituitary adenoma, prolactin-secreting</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hepatic tissue</term>
                      <definition>The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes. (NCI Thesaurus).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Liver tissue</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Membrane</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell membrane</term>
                      <definition>A cellular compartment that separates a cellВ interiorВ from its exterior.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cellular membrane</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical process</term>
                      <definition>A biological process occurring at the subcellular level, involving biochemical reactions.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid transport</term>
                          <definition>A process in which a lipid molecules is translocated between cellular sites or compartments.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of lipids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Lipid metabolic process</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fatty acid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of fatty acids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Chemical reaction</term>
                      <definition>A defined chemical event that occurs within or between organism cells.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid peroxidation</term>
                          <definition>A chemical reaction involving oxidative attack from free radicals on a lipid molecule, resulting in its degradation. .</definition>
                          <parent_id>7663</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>System process</term>
                      <definition>A biological process occurring in an organ, a system or at the organism level.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Reproduction</term>
                          <definition>The process by which an offspring is generated by a living organism.</definition>
                          <parent_id>7667</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Cellular process</term>
                      <definition>A biological process occurring within a cell or its surroundings.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Cell signaling</term>
                          <definition>The process by which a cell responds to substances in its environment.</definition>
                          <parent_id>7665</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Signal transduction</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Estrone Metabolism</term>
                          <definition> it is one of three major endogenous estrogens, the others being estradiol and estriol. estrone, as well as the other estrogens, are synthesized from cholesterol and secreted mainly from the gonads, though they can also be formed from adrenal androgens in adipose tissue.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism pathway</term>
                          <definition>A cellular process that consists of synthesis or breakdown of lipid molecules for energy or storage.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Biological role</term>
              <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Membrane stabilizer</term>
                  <definition>A chemical substance that supports the formation and maintenance of a structurally-sound and functioning cell or organelle membrane. Phospholipids form a bilayer and maintain the stability of the membrane structure together with proteins, and other lipids (i.e. cholesterol) which further strengthen it and decrease its permeability. </definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Membrane stability agent</synonym>
                    <synonym>Membrane integrity agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy source</term>
                  <definition/>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy storage</term>
                  <definition>A chemical substance which can be utilized for production of energy in the organism.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Molecular messenger</term>
                  <definition> a chemical substance that is involved in transmission of biochemical signals.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hormone</term>
                      <definition>Substances produces in animals or plant that regulate the activity of certain organs or control processes in other parts of the plant.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Signaling molecule</term>
                      <definition>A chemical substance that particpiates in signal transduction processes in a living cell.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Signalling molecule</synonym>
                        <synonym>Signaling agent</synonym>
                        <synonym>Cell signaling agent</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Surfactant</term>
                  <definition>A chemical substance that has the ability to lower the surface tension of water or to reduce the interfacial tension between two immiscible substances. in the cspa consumer product ingredients dictionary, surfactants are classified on the basis of their ionic characteristics, as amphoteric, anionic, cationic, or nonionic; and functions, which are subdivided into the following major groups: surfactant - cleaning agent, surfactant - conditioning agent,  surfactant - emulsifying agent,  surfactant - foam booster , surfactant hydrotrop , surfactant - solubility agent, surfactant - suspending agent.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Surface-active agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Emulsifier</term>
                  <definition>Substances that promote the formation and stability of a suspension of fine particles of a liquid in another liquid.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>melting_point</kind>
          <value>187.0 - 189.5 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>3.50</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-4.60</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>0.0075 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>4.15</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>10.29</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-4.9</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>300.3921</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>300.172544634</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C19H24O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>WHEUWNKSCXYKBU-QPWUGHHJSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>46.53</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>85.55</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>34.34</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2161</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2170</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>23019</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30947</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30948</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37240</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>919</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1026</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>13</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>14</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>15</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317137</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317138</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317139</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363541</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363542</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363543</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Extracellular</cellular>
          <cellular>Membrane</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Estrone Metabolism</name>
            <smpdb_id>SMP30880</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex/>
          <subject_condition>Normal</subject_condition>
          <comment>Inferred from detection in urine</comment>
          <references>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.005 (0.004-0.006)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Nam SY, Chung BC: Altered profile of endogenous steroids in the urine of patients with prolactinoma. Clin Biochem. 1998 Oct;31(7):529-35.</reference_text>
              <pubmed_id>9812172</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.025 (0.02-0.03)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Prolactinoma</patient_information>
          <references>
            <reference>
              <reference_text>Lee SH, Nam SY, Chung BC: Altered profile of endogenous steroids in the urine of patients with prolactinoma. Clin Biochem. 1998 Oct;31(7):529-35.</reference_text>
              <pubmed_id>9812172</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Prolactinoma</name>
          <omim_id>600634</omim_id>
          <references>
            <reference>
              <reference_text>Lee SH, Nam SY, Chung BC: Altered profile of endogenous steroids in the urine of patients with prolactinoma. Clin Biochem. 1998 Oct;31(7):529-35.</reference_text>
              <pubmed_id>9812172</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB021868</foodb_id>
      <chemspider_id>389515</chemspider_id>
      <kegg_id>C05299</kegg_id>
      <pubchem_compound_id>440624</pubchem_compound_id>
      <chebi_id>1189</chebi_id>
      <drugbank_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id/>
      <wikipedia_id>2-Methoxyestrone</wikipedia_id>
      <metlin_id>2578</metlin_id>
      <biocyc_id/>
      <pdb_id/>
      <synthesis_reference>Stoelwinder, Johannes; Moers, Nicolaas Elisabeth Cornelis. Process for the preparation 2-substituted derivatives of estrone and estradiol.PCT Int. Appl.  (2006), 40 pp.</synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Lee SH, Nam SY, Chung BC: Altered profile of endogenous steroids in the urine of patients with prolactinoma. Clin Biochem. 1998 Oct;31(7):529-35.</reference_text>
          <pubmed_id>9812172</pubmed_id>
        </reference>
        <reference>
          <reference_text>Longcope C, Flood C, Femino A, Williams KI: Metabolism of 2-methoxyestrone in normal men. J Clin Endocrinol Metab. 1983 Aug;57(2):277-82.</reference_text>
          <pubmed_id>6863476</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ball P, Reu G, Schwab J, Knuppen R: Radioimmunoassay of 2-hydroxyesterone and 2-methoxyestrone in human urine. Steroids. 1979 May;33(5):563-76.</reference_text>
          <pubmed_id>462497</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lewis KM, Archer RD: pKa values of estrone, 17 beta-estradiol and 2-methoxyestrone. Steroids. 1979 Nov;34(5):485-99.</reference_text>
          <pubmed_id>516114</pubmed_id>
        </reference>
        <reference>
          <reference_text>Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9.</reference_text>
          <pubmed_id>11413487</pubmed_id>
        </reference>
        <reference>
          <reference_text>Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10.</reference_text>
          <pubmed_id>16902246</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20.</reference_text>
          <pubmed_id>17374880</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621.</reference_text>
          <pubmed_id>20044567</pubmed_id>
        </reference>
        <reference>
          <reference_text>S. Kraychy, T. F. Gallagher. 2-Methoxyestrone, A Metabolite of Estradiol-17β in the Human. J. Am. Chem. Soc., 1957, 79 (3), pp 754–754</reference_text>
        </reference>
        <reference>
          <reference_text>Miyazaki M, Fishman J. Isomeric aryl monsulfates of estrogen catechols. J Org Chem. 1968 Feb;33(2):662-4</reference_text>
        </reference>
        <reference>
          <reference_text>Shimada, K. et al., J. Chromatogr., 1979, 178, 350, (HPLC)</reference_text>
        </reference>
        <reference>
          <reference_text>Gelbke, H.P. et al., Steroids, 1973, 21, 205, (synthesis, PMR)</reference_text>
        </reference>
        <reference>
          <reference_text>Douglas GH, Walk CR, Smith H. Totally synthetic steroid hormones. V. (+ -)-2,3-Dimethoxyestra-1,3,5(10)-trien-17-beta-ol and some congeners. J Med Chem. 1966 Jan;9(1):27-9.</reference_text>
        </reference>
        <reference>
          <reference_text>The lipid handbook with CD-ROM</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00272</protein_accession>
          <name>Catechol O-methyltransferase</name>
          <uniprot_id>P21964</uniprot_id>
          <gene_name>COMT</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00449</protein_accession>
          <name>UDP-glucuronosyltransferase 2B28</name>
          <uniprot_id>Q9BY64</uniprot_id>
          <gene_name>UGT2B28</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00458</protein_accession>
          <name>UDP-glucuronosyltransferase 2B4</name>
          <uniprot_id>P06133</uniprot_id>
          <gene_name>UGT2B4</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00478</protein_accession>
          <name>UDP-glucuronosyltransferase 1-4</name>
          <uniprot_id>P22310</uniprot_id>
          <gene_name>UGT1A4</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00479</protein_accession>
          <name>UDP-glucuronosyltransferase 2B10</name>
          <uniprot_id>P36537</uniprot_id>
          <gene_name>UGT2B10</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00480</protein_accession>
          <name>UDP-glucuronosyltransferase 2B7</name>
          <uniprot_id>P16662</uniprot_id>
          <gene_name>UGT2B7</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00481</protein_accession>
          <name>UDP-glucuronosyltransferase 2B15</name>
          <uniprot_id>P54855</uniprot_id>
          <gene_name>UGT2B15</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00482</protein_accession>
          <name>UDP-glucuronosyltransferase 2A1</name>
          <uniprot_id>Q9Y4X1</uniprot_id>
          <gene_name>UGT2A1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00483</protein_accession>
          <name>UDP-glucuronosyltransferase 1-1</name>
          <uniprot_id>P22309</uniprot_id>
          <gene_name>UGT1A1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00484</protein_accession>
          <name>UDP-glucuronosyltransferase 1-9</name>
          <uniprot_id>O60656</uniprot_id>
          <gene_name>UGT1A9</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00485</protein_accession>
          <name>UDP-glucuronosyltransferase 1-8</name>
          <uniprot_id>Q9HAW9</uniprot_id>
          <gene_name>UGT1A8</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00486</protein_accession>
          <name>UDP-glucuronosyltransferase 1-3</name>
          <uniprot_id>P35503</uniprot_id>
          <gene_name>UGT1A3</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00487</protein_accession>
          <name>UDP-glucuronosyltransferase 1-10</name>
          <uniprot_id>Q9HAW8</uniprot_id>
          <gene_name>UGT1A10</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00488</protein_accession>
          <name>UDP-glucuronosyltransferase 2B17</name>
          <uniprot_id>O75795</uniprot_id>
          <gene_name>UGT2B17</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00489</protein_accession>
          <name>UDP-glucuronosyltransferase 1-6</name>
          <uniprot_id>P19224</uniprot_id>
          <gene_name>UGT1A6</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00490</protein_accession>
          <name>UDP-glucuronosyltransferase 1-5</name>
          <uniprot_id>P35504</uniprot_id>
          <gene_name>UGT1A5</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00491</protein_accession>
          <name>UDP-glucuronosyltransferase 2B11</name>
          <uniprot_id>O75310</uniprot_id>
          <gene_name>UGT2B11</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00494</protein_accession>
          <name>UDP-glucuronosyltransferase 1-7</name>
          <uniprot_id>Q9HAW7</uniprot_id>
          <gene_name>UGT1A7</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01623</protein_accession>
          <name>Sex hormone-binding globulin</name>
          <uniprot_id>P04278</uniprot_id>
          <gene_name>SHBG</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07348</protein_accession>
          <name>UDP-glucuronosyltransferase 2A3</name>
          <uniprot_id>Q6UWM9</uniprot_id>
          <gene_name>UGT2A3</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09238</protein_accession>
          <name>HCG2039726, isoform CRA_f</name>
          <uniprot_id>Q5DT02</uniprot_id>
          <gene_name>UGT1A10</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09239</protein_accession>
          <name>HCG2039726, isoform CRA_e</name>
          <uniprot_id>Q5DSZ6</uniprot_id>
          <gene_name>UGT1A8</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09240</protein_accession>
          <name>UDP glycosyltransferase 1 family polypeptide A7</name>
          <uniprot_id>Q5DSZ7</uniprot_id>
          <gene_name>UGT1A7</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-06-15 17:04:51 UTC</update_date>
      <accession>HMDB0000011</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB0000357</accession>
        <accession>HMDB00011</accession>
        <accession>HMDB00357</accession>
      </secondary_accessions>
      <name>3-Hydroxybutyric acid</name>
      <description>3-Hydroxybutyric acid (CAS: 300-85-6), also known as beta-hydroxybutanoic acid, is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis. This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of 3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid, and is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for the synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. 3-Hydroxybutyric acid is a metabolite of Alcaligenes and can be produced from plastic metabolization or incorporated into polymers, depending on the species (PMID: 7646009, 18615882).</description>
      <synonyms>
        <synonym>(R)-(-)-beta-Hydroxybutyric acid</synonym>
        <synonym>(R)-3-Hydroxybutanoic acid</synonym>
        <synonym>3-D-Hydroxybutyric acid</synonym>
        <synonym>D-3-Hydroxybutyric acid</synonym>
        <synonym>D-beta-Hydroxybutyric acid</synonym>
        <synonym>(R)-(-)-b-Hydroxybutyrate</synonym>
        <synonym>(R)-(-)-b-Hydroxybutyric acid</synonym>
        <synonym>(R)-(-)-beta-Hydroxybutyrate</synonym>
        <synonym>(R)-(-)-Β-hydroxybutyrate</synonym>
        <synonym>(R)-(-)-Β-hydroxybutyric acid</synonym>
        <synonym>(R)-3-Hydroxybutanoate</synonym>
        <synonym>3-D-Hydroxybutyrate</synonym>
        <synonym>D-3-Hydroxybutyrate</synonym>
        <synonym>D-b-Hydroxybutyrate</synonym>
        <synonym>D-b-Hydroxybutyric acid</synonym>
        <synonym>D-beta-Hydroxybutyrate</synonym>
        <synonym>D-Β-hydroxybutyrate</synonym>
        <synonym>D-Β-hydroxybutyric acid</synonym>
        <synonym>(R)-3-Hydroxybutyrate</synonym>
        <synonym>3-delta-Hydroxybutyrate</synonym>
        <synonym>3-delta-Hydroxybutyric acid</synonym>
        <synonym>BHIB</synonym>
        <synonym>D-(-)-3-Hydroxybutyrate</synonym>
        <synonym>delta-(-)-3-Hydroxybutyrate</synonym>
        <synonym>delta-3-Hydroxybutyrate</synonym>
        <synonym>delta-3-Hydroxybutyric acid</synonym>
        <synonym>delta-beta-Hydroxybutyrate</synonym>
        <synonym>3R-Hydroxy-butanoate</synonym>
        <synonym>(R)-3-Hydroxybutyric acid</synonym>
        <synonym>(-)-3-Hydroxy-n-butyric acid</synonym>
        <synonym>(-)-3-Hydroxybutyric acid</synonym>
        <synonym>(3R)-3-Hydroxybutanoic acid</synonym>
        <synonym>(3R)-3-Hydroxybutyric acid</synonym>
        <synonym>(3R)-Hydroxybutyrate</synonym>
        <synonym>(R)-(-)-3-Hydroxybutyric acid</synonym>
        <synonym>(R)-beta-Hydroxybutanoic acid</synonym>
        <synonym>(R)-beta-Hydroxybutyric acid</synonym>
        <synonym>(R)-β-Hydroxybutanoic acid</synonym>
        <synonym>(R)-β-Hydroxybutyric acid</synonym>
        <synonym>3-Hydroxy-n-butyric acid</synonym>
        <synonym>3-Hydroxybutanoic acid</synonym>
        <synonym>3-Hydroxybutyric acid</synonym>
        <synonym>3R-Hydroxybutanoic acid</synonym>
        <synonym>D-(-)-3-Hydroxybutanoic acid</synonym>
        <synonym>D-(-)-3-Hydroxybutyric acid</synonym>
        <synonym>D-(-)-beta-Hydroxybutyric acid</synonym>
        <synonym>D-(-)-β-Hydroxybutyric acid</synonym>
        <synonym>beta-Hydroxy-n-butyric acid</synonym>
        <synonym>beta-Hydroxybutanoic acid</synonym>
        <synonym>beta-Hydroxybutyric acid</synonym>
        <synonym>β-Hydroxy-n-butyric acid</synonym>
        <synonym>β-Hydroxybutanoic acid</synonym>
        <synonym>β-Hydroxybutyric acid</synonym>
      </synonyms>
      <chemical_formula>C4H8O3</chemical_formula>
      <average_molecular_weight>104.1045</average_molecular_weight>
      <monisotopic_molecular_weight>104.047344122</monisotopic_molecular_weight>
      <iupac_name>(3R)-3-hydroxybutanoic acid</iupac_name>
      <traditional_iupac>(-)-3-hydroxybutyric acid</traditional_iupac>
      <cas_registry_number>625-72-9</cas_registry_number>
      <smiles>C[C@@H](O)CC(O)=O</smiles>
      <inchi>InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1</inchi>
      <inchikey>WHBMMWSBFZVSSR-GSVOUGTGSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.</description>
        <direct_parent>Beta hydroxy acids and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Hydroxy acids and derivatives</class>
        <sub_class>Beta hydroxy acids and derivatives</sub_class>
        <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Carbonyl compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Fatty acids and conjugates</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Secondary alcohols</alternative_parent>
          <alternative_parent>Short-chain hydroxy acids and derivatives</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alcohol</substituent>
          <substituent>Aliphatic acyclic compound</substituent>
          <substituent>Beta-hydroxy acid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Fatty acid</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Secondary alcohol</substituent>
          <substituent>Short-chain hydroxy acid</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>3-hydroxybutyric acid</external_descriptor>
          <external_descriptor>Hydroxy fatty acids</external_descriptor>
          <external_descriptor>ketone body</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Diabetes mellitus type 2</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Non-insulin-dependent diabetes mellitus</synonym>
                        <synonym>Niddm</synonym>
                        <synonym>Adult-onset diabetes</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Schizophrenia</term>
                      <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Anoxia</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Metabolism and nutrition disorders</term>
                      <definition>A group of disorders, inherited or not, that result in a metabolic malfunction.</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Obesity</term>
                          <definition>A disorder characterized by having a high amount of body fat. (nci ctcae).</definition>
                          <parent_id>7708</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Infections and infestations</term>
                      <definition>Any  disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. it can be transmitted by direct or indirect contact. (nci).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Meningitis</term>
                          <definition>A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord. (nci ctcae).</definition>
                          <parent_id>7713</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Microbe</term>
                      <definition>A living organism that is of a microscopic scale, either single-celled or a cluster of cells.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Alcaligenes</term>
                          <definition/>
                          <parent_id>7739</parent_id>
                          <level>5</level>
                          <type>parent</type>
                          <synonyms>
                          </synonyms>
                          <descendants>
                            <descendant>
                              <term>Alcaligenes eutrophus</term>
                              <definition/>
                              <parent_id>11250</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                          </descendants>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Brain</term>
                      <definition>An organ composed of grey and white matter that is the center for intelligence and reasoning. it is protected by the bony cranium. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Liver</term>
                      <definition>An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell</term>
                      <definition/>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Nerve cell</term>
                          <definition>A cell in the nervous system, that is able to conduct weak electric signals between the brain and the body. A typical neuron consists of a cell body, containing the nucleus and the surrounding cytoplasm (perikaryon); several short radiating processes (dendrites); and one long process (the axon), which terminates in twiglike branches (telodendrons) and may have branches (collaterals) projecting along its course. (NCI).</definition>
                          <parent_id>7734</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Neuron</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Ketone Body Metabolism</term>
                          <definition> the first two are synthesized from acetyl-coa, in the mitochondria of liver cells; acetone is formed by spontaneous decarboxylation of acetoacetate. ketone body synthesis (ketogenesis) in liver is effectively irreversible because the enzyme that catalyzes the conversion of acetoacetate to acetoacetyl-coa is not present in liver cells.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fatty Acid Biosynthesis</term>
                          <definition> the entire synthesis process which produces palmitic acid occurs on a multifunctional dimeric protein fatty acid synthase (fa) in the cytosol. the production of palmitic acid can be summarized as the successive addition of two carbons to an initial acetyl moiety primer.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>melting_point</kind>
          <value>49 - 50 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-0.50</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>0.71</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>539 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-0.39</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>4.41</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-2.6</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(3R)-3-hydroxybutanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>104.1045</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>104.047344122</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>C[C@@H](O)CC(O)=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C4H8O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>WHBMMWSBFZVSSR-GSVOUGTGSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>57.53</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>23.46</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>9.96</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>920</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::EiMs</type>
          <spectrum_id>2010</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1027</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>26212</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30136</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37241</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>99520</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>16</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>17</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>18</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2526</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2527</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2528</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2529</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2530</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>324085</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>324086</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>324087</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>372409</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>372410</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>372411</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437816</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437817</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437818</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437819</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437820</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>440114</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Extracellular</cellular>
          <cellular>Mitochondria</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cellular Cytoplasm</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Fatty Acid Biosynthesis</name>
            <smpdb_id>SMP00456</smpdb_id>
            <kegg_map_id></kegg_map_id>
          </pathway>
          <pathway>
            <name>Ketone Body Metabolism</name>
            <smpdb_id>SMP00071</smpdb_id>
            <kegg_map_id>map00072</kegg_map_id>
          </pathway>
          <pathway>
            <name>Succinyl CoA: 3-ketoacid CoA transferase deficiency</name>
            <smpdb_id>SMP00569</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>60.0 +/- 20.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
              <pubmed_id>16540841</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>40.0 +/- 10.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Burns SF, Broom DR, Miyashita M, Ueda C, Stensel DJ: Increased postprandial triacylglycerol concentrations following resistance exercise. Med Sci Sports Exerc. 2006 Mar;38(3):527-33.</reference_text>
              <pubmed_id>16540841</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>323.0 +/- 29.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
              <pubmed_id>16253646</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>36 +/- 20</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hansen JL, Freier EF: Direct assays of lactate, pyruvate, beta-hydroxybutyrate, and acetoacetate with a centrifugal analyzer. Clin Chem. 1978 Mar;24(3):475-9.</reference_text>
              <pubmed_id>415828</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>86 +/- 53</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Ozand PT, Hawkins RL, Collins RM Jr, Tildon JT, Cornblath M: A micro-autoanalytic procedure developed for the determination of ketone bodies, gluconeogenic amino acids, pyruvate, lactate, and glucose in metabolic studies. Biochem Med. 1975 Oct;14(2):170-83.</reference_text>
              <pubmed_id>1220702</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>38 +/- 31</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Wildenhoff KE: Diurnal variations in the concentrations of blood acetoacetate, 3-hydroxybutyrate and glucose in normal persons. Acta Med Scand. 1972 Apr;191(4):303-6.</reference_text>
              <pubmed_id>5032673</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detcted by 1H NMR</comment>
          <references>
            <reference>
              <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
              <pubmed_id>22800120</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;500</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
              <pubmed_id>172850</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>260-5040</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>n=7</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>50.0 (0.0-100.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Darzy KH, Murray RD, Gleeson HK, Pezzoli SS, Thorner MO, Shalet SM: The impact of short-term fasting on the dynamics of 24-hour growth hormone (GH) secretion in patients with severe radiation-induced GH deficiency. J Clin Endocrinol Metab. 2006 Mar;91(3):987-94. Epub 2005 Dec 29.</reference_text>
              <pubmed_id>16384844</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>46.5 +/- 10.1</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detected by HPLC</comment>
          <references>
            <reference>
              <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
              <pubmed_id>25004141</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;600</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
              <pubmed_id>23430856</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;150</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
              <pubmed_id>12072887</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>100.0 +/- 90.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Jovanovic L, Metzger BE, Knopp RH, conley MR, Park E, Lee YJ, Simpson JL, Holmes L, Aarons JH, Mills JL: The Diabetes in Early Pregnancy Study: beta-hydroxybutyrate levels in type 1 diabetic pregnancy compared with normal pregnancy. NICHD-Diabetes in Early Pregnancy Study Group (DIEP). National Institute of Child Health and Development. Diabetes Care. 1998 Nov;21(11):1978-84.</reference_text>
              <pubmed_id>9802754</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>565.0 +/- 255.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>36.0 (13.0-95.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>80-3600</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
              <pubmed_id>8295396</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>64.88(60.4)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
              <pubmed_id>26010610</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>200 +/- 120</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Evening.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>170 +/- 110</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Morning.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>10.60-143.2</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
              <pubmed_id>21359215</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>500-3000</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>After ingestion of medium-chain triglycerides.</comment>
          <references>
            <reference>
              <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
              <pubmed_id>9337379</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR </comment>
          <references>
            <reference>
              <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
              <pubmed_id>21505807</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>76.9 +/- 66.3</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
              <pubmed_id>21359215</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>180.0 (22.0-700.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cellular Cytoplasm</biospecimen>
          <concentration_value>1300 (1200-1400)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
              <pubmed_id>8579834</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>34 +/- 31</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
              <pubmed_id>18502700</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>50.0 (4.0 - 96.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
              <pubmed_id>9693263</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>286 (207-365)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
              <pubmed_id>15627241</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>46.4 +/- 23.9</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>48.0 +/- 48.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Barrios C, Spector TD, Menni C: Blood, urine and faecal metabolite profiles in the study of adult renal disease. Arch Biochem Biophys. 2016 Jan 1;589:81-92. doi: 10.1016/j.abb.2015.10.006. Epub  2015 Oct 21.</reference_text>
              <pubmed_id>26476344</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-TOFMS on lyophilized fecal samples</comment>
          <references>
            <reference>
              <reference_text>Phua LC, Koh PK, Cheah PY, Ho HK, Chan EC: Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:103-13. doi: 10.1016/j.jchromb.2013.08.025. Epub 2013 Aug 26.</reference_text>
              <pubmed_id>24029555</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>22.0932 +/- 9.606</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-MS on fecal extract. The original unit of the concentration was reported as ug/mL. The concentration has been converted to nmol/g using the assumption that 1 mL = 1 g of feces.</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
              <pubmed_id>20669995</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Wet feces samples (n=183) were used in the study.  Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>GC-MS on fecal extract</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
              <pubmed_id>20669995</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>5.00 +/- 4.25</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI &lt; 21.00 kg/m2 (n=45)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.</reference_text>
              <pubmed_id>12097436</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>2.64 +/- 1.83</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=27)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Organic acid. By GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>3.22 +/- 2.77</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI ≥ 21.00 kg/m2 (n=22)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>3.88 +/- 4.26</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>16.44 +/- 19.52</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>4.71 +/- 7.21</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=24)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.5-9.8</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
          <references>
            <reference>
              <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
              <pubmed_id>31506554</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;99</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
              <pubmed_id>28649521</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.4-2.7 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;54.301</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>180.280 +/- 115.119</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>&lt;8 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>27.151 +/- 14.118</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>12 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>272.592 +/- 419.205</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>18 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.4</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
              <pubmed_id>6321058</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3397.0835 +/- 5584.336</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>30 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>616.862 +/- 982.852</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>24 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>7-120</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
              <pubmed_id>6616873</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>7569.588 +/- 3599.0840</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>36 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.72-23.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>4.02(0.78-12.39)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.14(0.71-23.84)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>López Hernández Y and Wishart DS. The urinary metabolome of healthy newborns (in preparation)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.60 +/- 3.50</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
              <pubmed_id>2026685</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>27.151 +/- 14.118</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>12-h Fast</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>272.592 +/- 419.205</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>18-h Fast</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>636.410 +/- 982.852</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>24-h Fast</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>6.651 +/- 7.809</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>180.4 +/- 115.00</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3397.0835 +/- 5584.336</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>30-h Fast</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>7569.588 +/- 3599.0840</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>36-h Fast</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>13.0 (1.0-27.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 130. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp. Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.4 +/- 1.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Jones MG, Cooper E, Amjad S, Goodwin CS, Barron JL, Chalmers RA: Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta. 2005 Nov;361(1-2):150-8.</reference_text>
              <pubmed_id>15992788</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.7 (0-2.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L: Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem. 1989 Apr;35(4):587-95.</reference_text>
              <pubmed_id>2702744</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;21.17</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GCMS.</comment>
          <references>
            <reference>
              <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>38.9 +/- 13.9</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Individuals were fasted for 8-12 hours'</comment>
          <references>
            <reference>
              <reference_text>Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008 Mar;21(3):195-207.</reference_text>
              <pubmed_id>17474139</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>32.3 +/- 8.7</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Individuals were fasted for 8-12 hours</comment>
          <references>
            <reference>
              <reference_text>Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008 Mar;21(3):195-207.</reference_text>
              <pubmed_id>17474139</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>48.0 (0.00-200.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
              <pubmed_id>6321058</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.4-2.2 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.6 (1.3-6.4)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.257  +/-  1.254</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-MS Hewlett-Packard HP-5890 Series</comment>
          <references>
            <reference>
              <reference_text>Chu CY, Xiao X, Zhou XG, Lau TK, Rogers MS, Fok TF, Law LK, Pang CP, Wang CC: Metabolomic and bioinformatic analyses in asphyxiated neonates. Clin Biochem. 2006 Mar;39(3):203-9. doi: 10.1016/j.clinbiochem.2006.01.006. Epub  2006 Feb 7.</reference_text>
              <pubmed_id>16460720</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.0 (0.5-9.8)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.4 (0.1-2.7)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.3 (0.1-5.8)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>29.712 +/- 14.532</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.62 (0.0-12.09)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Raknes G, Aronsen L, Fuskevag OM: Urinary concentrations of gamma-hydroxybutyric acid and related compounds in pregnancy. J Anal Toxicol. 2010 Sep;34(7):394-9.</reference_text>
              <pubmed_id>20822677</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.24 (0.0-17.6)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Pregnant woman </comment>
          <references>
            <reference>
              <reference_text>Raknes G, Aronsen L, Fuskevag OM: Urinary concentrations of gamma-hydroxybutyric acid and related compounds in pregnancy. J Anal Toxicol. 2010 Sep;34(7):394-9.</reference_text>
              <pubmed_id>20822677</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.6 (1.3-6.4)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.0 (0.6-5.6)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>235.0 +/- 17.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Obesity</patient_information>
          <references>
            <reference>
              <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
              <pubmed_id>16253646</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>35.1 +/- 33.9</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Heart Transplant</patient_information>
          <references>
            <reference>
              <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
              <pubmed_id>21359215</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>62.7 (85.0) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Down syndrome pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>21.0 (19.4) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>500</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <comment>n=1. Fasting.</comment>
          <references>
            <reference>
              <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
              <pubmed_id>11241047</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>660</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adolescent (13-18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <comment>n=1. Fasting.</comment>
          <references>
            <reference>
              <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
              <pubmed_id>11241047</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>200-2800</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <comment>n=3. Fasting.</comment>
          <references>
            <reference>
              <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
              <pubmed_id>11241047</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>770-2900</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <comment>n=3. Fasting.</comment>
          <references>
            <reference>
              <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
              <pubmed_id>11241047</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Oesophageal cancer</patient_information>
          <comment>By NMR and LC-MS </comment>
          <references>
            <reference>
              <reference_text>Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, Raftery D: Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One. 2012;7(1):e30181. doi: 10.1371/journal.pone.0030181. Epub 2012 Jan 23.</reference_text>
              <pubmed_id>22291914</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Detected by 1H NMR</comment>
          <references>
            <reference>
              <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
              <pubmed_id>22800120</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>220</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Very long-chain acyl-CoA dehydrogenase deficiency (vLCAD)</patient_information>
          <comment>n=1</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>80-200</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency</patient_information>
          <comment>n=2</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>700-1340</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium chain acyl-CoA dehydrogenase deficiency (MCAD)</patient_information>
          <comment>n=3</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1800</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Pyruvate dehydrogenase phosphatase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
              <pubmed_id>172850</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;100</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Carnitine palmitoyltransferase deficiency I</patient_information>
          <references>
            <reference>
              <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
              <pubmed_id>11286380</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1500.0 +/- 100.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>Without diabetic ketoacidosis</comment>
          <references>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0-380</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</patient_information>
          <comment>n=5. Patients have hyperinsulinism.</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1490-5040</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Ketotic hypoglycemia</patient_information>
          <comment>n=5</comment>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>10-1380</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <references>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>35.5 +/- 92.2</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>Type 1
    </comment>
          <references>
            <reference>
              <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
              <pubmed_id>14512036</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>17.6 +/- 3.84</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Measured by HPLC</comment>
          <references>
            <reference>
              <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
              <pubmed_id>25004141</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>7700.0 +/- 300.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>With diabetic ketoacidosis</comment>
          <references>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>54.57 +/- 64.53 </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy with fetuses with trisomy 18</patient_information>
          <comment>Pregnancies between 11 weeks and 13 weeks 6 daysâ€™ gestation with fetuses with trisomy 18</comment>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>32.9 +/- 53.42 </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0-200</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>3-Hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)</patient_information>
          <references>
            <reference>
              <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
              <pubmed_id>23430856</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>31.6 (19.1) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Early preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>27.0 (16.2) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>64</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</patient_information>
          <comment>n=1</comment>
          <references>
            <reference>
              <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
              <pubmed_id>12072887</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>100</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Newborn (0-30 days old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>2-Ketoglutarate dehydrogenase complex deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
              <pubmed_id>8295396</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>120-2000</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>2-Ketoglutarate dehydrogenase complex deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
              <pubmed_id>8295396</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Pancreatic cancer</patient_information>
          <comment>By NMR. Significantly decreased vs control.</comment>
          <references>
            <reference>
              <reference_text>Zhang L, Jin H, Guo X, Yang Z, Zhao L, Tang S, Mo P, Wu K, Nie Y, Pan Y, Fan D: Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem. 2012 Sep;45(13-14):1064-9. doi: 10.1016/j.clinbiochem.2012.05.012.  Epub 2012 May 19.</reference_text>
              <pubmed_id>22613268</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>33.63 (42.57) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy with fetus having congenital heart defect</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>30.15 (37.69) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>29.61(44.27)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Heart failure with reduced ejection fraction</patient_information>
          <references>
            <reference>
              <reference_text>Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR: Metabolomic fingerprint of heart failure with preserved ejection fraction. PLoS One. 2015 May 26;10(5):e0124844. doi: 10.1371/journal.pone.0124844. eCollection 2015.</reference_text>
              <pubmed_id>26010610</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>49.9 (46.7) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Late-onset preeclampsia</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>29.7 (19.1) </concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Pregnancy</patient_information>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>130 +/- 80</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
          <comment>Evening. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>300 +/- 390</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
          <comment>Evening. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>300 +/- 200</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
          <comment>Morning. With Dexamethasone and Hydrocortisone treatment, high dose.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>250 +/- 160</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</patient_information>
          <comment>Morning. With Dexamethasone and Hydrocortisone treatment, standard dose.</comment>
          <references>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>By NMR. Significantly decreased vs control.</patient_information>
          <comment>By NMR </comment>
          <references>
            <reference>
              <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
              <pubmed_id>21505807</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1400.0 +/- 100.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>Without diabetic ketoacidosis</comment>
          <references>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>7700.0 +/- 200.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>With diabetic ketoacidosis</comment>
          <references>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>5700 (4300-6000)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetic ketoacidosis</patient_information>
          <references>
            <reference>
              <reference_text>Charles RA, Bee YM, Eng PH, Goh SY: Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emergency department. Singapore Med J. 2007 Nov;48(11):986-9.</reference_text>
              <pubmed_id>17975686</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>20-50</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</patient_information>
          <comment>During fasting.</comment>
          <references>
            <reference>
              <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
              <pubmed_id>9727719</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cellular Cytoplasm</biospecimen>
          <concentration_value>2600 (2500-2700)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Anoxia</patient_information>
          <references>
            <reference>
              <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
              <pubmed_id>8579834</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>430 (359-501)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Meningitis</patient_information>
          <comment> Bacterial
    </comment>
          <references>
            <reference>
              <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
              <pubmed_id>15627241</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>6360 (5350-7370)</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <comment>with ketoacidosis
    </comment>
          <references>
            <reference>
              <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
              <pubmed_id>15982426</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.01, lower than control. Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Crohn disease</patient_information>
          <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.05, lower than control. Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>5.04 +/- 3.02</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Tooth alignment disorders</patient_information>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>6.62 +/- 0.72</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Alzheimer's disease</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>6.37 +/- 1.75</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Frontotemporal lobe dementia</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>24.25 +/- 32.08</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Lewy body disease</patient_information>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>11.946</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <comment>5 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>16.29</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <comment>12 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>27.151</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <comment>16 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>31.495</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <comment>8 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>56.473</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <comment>22 h fasting</comment>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>351.872</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Fumarase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>45000</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex/>
          <patient_information>Pyruvate carboxylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
              <pubmed_id>28649521</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>8359</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex/>
          <patient_information>Pyruvate carboxylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
              <pubmed_id>28649521</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3-1050</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
              <pubmed_id>6616873</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>55.399-1634.282</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Medium Chain Acyl-CoA Dehydrogenase Deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Duran M, De Klerk JB, Wadman SK, Bruinvis L, Ketting D: The differential diagnosis of dicarboxylic aciduria. J Inherit Metab Dis. 1984;7 Suppl 1:48-51.</reference_text>
              <pubmed_id>6434845</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>170-390</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>3-Hydroxyisobutyric acid dehydrogenase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Ko FJ, Nyhan WL, Wolff J, Barshop B, Sweetman L: 3-Hydroxyisobutyric aciduria: an inborn error of valine metabolism. Pediatr Res. 1991 Oct;30(4):322-6. doi: 10.1203/00006450-199110000-00006.</reference_text>
              <pubmed_id>1956714</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>35.352 +/- 40.756</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>51.0431-56.473</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>3-Hydroxydicarboxylic aciduria</patient_information>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Bladder cancer</patient_information>
          <references>
            <reference>
              <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
              <pubmed_id>28157703</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>224</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Diabetes</patient_information>
          <references>
            <reference>
              <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
              <pubmed_id>6321058</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <comment>Detected by GC-TOFMS</comment>
          <references>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>30.883 +/- 22.266</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>74.311 +/- 155.898</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Gastroesophageal reflux disease</patient_information>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Diabetes mellitus type 2</name>
          <omim_id>125853</omim_id>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.</reference_text>
              <pubmed_id>11887176</pubmed_id>
            </reference>
            <reference>
              <reference_text>Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.</reference_text>
              <pubmed_id>16731998</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.</reference_text>
              <pubmed_id>18184896</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.</reference_text>
              <pubmed_id>15982426</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.</reference_text>
              <pubmed_id>6321058</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.</reference_text>
              <pubmed_id>10431355</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.</reference_text>
              <pubmed_id>6810706</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.</reference_text>
              <pubmed_id>7758205</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.</reference_text>
              <pubmed_id>9357814</pubmed_id>
            </reference>
            <reference>
              <reference_text>del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.</reference_text>
              <pubmed_id>14512036</pubmed_id>
            </reference>
            <reference>
              <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
              <pubmed_id>12067838</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.</reference_text>
              <pubmed_id>17161231</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.</reference_text>
              <pubmed_id>11315839</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.</reference_text>
              <pubmed_id>17659063</pubmed_id>
            </reference>
            <reference>
              <reference_text>Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.</reference_text>
              <pubmed_id>17705693</pubmed_id>
            </reference>
            <reference>
              <reference_text>McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.</reference_text>
              <pubmed_id>1456422</pubmed_id>
            </reference>
            <reference>
              <reference_text>Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.</reference_text>
              <pubmed_id>484160</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.</reference_text>
              <pubmed_id>8234346</pubmed_id>
            </reference>
            <reference>
              <reference_text>Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.</reference_text>
              <pubmed_id>9591306</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.</reference_text>
              <pubmed_id>16966827</pubmed_id>
            </reference>
            <reference>
              <reference_text>Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.</reference_text>
              <pubmed_id>7096503</pubmed_id>
            </reference>
            <reference>
              <reference_text>Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.</reference_text>
              <pubmed_id>2614280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.</reference_text>
              <pubmed_id>18760976</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.</reference_text>
              <pubmed_id>11815509</pubmed_id>
            </reference>
            <reference>
              <reference_text>Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.</reference_text>
              <pubmed_id>10694785</pubmed_id>
            </reference>
            <reference>
              <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
              <pubmed_id>17919531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.</reference_text>
              <pubmed_id>17190852</pubmed_id>
            </reference>
            <reference>
              <reference_text>Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.</reference_text>
              <pubmed_id>22031514</pubmed_id>
            </reference>
            <reference>
              <reference_text>Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013  May 2.</reference_text>
              <pubmed_id>23637065</pubmed_id>
            </reference>
            <reference>
              <reference_text>World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study.  Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Obesity</name>
          <omim_id>601665</omim_id>
          <references>
            <reference>
              <reference_text>Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.</reference_text>
              <pubmed_id>15899597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Vice E, Privette JD, Hickner RC, Barakat HA: Ketone body metabolism in lean and obese women. Metabolism. 2005 Nov;54(11):1542-5.</reference_text>
              <pubmed_id>16253646</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brind J, Strain G, Miller L, Zumoff B, Vogelman J, Orentreich N: Obese men have elevated plasma levels of estrone sulfate. Int J Obes. 1990 Jun;14(6):483-6.</reference_text>
              <pubmed_id>2401584</pubmed_id>
            </reference>
            <reference>
              <reference_text>Serlie MJ, Meijer AJ, Groener JE, Duran M, Endert E, Fliers E, Aerts JM, Sauerwein HP: Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. Epub 2007 Jan 30.</reference_text>
              <pubmed_id>17264178</pubmed_id>
            </reference>
            <reference>
              <reference_text>Driskell JA, Chrisley BM, Reynolds LK, Moak SW: Plasma B6 vitamer and plasma and urinary 4-pyridoxic acid concentrations of middle-aged obese black women. J Chromatogr. 1991 Aug 23;568(2):333-40.</reference_text>
              <pubmed_id>1783639</pubmed_id>
            </reference>
            <reference>
              <reference_text>Haro C, Montes-Borrego M, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, Quintana-Navarro GM, Tinahones FJ, Landa BB, Lopez-Miranda J, Camargo A, Perez-Jimenez F: Two Healthy Diets Modulate Gut Microbial Community Improving Insulin Sensitivity in a Human Obese Population. J Clin Endocrinol Metab. 2016 Jan;101(1):233-42. doi: 10.1210/jc.2015-3351. Epub  2015 Oct 27.</reference_text>
              <pubmed_id>26505825</pubmed_id>
            </reference>
            <reference>
              <reference_text>Vioque J, Weinbrenner T, Asensio L, Castello A, Young IS, Fletcher A: Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr. 2007 May;97(5):977-86.</reference_text>
              <pubmed_id>17408529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Burrows TL, Warren JM, Colyvas K, Garg ML, Collins CE: Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity (Silver Spring). 2009 Jan;17(1):162-8. doi: 10.1038/oby.2008.495. Epub 2008 Nov 6.</reference_text>
              <pubmed_id>18997681</pubmed_id>
            </reference>
            <reference>
              <reference_text>Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr  17.</reference_text>
              <pubmed_id>24740590</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4.</reference_text>
              <pubmed_id>23108202</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cho K, Moon JS, Kang JH, Jang HB, Lee HJ, Park SI, Yu KS, Cho JY: Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. doi: 10.1111/ijpo.12114. Epub 2016 Feb 22.</reference_text>
              <pubmed_id>26910390</pubmed_id>
            </reference>
            <reference>
              <reference_text>Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pancreatic cancer</name>
          <omim_id>260350</omim_id>
          <references>
            <reference>
              <reference_text>Loser C, Folsch UR, Paprotny C, Creutzfeldt W: Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. Pancreas. 1990 Mar;5(2):119-27.</reference_text>
              <pubmed_id>2315288</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
              <pubmed_id>20300169</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang L, Jin H, Guo X, Yang Z, Zhao L, Tang S, Mo P, Wu K, Nie Y, Pan Y, Fan D: Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem. 2012 Sep;45(13-14):1064-9. doi: 10.1016/j.clinbiochem.2012.05.012.  Epub 2012 May 19.</reference_text>
              <pubmed_id>22613268</pubmed_id>
            </reference>
            <reference>
              <reference_text>OuYang D, Xu J, Huang H, Chen Z: Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol. 2011 Sep;165(1):148-54. doi: 10.1007/s12010-011-9240-0.  Epub 2011 Apr 20.</reference_text>
              <pubmed_id>21505807</pubmed_id>
            </reference>
            <reference>
              <reference_text>Xie G, Lu L, Qiu Y, Ni Q, Zhang W, Gao YT, Risch HA, Yu H, Jia W: Plasma metabolite biomarkers for the detection of pancreatic cancer. J Proteome Res. 2015 Feb 6;14(2):1195-202. doi: 10.1021/pr501135f. Epub 2014 Dec  8.</reference_text>
              <pubmed_id>25429707</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Schizophrenia</name>
          <omim_id>181500</omim_id>
          <references>
            <reference>
              <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
              <pubmed_id>115032</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
            <reference>
              <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
              <pubmed_id>2480613</pubmed_id>
            </reference>
            <reference>
              <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
              <pubmed_id>17276036</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
              <pubmed_id>11877547</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
              <pubmed_id>12796220</pubmed_id>
            </reference>
            <reference>
              <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
              <pubmed_id>7595563</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
              <pubmed_id>20814316</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
              <pubmed_id>25004141</pubmed_id>
            </reference>
            <reference>
              <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
              <pubmed_id>24713860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
              <pubmed_id>23823132</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
              <pubmed_id>2415198</pubmed_id>
            </reference>
            <reference>
              <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
              <pubmed_id>1694425</pubmed_id>
            </reference>
            <reference>
              <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
              <pubmed_id>7711000</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
              <pubmed_id>19390223</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
            <reference>
              <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
              <pubmed_id>22007635</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
              <pubmed_id>21483431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
              <pubmed_id>3741918</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
              <pubmed_id>11979513</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
              <pubmed_id>20206656</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
              <pubmed_id>436860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19401681</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
              <pubmed_id>6184954</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
              <pubmed_id>26952797</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
              <pubmed_id>22800120</pubmed_id>
            </reference>
            <reference>
              <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
              <pubmed_id>24789758</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
              <pubmed_id>22944140</pubmed_id>
            </reference>
            <reference>
              <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
              <pubmed_id>22892715</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
              <pubmed_id>17440431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
              <pubmed_id>25729574</pubmed_id>
            </reference>
            <reference>
              <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
              <pubmed_id>22257447</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Early preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pregnancy</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Yang XL, Wu XR: The dynamic changes of several reproductive hormones during termination of early pregnancy by RU486 in combination with PG-05 in Chinese women. Adv Contracept. 1988 Dec;4(4):319-26.</reference_text>
              <pubmed_id>3252730</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ball P, Emons G, Haupt O, Hoppen HO, Knuppen R: Radioimmunoassay of 2-hydroxyestrone. Steroids. 1978 Feb;31(2):249-58.</reference_text>
              <pubmed_id>663967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang YJ, Lee J, Choi MH, Chung BC: Direct determination of estriol 3- and 16-glucuronides in pregnancy urine by column-switching liquid chromatography with electrospray tandem mass spectrometry. Biomed Chromatogr. 2003 Jun;17(4):219-25.</reference_text>
              <pubmed_id>12833386</pubmed_id>
            </reference>
            <reference>
              <reference_text>Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702.</reference_text>
              <pubmed_id>2994907</pubmed_id>
            </reference>
            <reference>
              <reference_text>Huang PC, Kuo PL, Guo YL, Liao PC, Lee CC: Associations between urinary phthalate monoesters and thyroid hormones in pregnant women. Hum Reprod. 2007 Oct;22(10):2715-22. Epub 2007 Aug 17.</reference_text>
              <pubmed_id>17704099</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ribar S, Mesaric M, Sedic M: Sphingoid bases as possible diagnostic parameters. Croat Med J. 2003 Apr;44(2):165-70.</reference_text>
              <pubmed_id>12698507</pubmed_id>
            </reference>
            <reference>
              <reference_text>Khan HA, Sobki SH, Alhomida AS: Fluctuations in fasting blood glucose and serum fructosamine in pregnant women monitored on successive antenatal visits. Clin Exp Med. 2006 Oct;6(3):134-7.</reference_text>
              <pubmed_id>17061063</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mikkelsen TB, Osler M, Olsen SF: Validity of protein, retinol, folic acid and n-3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutr. 2006 Sep;9(6):771-8.</reference_text>
              <pubmed_id>16925883</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shiraishi M, Haruna M, Matsuzaki M, Murayama R, Sasaki S, Murashima S: Validity and reproducibility of folate and vitamin B(12) intakes estimated from a self-administered diet history questionnaire in Japanese pregnant women. Nutr J. 2012 Mar 15;11:15. doi: 10.1186/1475-2891-11-15.</reference_text>
              <pubmed_id>22420377</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brantsaeter AL, Haugen M, Julshamn K, Alexander J, Meltzer HM: Evaluation of urinary iodine excretion as a biomarker for intake of milk and dairy products in pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Clin Nutr. 2009 Mar;63(3):347-54. Epub 2007 Dec 5.</reference_text>
              <pubmed_id>18059417</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28.</reference_text>
              <pubmed_id>22494326</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8.</reference_text>
              <pubmed_id>23313728</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25.</reference_text>
              <pubmed_id>23535240</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1.</reference_text>
              <pubmed_id>24704061</pubmed_id>
            </reference>
            <reference>
              <reference_text>The Merck Manual, 17th ed. Mark H. Beers, MD, Robert Berkow, MD, eds. Whitehouse Station, NJ: Merck Research Labs, 1999.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Late-onset preeclampsia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13.</reference_text>
              <pubmed_id>23159745</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>2-Ketoglutarate dehydrogenase complex deficiency</name>
          <omim_id>203740</omim_id>
          <references>
            <reference>
              <reference_text>Bonnefont JP, Chretien D, Rustin P, Robinson B, Vassault A, Aupetit J, Charpentier C, Rabier D, Saudubray JM, Munnich A: Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr. 1992 Aug;121(2):255-8.</reference_text>
              <pubmed_id>1640293</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kohlschutter A, Behbehani A, Langenbeck U, Albani M, Heidemann P, Hoffmann G, Kleineke J, Lehnert W, Wendel U: A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Eur J Pediatr. 1982 Feb;138(1):32-7.</reference_text>
              <pubmed_id>7075624</pubmed_id>
            </reference>
            <reference>
              <reference_text>Guffon N, Lopez-Mediavilla C, Dumoulin R, Mousson B, Godinot C, Carrier H, Collombet JM, Divry P, Mathieu M, Guibaud P: 2-Ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis. 1993;16(5):821-30.</reference_text>
              <pubmed_id>8295396</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency</name>
          <omim_id>605911</omim_id>
          <references>
            <reference>
              <reference_text>Thompson GN, Hsu BY, Pitt JJ, Treacy E, Stanley CA: Fasting hypoketotic coma in a child with deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase. N Engl J Med. 1997 Oct 23;337(17):1203-7. doi: 10.1056/NEJM199710233371704.</reference_text>
              <pubmed_id>9337379</pubmed_id>
            </reference>
            <reference>
              <reference_text>Morris AA, Lascelles CV, Olpin SE, Lake BD, Leonard JV, Quant PA: Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency. Pediatr Res. 1998 Sep;44(3):392-6. doi: 10.1203/00006450-199809000-00021.</reference_text>
              <pubmed_id>9727719</pubmed_id>
            </reference>
            <reference>
              <reference_text>Conboy E, Vairo F, Schultz M, Agre K, Ridsdale R, Deyle D, Oglesbee D, Gavrilov D, Klee EW, Lanpher B: Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features. JIMD Rep. 2017 Oct 14. doi: 10.1007/8904_2017_59.</reference_text>
              <pubmed_id>29030856</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>3-Hydroxyacyl-CoA dehydrogenase deficiency</name>
          <omim_id>231530</omim_id>
          <references>
            <reference>
              <reference_text>Hsu BY, Kelly A, Thornton PS, Greenberg CR, Dilling LA, Stanley CA: Protein-sensitive and fasting hypoglycemia in children with the hyperinsulinism/hyperammonemia syndrome. J Pediatr. 2001 Mar;138(3):383-9. doi: 10.1067/mpd.2001.111818.</reference_text>
              <pubmed_id>11241047</pubmed_id>
            </reference>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njolstad PR, Jellum E, Sovik O: Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 2004 Jan;53(1):221-7.</reference_text>
              <pubmed_id>14693719</pubmed_id>
            </reference>
            <reference>
              <reference_text>Vilarinho L, Marques JS, Rocha H, Ramos A, Lopes L, Narayan SB, Bennett MJ: Diagnosis of a patient with a kinetic variant of medium and short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency by newborn screening. Mol Genet Metab. 2012 Jul;106(3):277-80. doi: 10.1016/j.ymgme.2012.04.005. Epub 2012 Apr 13.</reference_text>
              <pubmed_id>22579592</pubmed_id>
            </reference>
            <reference>
              <reference_text>Popa FI, Perlini S, Teofoli F, Degani D, Funghini S, La Marca G, Rinaldo P, Vincenzi M, Antoniazzi F, Boner A, Camilot M: 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. JIMD Rep. 2012;2:71-7. doi: 10.1007/8904_2011_50. Epub 2011 Sep 6.</reference_text>
              <pubmed_id>23430856</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Long-chain-3-hydroxyacyl CoA dehydrogenase deficiency</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Divry P, Vianey-Saban C, Mathieu M: Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects. J Inherit Metab Dis. 1999 May;22(3):286-8.</reference_text>
              <pubmed_id>10384388</pubmed_id>
            </reference>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ketotic hypoglycemia</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>3-Hydroxy-3-methylglutaryl-CoA lyase deficiency</name>
          <omim_id>246450</omim_id>
          <references>
            <reference>
              <reference_text>Jakobs C, Bojasch M, Duran M, Ketting D, Wadman SK, Leupold D: 3-methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. Clin Chim Acta. 1980 Sep 8;106(1):85-9.</reference_text>
              <pubmed_id>6157502</pubmed_id>
            </reference>
            <reference>
              <reference_text>Muroi J, Yorifuji T, Uematsu A, Shigematsu Y, Onigata K, Maruyama H, Nobutoki T, Kitamura A, Nakahata T: Molecular and clinical analysis of Japanese patients with 3-hydroxy-3-methylglutaryl CoA lyase (HL) deficiency. Hum Genet. 2000 Oct;107(4):320-6.</reference_text>
              <pubmed_id>11129331</pubmed_id>
            </reference>
            <reference>
              <reference_text>Grunert SC, Schlatter SM, Schmitt RN, Gemperle-Britschgi C, Mrazova L, Balci MC, Bischof F, Coker M, Das AM, Demirkol M, de Vries M, Gokcay G, Haberle J, Ucar SK, Lotz-Havla AS, Lucke T, Roland D, Rutsch F, Santer R, Schlune A, Staufner C, Schwab KO, Mitchell GA, Sass JO: 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients. Mol Genet Metab. 2017 Jul;121(3):206-215. doi: 10.1016/j.ymgme.2017.05.014. Epub  2017 May 22.</reference_text>
              <pubmed_id>28583327</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy. Ann Neurol. 2004 Nov;56(5):727-30.</reference_text>
              <pubmed_id>15505778</pubmed_id>
            </reference>
            <reference>
              <reference_text>Dos Santos Mello M, Ribas GS, Wayhs CA, Hammerschmidt T, Guerreiro GB, Favenzani JL, Sitta A, de Moura Coelho D, Wajner M, Vargas CR: Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Mol Cell Biochem. 2015 Apr;402(1-2):149-55. doi: 10.1007/s11010-014-2322-x. Epub  2015 Jan 4.</reference_text>
              <pubmed_id>25557019</pubmed_id>
            </reference>
            <reference>
              <reference_text>Santarelli F, Cassanello M, Enea A, Poma F, D'Onofrio V, Guala G, Garrone G, Puccinelli P, Caruso U, Porta F, Spada M: A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr. 2013 May 24;39:33. doi: 10.1186/1824-7288-39-33.</reference_text>
              <pubmed_id>23705938</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174-88.</reference_text>
              <pubmed_id>1886403</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zschocke J, Penzien JM, Bielen R, Casals N, Aledo R, Pie J, Hoffmann GF, Hegardt FG, Mayatepek E: The diagnosis of mitochondrial HMG-CoA synthase deficiency. J Pediatr. 2002 Jun;140(6):778-80. doi: 10.1067/mpd.2002.123854.</reference_text>
              <pubmed_id>12072887</pubmed_id>
            </reference>
            <reference>
              <reference_text>Leung AA, Chan AK, Ezekowitz JA, Leung AK: A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency. Case Rep Med. 2009;2009:183125. doi: 10.1155/2009/183125. Epub 2009 Nov 4.</reference_text>
              <pubmed_id>19893767</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency</name>
          <omim_id>201810</omim_id>
          <references>
            <reference>
              <reference_text>Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9.</reference_text>
              <pubmed_id>7951484</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lutfallah C, Wang W, Mason JI, Chang YT, Haider A, Rich B, Castro-Magana M, Copeland KC, David R, Pang S: Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2002 Jun;87(6):2611-22. doi: 10.1210/jcem.87.6.8615.</reference_text>
              <pubmed_id>12050224</pubmed_id>
            </reference>
            <reference>
              <reference_text>Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA: Severe Salt-Losing 3beta-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G&gt;A Homozygotes. J Clin Endocrinol Metab. 2015 Aug;100(8):E1105-15. doi: 10.1210/jc.2015-2098. Epub 2015 Jun 16.</reference_text>
              <pubmed_id>26079780</pubmed_id>
            </reference>
            <reference>
              <reference_text>Guven A, Polat S: Testicular Adrenal Rest Tumor in Two Brothers with a Novel Mutation in the 3-Beta-Hydroxysteroid Dehydrogenase-2 Gene. J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):85-90. doi: 10.4274/jcrpe.3306. Epub 2016 Jul 29.</reference_text>
              <pubmed_id>27476613</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pyruvate dehydrogenase phosphatase deficiency</name>
          <omim_id>608782</omim_id>
          <references>
            <reference>
              <reference_text>Robinson BH, Sherwood WG: Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy. Pediatr Res. 1975 Dec;9(12):935-9. doi: 10.1203/00006450-197512000-00015.</reference_text>
              <pubmed_id>172850</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Carnitine palmitoyltransferase I deficiency</name>
          <omim_id>255120</omim_id>
          <references>
            <reference>
              <reference_text>Olpin SE, Allen J, Bonham JR, Clark S, Clayton PT, Calvin J, Downing M, Ives K, Jones S, Manning NJ, Pollitt RJ, Standing SJ, Tanner MS: Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis. 2001 Feb;24(1):35-42.</reference_text>
              <pubmed_id>11286380</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Anoxia</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
              <pubmed_id>8579834</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Meningitis</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev. 2003 Mar;25(2):102-6.</reference_text>
              <pubmed_id>12581805</pubmed_id>
            </reference>
            <reference>
              <reference_text>Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R, Nigam A, Kumar R, Mandal SK, Roy R: Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed. 2005 Jun;18(4):213-25.</reference_text>
              <pubmed_id>15627241</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wevers RA, Engelke U, Wendel U, de Jong JG, Gabreels FJ, Heerschap A: Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem. 1995 May;41(5):744-51.</reference_text>
              <pubmed_id>7729054</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qureshi GA, Baig SM, Bednar I, Halawa A, Parvez SH: The neurochemical markers in cerebrospinal fluid to differentiate between aseptic and tuberculous meningitis. Neurochem Int. 1998 Feb;32(2):197-203.</reference_text>
              <pubmed_id>9542731</pubmed_id>
            </reference>
            <reference>
              <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
              <pubmed_id>15061359</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kastenbauer S, Koedel U, Becker BF, Pfister HW: Oxidative stress in bacterial meningitis in humans. Neurology. 2002 Jan 22;58(2):186-91.</reference_text>
              <pubmed_id>11805243</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lerche A, Svenson M, Wiik A: Cerebrospinal fluid levels of cyclic nucleotides in meningitis and idiopathic polyneuritis. Acta Neurol Scand. 1984 Mar;69(3):168-75.</reference_text>
              <pubmed_id>6326460</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A: High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res. 2005 Oct;39(3):302-6.</reference_text>
              <pubmed_id>16150112</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rating D, Siemes H, Loscher W: Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis. J Neurol. 1983;230(4):217-25.</reference_text>
              <pubmed_id>6198481</pubmed_id>
            </reference>
            <reference>
              <reference_text>Westcott JY, Murphy RC, Stenmark K: Eicosanoids in human ventricular cerebrospinal fluid following severe brain injury. Prostaglandins. 1987 Dec;34(6):877-87.</reference_text>
              <pubmed_id>2835791</pubmed_id>
            </reference>
            <reference>
              <reference_text>Laurent UB, Laurent TC, Hellsing LK, Persson L, Hartman M, Lilja K: Hyaluronan in human cerebrospinal fluid. Acta Neurol Scand. 1996 Sep;94(3):194-206.</reference_text>
              <pubmed_id>8899053</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ulcerative colitis</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
              <pubmed_id>21059682</pubmed_id>
            </reference>
            <reference>
              <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
              <pubmed_id>1740537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
              <pubmed_id>17314143</pubmed_id>
            </reference>
            <reference>
              <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
              <pubmed_id>21761941</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Crohn's disease</name>
          <omim_id>266600</omim_id>
          <references>
            <reference>
              <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
              <pubmed_id>16440420</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
              <pubmed_id>8723414</pubmed_id>
            </reference>
            <reference>
              <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19491857</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Alzheimer's disease</name>
          <omim_id>104300</omim_id>
          <references>
            <reference>
              <reference_text>Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.</reference_text>
              <pubmed_id>17031479</pubmed_id>
            </reference>
            <reference>
              <reference_text>Selley ML, Close DR, Stern SE: The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8.</reference_text>
              <pubmed_id>11959400</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shetty HU, Holloway HW, Schapiro MB: Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem. 1996 Feb;42(2):298-302.</reference_text>
              <pubmed_id>8595727</pubmed_id>
            </reference>
            <reference>
              <reference_text>Jia JP, Jia JM, Zhou WD, Xu M, Chu CB, Yan X, Sun YX: Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia. Chin Med J (Engl). 2004 Aug;117(8):1161-4.</reference_text>
              <pubmed_id>15361288</pubmed_id>
            </reference>
            <reference>
              <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
              <pubmed_id>9693263</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303.</reference_text>
              <pubmed_id>15465626</pubmed_id>
            </reference>
            <reference>
              <reference_text>Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91.</reference_text>
              <pubmed_id>15061359</pubmed_id>
            </reference>
            <reference>
              <reference_text>Raskind MA, Peskind ER, Holmes C, Goldstein DS: Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry. 1999 Sep 15;46(6):756-65.</reference_text>
              <pubmed_id>10494443</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lovell MA, Markesbery WR: Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol. 2001 Mar;58(3):392-6.</reference_text>
              <pubmed_id>11255442</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G, Sauer H: Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging. 2003 Mar-Apr;24(2):333-8.</reference_text>
              <pubmed_id>12498967</pubmed_id>
            </reference>
            <reference>
              <reference_text>Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.</reference_text>
              <pubmed_id>16227558</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC: Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna). 1998;105(4-5):479-88.</reference_text>
              <pubmed_id>9720975</pubmed_id>
            </reference>
            <reference>
              <reference_text>Molina JA, Jimenez-Jimenez FJ, Hernanz A, Fernandez-Vivancos E, Medina S, de Bustos F, Gomez-Escalonilla C, Sayed Y: Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease. J Neural Transm (Vienna). 2002 Jul;109(7-8):1035-44.</reference_text>
              <pubmed_id>12111441</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bocca B, Forte G, Petrucci F, Pino A, Marchione F, Bomboi G, Senofonte O, Giubilei F, Alimonti A: Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. Ann Ist Super Sanita. 2005;41(2):197-203.</reference_text>
              <pubmed_id>16244393</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.</reference_text>
              <pubmed_id>8356878</pubmed_id>
            </reference>
            <reference>
              <reference_text>Abe T, Tohgi H, Isobe C, Murata T, Sato C: Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J Neurosci Res. 2002 Nov 1;70(3):447-50.</reference_text>
              <pubmed_id>12391605</pubmed_id>
            </reference>
            <reference>
              <reference_text>Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst. 1993 May 5;85(9):722-7.</reference_text>
              <pubmed_id>8478958</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
              <pubmed_id>21292280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Motawaj M, Peoc'h K, Callebert J, Arrang JM: CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J Alzheimers Dis. 2010;22(3):861-71. doi: 10.3233/JAD-2010-100381.</reference_text>
              <pubmed_id>20858978</pubmed_id>
            </reference>
            <reference>
              <reference_text>Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K: Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Eur Neurol. 2011;65(5):270-8. doi: 10.1159/000326301. Epub 2011 Apr 8.</reference_text>
              <pubmed_id>21474939</pubmed_id>
            </reference>
            <reference>
              <reference_text>Linnebank M, Popp J, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kolsch H, Weller M, Jessen F: S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis. 2010;7(6):373-8. doi: 10.1159/000309657. Epub 2010 Jun 3.</reference_text>
              <pubmed_id>20523031</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rosler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J Neural Transm (Vienna). 2001;108(2):231-46.</reference_text>
              <pubmed_id>11314776</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sunderland T, Berrettini WH, Molchan SE, Lawlor BA, Martinez RA, Vitiello B, Tariot PN, Cohen RM: Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease. Biol Psychiatry. 1991 Jul 1;30(1):81-7.</reference_text>
              <pubmed_id>1716470</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Frontotemporal dementia</name>
          <omim_id>600274</omim_id>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Lewy body disease</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013  Sep 6.</reference_text>
              <pubmed_id>23857558</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Medium Chain Acyl-CoA Dehydrogenase Deficiency</name>
          <omim_id>201450</omim_id>
          <references>
            <reference>
              <reference_text>Duran M, De Klerk JB, Wadman SK, Bruinvis L, Ketting D: The differential diagnosis of dicarboxylic aciduria. J Inherit Metab Dis. 1984;7 Suppl 1:48-51.</reference_text>
              <pubmed_id>6434845</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency. J Lipid Res. 1990 May;31(5):763-71.</reference_text>
              <pubmed_id>2380628</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gregersen N, Kolvraa S, Rasmussen K, Mortensen PB, Divry P, David M, Hobolth N: General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983 Aug 15;132(2):181-91.</reference_text>
              <pubmed_id>6616873</pubmed_id>
            </reference>
            <reference>
              <reference_text>Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J Clin Invest. 2001 Aug;108(3):457-65.</reference_text>
              <pubmed_id>11489939</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases. 2nd ed. Berlin, Germany, Springer, 2003</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom Ion Proc. 1991;111:211-228</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Fumarase deficiency</name>
          <omim_id>606812</omim_id>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
            <reference>
              <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
              <pubmed_id>20549362</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tregoning S, Salter W, Thorburn DR, Durkie M, Panayi M, Wu JY, Easterbrook A, Coman DJ: Fumarase deficiency in dichorionic diamniotic twins. Twin Res Hum Genet. 2013 Dec;16(6):1117-20. doi: 10.1017/thg.2013.72. Epub 2013 Nov 4.</reference_text>
              <pubmed_id>24182348</pubmed_id>
            </reference>
            <reference>
              <reference_text>Whelan DT, Hill RE, McClorry S: Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983 Aug 31;132(3):301-8.</reference_text>
              <pubmed_id>6616883</pubmed_id>
            </reference>
            <reference>
              <reference_text>Maradin M, Fumic K, Hansikova H, Tesarova M, Wenchich L, Dorner S, Sarnavka V, Zeman J, Baric I: Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis. 2006 Oct;29(5):683. Epub 2006 Aug 5.</reference_text>
              <pubmed_id>16972175</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>3-Hydroxyisobutyric acid dehydrogenase deficiency</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Ko FJ, Nyhan WL, Wolff J, Barshop B, Sweetman L: 3-Hydroxyisobutyric aciduria: an inborn error of valine metabolism. Pediatr Res. 1991 Oct;30(4):322-6. doi: 10.1203/00006450-199110000-00006.</reference_text>
              <pubmed_id>1956714</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>3-Hydroxydicarboxylic aciduria</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Tserng KY, Jin SJ, Kerr DS, Hoppel CL: Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism. 1991 Jul;40(7):676-82.</reference_text>
              <pubmed_id>1870421</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hagenfeldt L, von Dobeln U, Holme E, Alm J, Brandberg G, Enocksson E, Lindeberg L: 3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis. J Pediatr. 1990 Mar;116(3):387-92.</reference_text>
              <pubmed_id>2308028</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Pyruvate carboxylase deficiency</name>
          <omim_id>266150</omim_id>
          <references>
            <reference>
              <reference_text>Habarou F, Brassier A, Rio M, Chretien D, Monnot S, Barbier V, Barouki R, Bonnefont JP, Boddaert N, Chadefaux-Vekemans B, Le Moyec L, Bastin J, Ottolenghi C, de Lonlay P: Pyruvate carboxylase deficiency: An underestimated cause of lactic acidosis. Mol Genet Metab Rep. 2014 Nov 28;2:25-31. doi: 10.1016/j.ymgmr.2014.11.001. eCollection 2015 Mar.</reference_text>
              <pubmed_id>28649521</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C01089</kegg_id>
      <foodb_id>FDB021869</foodb_id>
      <chemspider_id>83181</chemspider_id>
      <drugbank_id/>
      <pdb_id/>
      <chebi_id>17066</chebi_id>
      <pubchem_compound_id>92135</pubchem_compound_id>
      <biocyc_id>CPD-335</biocyc_id>
      <wikipedia_id>Beta-Hydroxybutyric_acid</wikipedia_id>
      <knapsack_id/>
      <phenol_explorer_compound_id/>
      <bigg_id>36784</bigg_id>
      <metlin_id/>
      <vmh_id>BHB</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Le Sann, Christine; Munoz, Dulce M.; Saunders, Natalie; Simpson, Thomas J.; Smith, David I.; Soulas, Florilene; Watts, Paul; Willis, Christine L.  Assembly intermediates in polyketide biosynthesis: enantioselective syntheses of b-hydroxycarbonyl compounds. Org Biomol Chem. 2005 May 7;3(9):1719-28. Epub 2005 Mar 31. Pubmed: 15858656</synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP: Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J Cereb Blood Flow Metab. 2000 Oct;20(10):1502-7.</reference_text>
          <pubmed_id>11043913</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pan JW, Telang FW, Lee JH, de Graaf RA, Rothman DL, Stein DT, Hetherington HP: Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain. J Neurochem. 2001 Nov;79(3):539-44.</reference_text>
          <pubmed_id>11701757</pubmed_id>
        </reference>
        <reference>
          <reference_text>Plecko B, Stoeckler-Ipsiroglu S, Schober E, Harrer G, Mlynarik V, Gruber S, Moser E, Moeslinger D, Silgoner H, Ipsiroglu O: Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr Res. 2002 Aug;52(2):301-6.</reference_text>
          <pubmed_id>12149510</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raunio RP, Leivo PV, Kuusinen AM: Bioluminescent assay of D-3-hydroxybutyrate in serum. J Biolumin Chemilumin. 1986 Jun;1(1):11-4.</reference_text>
          <pubmed_id>3503522</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yeh YY, Sheehan PM: Preferential utilization of ketone bodies in the brain and lung of newborn rats. Fed Proc. 1985 Apr;44(7):2352-8.</reference_text>
          <pubmed_id>3884391</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kita K, Ishimaru K, Teraoka M, Yanase H, Kato N: Properties of poly(3-hydroxybutyrate) depolymerase from a marine bacterium, Alcaligenes faecalis AE122. Appl Environ Microbiol. 1995 May;61(5):1727-30.</reference_text>
          <pubmed_id>7646009</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kim BS, Lee SC, Lee SY, Chang HN, Chang YK, Woo SI: Production of poly(3-hydroxybutyric acid) by fed-batch culture of Alcaligenes eutrophus with glucose concentration control. Biotechnol Bioeng. 1994 Apr 15;43(9):892-8. doi: 10.1002/bit.260430908.</reference_text>
          <pubmed_id>18615882</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.</reference_text>
          <pubmed_id>8579834</pubmed_id>
        </reference>
        <reference>
          <reference_text>Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL: Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 1998;44(5):300-4.</reference_text>
          <pubmed_id>9693263</pubmed_id>
        </reference>
        <reference>
          <reference_text>Abrahamsson K, Eriksson BO, Holme E, Jodal U, Jonsson A, Lindstedt S: Pivalic acid-induced carnitine deficiency and physical exercise in humans. Metabolism. 1996 Dec;45(12):1501-7.</reference_text>
          <pubmed_id>8969283</pubmed_id>
        </reference>
        <reference>
          <reference_text>Teresinski G, Buszewicz G, Madro R: The influence of ethanol on the level of ketone bodies in hypothermia. Forensic Sci Int. 2002 Jun 25;127(1-2):88-96.</reference_text>
          <pubmed_id>12098531</pubmed_id>
        </reference>
        <reference>
          <reference_text>Nalecz KA, Miecz D, Berezowski V, Cecchelli R: Carnitine: transport and physiological functions in the brain. Mol Aspects Med. 2004 Oct-Dec;25(5-6):551-67.</reference_text>
          <pubmed_id>15363641</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
          <pubmed_id>2026685</pubmed_id>
        </reference>
        <reference>
          <reference_text>Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.</reference_text>
          <pubmed_id>12067838</pubmed_id>
        </reference>
        <reference>
          <reference_text>Krotkiewski M: Value of VLCD supplementation with medium chain triglycerides. Int J Obes Relat Metab Disord. 2001 Sep;25(9):1393-400.</reference_text>
          <pubmed_id>11571605</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kamijo T, Indo Y, Souri M, Aoyama T, Hara T, Yamamoto S, Ushikubo S, Rinaldo P, Matsuda I, Komiyama A, Hashimoto T: Medium chain 3-ketoacyl-coenzyme A thiolase deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Pediatr Res. 1997 Nov;42(5):569-76.</reference_text>
          <pubmed_id>9357925</pubmed_id>
        </reference>
        <reference>
          <reference_text>Geary N, Grotschel H, Scharrer E: Blood metabolites and feeding during postinsulin hypophagia. Am J Physiol. 1982 Sep;243(3):R304-11.</reference_text>
          <pubmed_id>7051864</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
          <pubmed_id>8412012</pubmed_id>
        </reference>
        <reference>
          <reference_text>Frenkel G, Peterson RN, Freund M: Oxidative and glycolytic metabolism of semen components by washed guinea pig spermatozoa. Fertil Steril. 1975 Feb;26(2):144-7.</reference_text>
          <pubmed_id>1126459</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bernardi, R. et al., Chem. Commun., 1984, 460, (resoln)</reference_text>
        </reference>
        <reference>
          <reference_text>Encyclopedia of Food and Color Additives, (ed. Burdock, G.A.), CRC Press, 1997, 994-995, (Et ester)</reference_text>
        </reference>
        <reference>
          <reference_text>Fenaroli's Handbook of Flavor Ingredients, 3rd edn., (ed. Burdock, G.A.), CRC Press, 1995, 1, 238, (Et ester)</reference_text>
        </reference>
        <reference>
          <reference_text>Forsyth, W.G.C. et al., Nature (London), 1958, 182, 800, (isol)</reference_text>
        </reference>
        <reference>
          <reference_text>Gottschalk, G. et al., Nature (London), 1965, 205, 308</reference_text>
        </reference>
        <reference>
          <reference_text>Krajewski, D. et al., Phytochemistry, 1997, 45, 1627, (ester glucosides)</reference_text>
        </reference>
        <reference>
          <reference_text>Levene, P.A. et al., J. Biol. Chem., 1926, 68, 418, (abs config)</reference_text>
        </reference>
        <reference>
          <reference_text>Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, MEF500 MKP250</reference_text>
        </reference>
        <reference>
          <reference_text>Marchessault, R.H. et al., Makromol. Chem., Macromol. Symp., 1988, 19, 235, (rev, polymers)</reference_text>
        </reference>
        <reference>
          <reference_text>Muller, H.-M. et al., Angew. Chem., Int. Ed., 1993, 32, 477, (rev, polymer)</reference_text>
        </reference>
        <reference>
          <reference_text>Org. Synth., 1993, 71, 39, (synth, acid, Meester, pmr, ir)</reference_text>
        </reference>
        <reference>
          <reference_text>Quang DN, Hashimoto T, Toyota M, Asakawa Y. Occurrence of a high concentration of spider pheromones in the ascomycete fungus Hypoxylon truncatum. J Nat Prod. 2003 Dec;66(12):1613-4.</reference_text>
        </reference>
        <reference>
          <reference_text>Schulz S, Toft S. Identification of a sex pheromone from a spider. Science. 1993 Jun 11;260(5114):1635-7.</reference_text>
        </reference>
        <reference>
          <reference_text>Seebach, D. et al., Helv. Chim. Acta, 1982, 65, 495-503, (esters, synth)</reference_text>
        </reference>
        <reference>
          <reference_text>Seebach, D. et al., Helv. Chim. Acta, 1988, 71, 155, (synth, dimer)</reference_text>
        </reference>
        <reference>
          <reference_text>Wipf, B. et al., Helv. Chim. Acta, 1983, 66, 485</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00355</protein_accession>
          <name>Sulfotransferase family cytosolic 2B member 1</name>
          <uniprot_id>O00204</uniprot_id>
          <gene_name>SULT2B1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00483</protein_accession>
          <name>UDP-glucuronosyltransferase 1-1</name>
          <uniprot_id>P22309</uniprot_id>
          <gene_name>UGT1A1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00540</protein_accession>
          <name>D-beta-hydroxybutyrate dehydrogenase, mitochondrial</name>
          <uniprot_id>Q02338</uniprot_id>
          <gene_name>BDH1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07259</protein_accession>
          <name>3-hydroxybutyrate dehydrogenase type 2</name>
          <uniprot_id>Q9BUT1</uniprot_id>
          <gene_name>BDH2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09102</protein_accession>
          <name>Novel protein similar to 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (Hydroxymethylglutaricaciduria)</name>
          <uniprot_id>Q9NT06</uniprot_id>
          <gene_name>DKFZp434G1411</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-04-23 20:53:26 UTC</update_date>
      <accession>HMDB0000012</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00012</accession>
      </secondary_accessions>
      <name>Deoxyuridine</name>
      <description>Deoxyuridine, also known as dU, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. Deoxyuridine exists in all living organisms, ranging from bacteria to humans. Within humans, deoxyuridine participates in a number of enzymatic reactions. In particular, deoxyuridine can be biosynthesized from deoxycytidine through its interaction with the enzyme cytidine deaminase. In addition, deoxyuridine can be converted into uracil and deoxyribose 1-phosphate through its interaction with the enzyme thymidine phosphorylase. Deoxyuridine is considered to be an antimetabolite that is converted into deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies. In humans, deoxyuridine is involved in the metabolic disorder called UMP synthase deficiency (orotic aciduria). Outside of the human body, deoxyuridine has been detected, but not quantified in, several different foods, such as lichee, highbush blueberries, agaves, macadamia nut (M. tetraphylla), and red bell peppers. This could make deoxyuridine a potential biomarker for the consumption of these foods.</description>
      <synonyms>
        <synonym>2-Deoxyuridine</synonym>
        <synonym>dU</synonym>
        <synonym>2'-Deoxyuridine</synonym>
        <synonym>1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione</synonym>
        <synonym>1-(2-Deoxy-beta-D-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione</synonym>
        <synonym>1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione</synonym>
        <synonym>1-(2-Deoxy-beta-delta-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione</synonym>
        <synonym>1-(2-Deoxy-D-erythro-pentofuranosyl)uracil</synonym>
        <synonym>1-(2-Deoxy-delta-erythro-pentofuranosyl)uracil</synonym>
        <synonym>2'-Desoxyuridine</synonym>
        <synonym>Deoxyribose uracil</synonym>
        <synonym>Desoxyuridine</synonym>
        <synonym>Uracil deoxyriboside</synonym>
        <synonym>Uracil desoxyuridine</synonym>
        <synonym>(beta 1-(2-Deoxyribopyranosyl))thymidine</synonym>
        <synonym>Deoxyuridine</synonym>
      </synonyms>
      <chemical_formula>C9H12N2O5</chemical_formula>
      <average_molecular_weight>228.202</average_molecular_weight>
      <monisotopic_molecular_weight>228.074621504</monisotopic_molecular_weight>
      <iupac_name>1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione</iupac_name>
      <traditional_iupac>2'-deoxyuridine</traditional_iupac>
      <cas_registry_number>951-78-0</cas_registry_number>
      <smiles>OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O</smiles>
      <inchi>InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1</inchi>
      <inchikey>MXHRCPNRJAMMIM-SHYZEUOFSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2.</description>
        <direct_parent>Pyrimidine 2'-deoxyribonucleosides</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Nucleosides, nucleotides, and analogues</super_class>
        <class>Pyrimidine nucleosides</class>
        <sub_class>Pyrimidine 2'-deoxyribonucleosides</sub_class>
        <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Azacyclic compounds</alternative_parent>
          <alternative_parent>Heteroaromatic compounds</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Hydropyrimidines</alternative_parent>
          <alternative_parent>Lactams</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Organonitrogen compounds</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
          <alternative_parent>Oxacyclic compounds</alternative_parent>
          <alternative_parent>Primary alcohols</alternative_parent>
          <alternative_parent>Pyrimidones</alternative_parent>
          <alternative_parent>Secondary alcohols</alternative_parent>
          <alternative_parent>Tetrahydrofurans</alternative_parent>
          <alternative_parent>Ureas</alternative_parent>
          <alternative_parent>Vinylogous amides</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alcohol</substituent>
          <substituent>Aromatic heteromonocyclic compound</substituent>
          <substituent>Azacycle</substituent>
          <substituent>Heteroaromatic compound</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Hydropyrimidine</substituent>
          <substituent>Lactam</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organoheterocyclic compound</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Oxacycle</substituent>
          <substituent>Primary alcohol</substituent>
          <substituent>Pyrimidine</substituent>
          <substituent>Pyrimidine 2'-deoxyribonucleoside</substituent>
          <substituent>Pyrimidone</substituent>
          <substituent>Secondary alcohol</substituent>
          <substituent>Tetrahydrofuran</substituent>
          <substituent>Urea</substituent>
          <substituent>Vinylogous amide</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>Deoxyribonucleosides</external_descriptor>
          <external_descriptor>pyrimidine 2'-deoxyribonucleoside</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fabaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Papilionoideae</synonym>
                            <synonym>Legume</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Glycine max</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Soy</synonym>
                            <synonym>Soya</synonym>
                            <synonym>Soybean</synonym>
                            <synonym>Soya bean</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Cucurbitaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Cucurbits</synonym>
                            <synonym>Gourds</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Intestine</term>
                      <definition>The portion of the gastrointestinal tract that includes the small and large intestines.</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Testicle</term>
                      <definition>Either of the paired male reproductive glands that produce the male germ cells and the male hormones. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Testes</synonym>
                        <synonym>Testis</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Bone marrow</term>
                      <definition>The tissue occupying the spaces of some bones. it consists of blood vessel sinuses and a network of hematopoietic cells. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Bladder</term>
                      <definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Prostate</term>
                      <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Prostate gland</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Pancreas</term>
                      <definition>A digestive organ in the abdomen that has both endocrine and exocrine functions. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Muscle</term>
                      <definition>A fibrous soft tissue with the ability to contract to produce force and motion. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell</term>
                      <definition/>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Nerve cell</term>
                          <definition>A cell in the nervous system, that is able to conduct weak electric signals between the brain and the body. A typical neuron consists of a cell body, containing the nucleus and the surrounding cytoplasm (perikaryon); several short radiating processes (dendrites); and one long process (the axon), which terminates in twiglike branches (telodendrons) and may have branches (collaterals) projecting along its course. (NCI).</definition>
                          <parent_id>7734</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Neuron</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fibroblast</term>
                          <definition>A cell in the connective tissue, that makes and secretes collagen proteins.</definition>
                          <parent_id>7734</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Nucleus</term>
                      <definition>A body within the cell, surrounded by a membrane, within which lie the chromosomes, one or more nucleoli, combined with proteins, and exhibits mitosis. (NCI)</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cell nucleus</synonym>
                        <synonym>Nucleic</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</term>
                          <definition> mngie causes accumulation of thymidine and deoxyuridine in the urine. symptoms of mngie include ptosis, progressive external ophthalmoplegia, gastrointestinal dysmotility (often pseudoobstruction), diffuse leukoencephalopathy, peripheral neuropathy, and myopathy.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Pyrimidine Metabolism</term>
                          <definition> cytosine, thymine, and uracil are pyrimidine derivatives. synthesis of the pyrimidines is less complex than that of the purines, since the base is much simpler this pathway depicts a number of processes including pyrimidine nucleotide biosynthesis, pyrimidine degradation and pyrimidine salvage.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>logp</kind>
          <value>-1.51</value>
          <source>BALZARINI,JM ET AL. (1989)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>167 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-1.49</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-0.40</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>90.6 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-1.5</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>9.71</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>228.202</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>228.074621504</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C9H12N2O5</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>MXHRCPNRJAMMIM-SHYZEUOFSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>99.1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>51.05</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>21.06</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>5</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1028</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>921</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>280</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>281</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1975</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1990</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>7117</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30425</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30426</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30949</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30950</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37242</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>19</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>20</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>21</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>251793</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>251794</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>251795</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>271734</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>271735</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>271736</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439582</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439583</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439584</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439585</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439586</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439587</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>440069</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>449646</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>449647</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Extracellular</cellular>
          <cellular>Mitochondria</cellular>
          <cellular>Nucleus</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Bladder</tissue>
          <tissue>Bone Marrow</tissue>
          <tissue>Fibroblasts</tissue>
          <tissue>Intestine</tissue>
          <tissue>Leukocyte</tissue>
          <tissue>Neuron</tissue>
          <tissue>Pancreas</tissue>
          <tissue>Placenta</tissue>
          <tissue>Prostate</tissue>
          <tissue>Skeletal Muscle</tissue>
          <tissue>Testis</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Beta Ureidopropionase Deficiency</name>
            <smpdb_id>SMP00172</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dihydropyrimidinase Deficiency</name>
            <smpdb_id>SMP00178</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</name>
            <smpdb_id>SMP00202</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Pyrimidine Metabolism</name>
            <smpdb_id>SMP00046</smpdb_id>
            <kegg_map_id>map00240</kegg_map_id>
          </pathway>
          <pathway>
            <name>UMP Synthase Deficiency (Orotic Aciduria)</name>
            <smpdb_id>SMP00219</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;0.1</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S139-43. doi: 10.1007/s10545-010-9049-y. Epub 2010 Feb 12.</reference_text>
              <pubmed_id>20151198</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.052 (0.049-0.056)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Li KM, Rivory LP, Clarke SJ: Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 5;820(1):121-30. Epub 2005 Apr 19.</reference_text>
              <pubmed_id>15866500</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.200 (0.100-0.300)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.</reference_text>
              <pubmed_id>6656991</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.6 +/- 0.6</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Traut TW: Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994 Nov 9;140(1):1-22.</reference_text>
              <pubmed_id>7877593</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0 - 0.1</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.</reference_text>
              <pubmed_id>6656991</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Children (6 - 18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0-2</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By LC-MS/MS</comment>
          <references>
            <reference>
              <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;0.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By LC-MS/MS (cutoff value)</comment>
          <references>
            <reference>
              <reference_text>Monostori P, Klinke G, Hauke J, Richter S, Bierau J, Garbade SF, Hoffmann GF, Langhans CD, Haas D, Okun JG: Extended diagnosis of purine and pyrimidine disorders from urine: LC MS/MS assay development and clinical validation. PLoS One. 2019 Feb 28;14(2):e0212458. doi: 10.1371/journal.pone.0212458. eCollection 2019.</reference_text>
              <pubmed_id>30817767</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.00 (0.00-2.00)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hartmann S, Okun JG, Schmidt C, Langhans CD, Garbade SF, Burgard P, Haas D, Sass JO, Nyhan WL, Hoffmann GF: Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry. Clin Chem. 2006 Jun;52(6):1127-37. Epub 2006 Apr 13.</reference_text>
              <pubmed_id>16613999</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;1</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S139-43. doi: 10.1007/s10545-010-9049-y. Epub 2010 Feb 12.</reference_text>
              <pubmed_id>20151198</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>20</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Thymidine phosphorylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S139-43. doi: 10.1007/s10545-010-9049-y. Epub 2010 Feb 12.</reference_text>
              <pubmed_id>20151198</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Crohns disease</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Unclassified IBD </patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.195</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>51</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Thymidine phosphorylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S139-43. doi: 10.1007/s10545-010-9049-y. Epub 2010 Feb 12.</reference_text>
              <pubmed_id>20151198</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Thymidine phosphorylase deficiency</name>
          <omim_id>603041</omim_id>
          <references>
            <reference>
              <reference_text>Bakker JA, Schlesser P, Smeets HJ, Francois B, Bierau J: Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S139-43. doi: 10.1007/s10545-010-9049-y. Epub 2010 Feb 12.</reference_text>
              <pubmed_id>20151198</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Crohn's disease</name>
          <omim_id>266600</omim_id>
          <references>
            <reference>
              <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
              <pubmed_id>16440420</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
              <pubmed_id>8723414</pubmed_id>
            </reference>
            <reference>
              <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19491857</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ulcerative colitis</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
              <pubmed_id>21059682</pubmed_id>
            </reference>
            <reference>
              <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
              <pubmed_id>1740537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
              <pubmed_id>17314143</pubmed_id>
            </reference>
            <reference>
              <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
              <pubmed_id>21761941</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00526</kegg_id>
      <drugbank_id>DB02256</drugbank_id>
      <foodb_id>FDB021870</foodb_id>
      <chemspider_id>13118</chemspider_id>
      <chebi_id>16450</chebi_id>
      <pubchem_compound_id>13712</pubchem_compound_id>
      <pdb_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id>C00019697</knapsack_id>
      <bigg_id>35251</bigg_id>
      <wikipedia_id>Deoxyuridine</wikipedia_id>
      <metlin_id>5086</metlin_id>
      <biocyc_id>DEOXYURIDINE</biocyc_id>
      <vmh_id>DURI</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Huang, Haoqiang; Chu, Chung K. A practical synthesis of 2'-deoxyuridine from uridine. Synthetic Communications  (1990),  20(7),  1039-46.</synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Li KM, Rivory LP, Clarke SJ: Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 5;820(1):121-30. Epub 2005 Apr 19.</reference_text>
          <pubmed_id>15866500</pubmed_id>
        </reference>
        <reference>
          <reference_text>Di Stefano G, Busi C, Derenzini M, Trere D, Fiume L: Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):173-7.</reference_text>
          <pubmed_id>9675653</pubmed_id>
        </reference>
        <reference>
          <reference_text>Reidy JA: Deoxyuridine increases folate-sensitive fragile site expression in human lymphocytes. Am J Med Genet. 1987 Jan;26(1):1-5.</reference_text>
          <pubmed_id>3812550</pubmed_id>
        </reference>
        <reference>
          <reference_text>Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.</reference_text>
          <pubmed_id>6656991</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huong PL, Kolk AH, Eggelte TA, Verstijnen CP, Gilis H, Hendriks JT: Measurement of antigen specific lymphocyte proliferation using 5-bromo-deoxyuridine incorporation. An easy and low cost alternative to radioactive thymidine incorporation. J Immunol Methods. 1991 Jul 5;140(2):243-8.</reference_text>
          <pubmed_id>1906076</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kanazawa S, Herbert V: Detection of folate deficiency in alcoholism using the peripheral blood lymphocyte deoxyuridine suppression test. J Nutr Sci Vitaminol (Tokyo). 1986 Jun;32(3):251-7.</reference_text>
          <pubmed_id>3761048</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zittoun J, Zittoun R: Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol. 1999 Jan;36(1):35-46.</reference_text>
          <pubmed_id>9930567</pubmed_id>
        </reference>
        <reference>
          <reference_text>Fairbanks LD, Marinaki AM, Carrey EA, Hammans SR, Duley JA: Deoxyuridine accumulation in urine in thymidine phosphorylase deficiency (MNGIE). J Inherit Metab Dis. 2002 Nov;25(7):603-4.</reference_text>
          <pubmed_id>12638947</pubmed_id>
        </reference>
        <reference>
          <reference_text>Remacha A, Barcelo MJ, Pastor M, Ubeda J, Espadaler M, Gimferrer E: The deoxyuridine suppression test in peripheral lymphocytes. Eur J Haematol. 1990 Mar;44(3):196-200.</reference_text>
          <pubmed_id>2328792</pubmed_id>
        </reference>
        <reference>
          <reference_text>Galanis E, Goldberg R, Reid J, Atherton P, Sloan J, Pitot H, Rubin J, Adjei AA, Burch P, Safgren SL, Witzig TE, Ames MM, Erlichman C: Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd). Ann Oncol. 2001 May;12(5):701-7.</reference_text>
          <pubmed_id>11432631</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
          <pubmed_id>19212411</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
        <reference>
          <reference_text>Akhrem, A.A. et al., Org. Magn. Reson., 1979, 12, 247, (cmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Fox, J.J. et al., Adv. Carbohydr. Chem., 1959, 14, 283, (rev)</reference_text>
        </reference>
        <reference>
          <reference_text>Rimerman, R.A. et al., J. Chromatogr., B: Biomed. Appl., 1993, 619, 29-35, (5'-triphosphate)</reference_text>
        </reference>
        <reference>
          <reference_text>Schinazi, R.F. et al., J. Med. Chem., 1978, 21, 1141, (synth, acid)</reference_text>
        </reference>
        <reference>
          <reference_text>Barr, P.J. et al., Tetrahedron, 1980, 36, 1269, (cryst struct)</reference_text>
        </reference>
        <reference>
          <reference_text>Ludwig, J. et al., Synthesis, 1982, 32-34, (5'-phosphate)</reference_text>
        </reference>
        <reference>
          <reference_text>Dematte, N. et al., Comp. Biochem. Physiol., B: Comp. Biochem., 1986, 84, 11, (isol, acid)</reference_text>
        </reference>
        <reference>
          <reference_text>Rahman, A. et al., Acta Cryst. B, 1972, 28, 2260, (cryst struct)</reference_text>
        </reference>
        <reference>
          <reference_text>Sakema, S. et al., Comp. Biochem. Physiol., B: Comp. Biochem., 1985, 82, 107-109, (isol)</reference_text>
        </reference>
        <reference>
          <reference_text>Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 816A, (ir)</reference_text>
        </reference>
        <reference>
          <reference_text>Kikugawa, K. et al., Chem. Pharm. Bull., 1969, 17, 785, (synth, deriv)</reference_text>
        </reference>
        <reference>
          <reference_text>Sprecher, C.A. et al., Biopolymers, 1977, 16, 2243, (cd)</reference_text>
        </reference>
        <reference>
          <reference_text>Komori, T. et al., Annalen, 1980, 653-668, (isol)</reference_text>
        </reference>
        <reference>
          <reference_text>Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 374B, (nmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Hruska, F.E. et al., Can. J. Chem., 1974, 52, 497, (conformn, pmr)</reference_text>
        </reference>
        <reference>
          <reference_text>U.S. Pat., 1966, 3 280 104, CA, 66, 38207y</reference_text>
        </reference>
        <reference>
          <reference_text>Lidgren, G. et al., J. Nat. Prod., 1988, 51, 1277-1280, (2'-Deoxy-3-methyluridine)</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP03052</protein_accession>
          <name>AID</name>
          <uniprot_id>Q546Y9</uniprot_id>
          <gene_name>AID</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03752</protein_accession>
          <name>Purine nucleoside phosphorylase</name>
          <uniprot_id>P00491</uniprot_id>
          <gene_name>PNP</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03814</protein_accession>
          <name>Thymidine kinase, cytosolic</name>
          <uniprot_id>P04183</uniprot_id>
          <gene_name>TK1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03815</protein_accession>
          <name>Thymidine kinase 2, mitochondrial</name>
          <uniprot_id>O00142</uniprot_id>
          <gene_name>TK2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03818</protein_accession>
          <name>Thymidine phosphorylase</name>
          <uniprot_id>P19971</uniprot_id>
          <gene_name>TYMP</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP05584</protein_accession>
          <name>Cytidine deaminase</name>
          <uniprot_id>P32320</uniprot_id>
          <gene_name>CDA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07410</protein_accession>
          <name>Uridine-cytidine kinase-like 1</name>
          <uniprot_id>Q9NWZ5</uniprot_id>
          <gene_name>UCKL1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09241</protein_accession>
          <name>Thymidine kinase</name>
          <uniprot_id>Q8IZR3</uniprot_id>
          <gene_name/>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP11596</protein_accession>
          <name>DNA dC-&gt;dU-editing enzyme APOBEC-3G</name>
          <uniprot_id>Q9HC16</uniprot_id>
          <gene_name>APOBEC3G</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000014</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00014</accession>
      </secondary_accessions>
      <name>Deoxycytidine</name>
      <description>One of the principal nucleosides of DNA composed of cytosine and deoxyribose. A nucleoside consists of only a pentose sugar linked to a purine or pyrimidine base, without a phosphate group. When N1 is linked to the C1 of deoxyribose, deoxynucleosides and nucleotides are formed from cytosine and deoxyribose; deoxycytidine monophosphate (dCMP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP). CTP is the source of the cytidine in RNA (ribonucleic acid) and deoxycytidine triphosphate (dCTP) is the source of the deoxycytidine in DNA (deoxyribonucleic acid).</description>
      <synonyms>
        <synonym>4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one</synonym>
        <synonym>dC</synonym>
        <synonym>DCYD</synonym>
        <synonym>2'-Deoxycytidine</synonym>
        <synonym>1-(2-Deoxy-b-D-ribofuranosyl)cytosine</synonym>
        <synonym>1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-cytosine</synonym>
        <synonym>1-(2-Deoxy-beta-D-ribofuranosyl)cytosine</synonym>
        <synonym>1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-cytosine</synonym>
        <synonym>1-(2-Deoxy-beta-delta-ribofuranosyl)cytosine</synonym>
        <synonym>2-Deoxy-cytidine</synonym>
        <synonym>4-Amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone</synonym>
        <synonym>4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone</synonym>
        <synonym>4-Amino-1-(2-deoxy-beta-delta-erythro-pentofuranosyl)-2(1H)-pyrimidinone</synonym>
        <synonym>Cytosine deoxyribonucleoside</synonym>
        <synonym>Cytosine deoxyriboside</synonym>
        <synonym>Deoxy-cytidine</synonym>
        <synonym>Deoxyribose cytidine</synonym>
        <synonym>Desoxycytidine</synonym>
        <synonym>Deoxyribonucleoside, cytosine</synonym>
        <synonym>Deoxyriboside, cytosine</synonym>
        <synonym>Deoxycytidine</synonym>
      </synonyms>
      <chemical_formula>C9H13N3O4</chemical_formula>
      <average_molecular_weight>227.2172</average_molecular_weight>
      <monisotopic_molecular_weight>227.090605919</monisotopic_molecular_weight>
      <iupac_name>4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one</iupac_name>
      <traditional_iupac>2'-deoxycytidine</traditional_iupac>
      <cas_registry_number>951-77-9</cas_registry_number>
      <smiles>NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1</smiles>
      <inchi>InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1</inchi>
      <inchikey>CKTSBUTUHBMZGZ-SHYZEUOFSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2.</description>
        <direct_parent>Pyrimidine 2'-deoxyribonucleosides</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Nucleosides, nucleotides, and analogues</super_class>
        <class>Pyrimidine nucleosides</class>
        <sub_class>Pyrimidine 2'-deoxyribonucleosides</sub_class>
        <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Aminopyrimidines and derivatives</alternative_parent>
          <alternative_parent>Azacyclic compounds</alternative_parent>
          <alternative_parent>Heteroaromatic compounds</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Hydropyrimidines</alternative_parent>
          <alternative_parent>Imidolactams</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
          <alternative_parent>Oxacyclic compounds</alternative_parent>
          <alternative_parent>Primary alcohols</alternative_parent>
          <alternative_parent>Primary amines</alternative_parent>
          <alternative_parent>Pyrimidones</alternative_parent>
          <alternative_parent>Secondary alcohols</alternative_parent>
          <alternative_parent>Tetrahydrofurans</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alcohol</substituent>
          <substituent>Amine</substituent>
          <substituent>Aminopyrimidine</substituent>
          <substituent>Aromatic heteromonocyclic compound</substituent>
          <substituent>Azacycle</substituent>
          <substituent>Heteroaromatic compound</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Hydropyrimidine</substituent>
          <substituent>Imidolactam</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organoheterocyclic compound</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Oxacycle</substituent>
          <substituent>Primary alcohol</substituent>
          <substituent>Primary amine</substituent>
          <substituent>Pyrimidine</substituent>
          <substituent>Pyrimidine 2'-deoxyribonucleoside</substituent>
          <substituent>Pyrimidone</substituent>
          <substituent>Secondary alcohol</substituent>
          <substituent>Tetrahydrofuran</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>Deoxyribonucleosides</external_descriptor>
          <external_descriptor>pyrimidine 2'-deoxyribonucleoside</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fabaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Papilionoideae</synonym>
                            <synonym>Legume</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Glycine max</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Soy</synonym>
                            <synonym>Soya</synonym>
                            <synonym>Soybean</synonym>
                            <synonym>Soya bean</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Cucurbitaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Cucurbits</synonym>
                            <synonym>Gourds</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>All tissues</term>
                      <definition>All tissues in the body of the organism.</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Nucleus</term>
                      <definition>A body within the cell, surrounded by a membrane, within which lie the chromosomes, one or more nucleoli, combined with proteins, and exhibits mitosis. (NCI)</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cell nucleus</synonym>
                        <synonym>Nucleic</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Lysosome</term>
                      <definition>В A sac-like compartment inside a cell that has enzymes that can break down cellular components that need to be destroyed. (NCI).</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</term>
                          <definition> mngie causes accumulation of thymidine and deoxyuridine in the urine. symptoms of mngie include ptosis, progressive external ophthalmoplegia, gastrointestinal dysmotility (often pseudoobstruction), diffuse leukoencephalopathy, peripheral neuropathy, and myopathy.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Pyrimidine Metabolism</term>
                          <definition> cytosine, thymine, and uracil are pyrimidine derivatives. synthesis of the pyrimidines is less complex than that of the purines, since the base is much simpler this pathway depicts a number of processes including pyrimidine nucleotide biosynthesis, pyrimidine degradation and pyrimidine salvage.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>870 mg/mL</value>
          <source/>
        </property>
        <property>
          <kind>logp</kind>
          <value>-1.77</value>
          <source>HANSCH,C ET AL. (1995)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>207 - 210 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-1.93</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-1.16</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>15.9 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-1.9</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>13.89</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>0.31</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>227.2172</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>227.090605919</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C9H13N3O4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>CKTSBUTUHBMZGZ-SHYZEUOFSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>108.38</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>53.03</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>21.65</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>6</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>922</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>3171</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37243</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1029</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1119</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>22</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>23</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>24</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2533</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2534</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2535</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2536</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2537</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2538</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2539</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2540</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2541</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2542</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2543</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2544</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2545</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2546</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>179610</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>179611</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>179612</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>181941</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>181942</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>181943</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437549</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437550</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Extracellular</cellular>
          <cellular>Lysosome</cellular>
          <cellular>Mitochondria</cellular>
          <cellular>Nucleus</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>All Tissues</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Beta Ureidopropionase Deficiency</name>
            <smpdb_id>SMP00172</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dihydropyrimidinase Deficiency</name>
            <smpdb_id>SMP00178</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</name>
            <smpdb_id>SMP00202</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Pyrimidine Metabolism</name>
            <smpdb_id>SMP00046</smpdb_id>
            <kegg_map_id>map00240</kegg_map_id>
          </pathway>
          <pathway>
            <name>UMP Synthase Deficiency (Orotic Aciduria)</name>
            <smpdb_id>SMP00219</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.2 (0.0-0.5)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Olivares J, Verdys M: Isocratic high-performance liquid chromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements. J Chromatogr. 1988 Dec 29;434(1):111-21.</reference_text>
              <pubmed_id>3243806</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Children (6 - 18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.65 +/- 0.27</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7.</reference_text>
              <pubmed_id>15116424</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Crohns disease</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Unclassified IBD </patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Crohn's disease</name>
          <omim_id>266600</omim_id>
          <references>
            <reference>
              <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
              <pubmed_id>16440420</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
              <pubmed_id>8723414</pubmed_id>
            </reference>
            <reference>
              <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19491857</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ulcerative colitis</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
              <pubmed_id>21059682</pubmed_id>
            </reference>
            <reference>
              <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
              <pubmed_id>1740537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
              <pubmed_id>17314143</pubmed_id>
            </reference>
            <reference>
              <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
              <pubmed_id>21761941</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00881</kegg_id>
      <drugbank_id>DB02594</drugbank_id>
      <foodb_id>FDB021871</foodb_id>
      <chemspider_id>13117</chemspider_id>
      <chebi_id>15698</chebi_id>
      <pubchem_compound_id>13711</pubchem_compound_id>
      <pdb_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id>36280</bigg_id>
      <wikipedia_id>Deoxycytidine</wikipedia_id>
      <metlin_id>3367</metlin_id>
      <biocyc_id>DEOXYCYTIDINE</biocyc_id>
      <vmh_id>DCYT</vmh_id>
      <fbonto_id/>
      <synthesis_reference> Fox, Jack F.; Yung, Naishun; Wempen, Iris; Hoffer, Max. Pyrimidine nucleosides. XII. Direct synthesis of 2'-deoxycytidine and its a-anomer. Journal of the American Chemical Society  (1961),  83  4066-50. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>van den Bosch J, Lubbert M, Verhoef G, Wijermans PW: The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes. Leuk Res. 2004 Aug;28(8):785-90.</reference_text>
          <pubmed_id>15203276</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7.</reference_text>
          <pubmed_id>15116424</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wepierre J, Marty JP, Chanal JL, Sincholle D: Percutaneous absorption of 5-iodo-2' deoxycytidine in the hairless rat and in man. Eur J Drug Metab Pharmacokinet. 1984 Jan-Mar;9(1):79-83.</reference_text>
          <pubmed_id>6714272</pubmed_id>
        </reference>
        <reference>
          <reference_text>Coral S, Sigalotti L, Altomonte M, Engelsberg A, Colizzi F, Cattarossi I, Maraskovsky E, Jager E, Seliger B, Maio M: 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin Cancer Res. 2002 Aug;8(8):2690-5.</reference_text>
          <pubmed_id>12171902</pubmed_id>
        </reference>
        <reference>
          <reference_text>Olivares J, Verdys M: Isocratic high-performance liquid chromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements. J Chromatogr. 1988 Dec 29;434(1):111-21.</reference_text>
          <pubmed_id>3243806</pubmed_id>
        </reference>
        <reference>
          <reference_text>Maley, F. et al., J. Biol. Chem., 1958, 233, 1538-1543, (5-diphosphate)</reference_text>
        </reference>
        <reference>
          <reference_text>Charubala, R. et al., Synthesis, 1984, 965-968, (5'-(4,4'-dimethoxytrityl) 4N-benzoyl)</reference_text>
        </reference>
        <reference>
          <reference_text>Schaller, H. et al., J.A.C.S., 1963, 85, 3821-3827, (5'-(4,4'-dimethoxytrityl) 4N-benzoyl)</reference_text>
        </reference>
        <reference>
          <reference_text>Benz, E. et al., J.O.C., 1965, 30, 3067-3071, (4N-benzoyl, 5'-tosyl, 3',4N-dibenzoyl, 4N,5'-dibenzoyl, 5'-tosyl 4N-benzoyl, 5'-trityl 3',4N-dibenzoyl)</reference_text>
        </reference>
        <reference>
          <reference_text>Hruska, F.E. et al., Can. J. Chem., 1974, 52, 497-508, (pmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Jones, A.J. et al., Proc. Natl. Acad. Sci. U.S.A., 1970, 65, 27-30, CA, 72, 96682j, (cmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Miles, H.T., J.A.C.S., 1963, 85, 1007-1008, (ir, pmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Young, D.W. et al., Acta Cryst. B, 1975, 31, 961-965, (cryst struct)</reference_text>
        </reference>
        <reference>
          <reference_text>Michelson, A.M. et al., J.C.S., 1954, 34-40, (phosphates, 3',4N-di-Ac, 5'-trityl, 5'-trityl 3',4N-di-Ac)</reference_text>
        </reference>
        <reference>
          <reference_text>Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, DAQ850</reference_text>
        </reference>
        <reference>
          <reference_text>Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 396A, 396C, (nmr)</reference_text>
        </reference>
        <reference>
          <reference_text>Stawinski, J. et al., Chem. Comm., 1976, 243-244, (3',4N,5'-tribenzoyl)</reference_text>
        </reference>
        <reference>
          <reference_text>Ulbricht TL. Nucleosides. 3. Synthesis of 1-methyl-2'-deoxycytidine, and comments on the N.m.r. spectra of cytosine nucleosides. J Chem Soc Perkin 1. 1965 Sep:6134-5.</reference_text>
        </reference>
        <reference>
          <reference_text>Wang Z, Prudhomme DR, Buck JR, Park M, Rizzo CJ. Stereocontrolled syntheses of deoxyribonucleosides via photoinduced electron-transfer deoxygenation of benzoyl-protected ribo- and arabinonucleosides. J Org Chem. 2000 Sep 22;65(19):5969-85. </reference_text>
        </reference>
        <reference>
          <reference_text>Saneyoshi M, Tohyama J, Nakayama C, Takiya S, Iwabuchi M. Inhibitory effects of 3'deoxycytidine 5'-triphosphate and 3'-deoxyuridine 5'-triphosphate on DNA-dependent RNA polymerases I and II purified from Dictyostelium discoideum cells. Nucleic Acids Res. 1981 Jul 10;9(13):3129-38.</reference_text>
        </reference>
        <reference>
          <reference_text>FOX JJ, WEMPEN I. Pyrimidine nucleosides. Adv Carbohydr Chem. 1959;14:283-380.</reference_text>
        </reference>
        <reference>
          <reference_text>Raffaele Saladino, Enrico Mincione, Claudia Crestini, Maurizio Mezzetti. Transformations of thiopyrimidine and thiopurine nucleosides following oxidation with dimethyldioxirane. Tetrahedron, 1996, 52, 6759-6780</reference_text>
        </reference>
        <reference>
          <reference_text>Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 832B, 838D, 839C, (ir)</reference_text>
        </reference>
        <reference>
          <reference_text>Yang, J.T. et al., CA, 1966, 65, 12454, (ord)</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00001</protein_accession>
          <name>5'-nucleotidase</name>
          <uniprot_id>P21589</uniprot_id>
          <gene_name>NT5E</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00004</protein_accession>
          <name>Cytosolic 5'-nucleotidase 1B</name>
          <uniprot_id>Q96P26</uniprot_id>
          <gene_name>NT5C1B</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00005</protein_accession>
          <name>Cytosolic 5'-nucleotidase 1A</name>
          <uniprot_id>Q9BXI3</uniprot_id>
          <gene_name>NT5C1A</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00006</protein_accession>
          <name>5'(3')-deoxyribonucleotidase, cytosolic type</name>
          <uniprot_id>Q8TCD5</uniprot_id>
          <gene_name>NT5C</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00007</protein_accession>
          <name>Deoxycytidine kinase</name>
          <uniprot_id>P27707</uniprot_id>
          <gene_name>DCK</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00008</protein_accession>
          <name>5'(3')-deoxyribonucleotidase, mitochondrial</name>
          <uniprot_id>Q9NPB1</uniprot_id>
          <gene_name>NT5M</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03052</protein_accession>
          <name>AID</name>
          <uniprot_id>Q546Y9</uniprot_id>
          <gene_name>AID</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03189</protein_accession>
          <name>Cytosolic 5'-nucleotidase 3</name>
          <uniprot_id>Q9H0P0</uniprot_id>
          <gene_name>NT5C3</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP03750</protein_accession>
          <name>Cytosolic purine 5'-nucleotidase</name>
          <uniprot_id>P49902</uniprot_id>
          <gene_name>NT5C2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP05584</protein_accession>
          <name>Cytidine deaminase</name>
          <uniprot_id>P32320</uniprot_id>
          <gene_name>CDA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07410</protein_accession>
          <name>Uridine-cytidine kinase-like 1</name>
          <uniprot_id>Q9NWZ5</uniprot_id>
          <gene_name>UCKL1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP11596</protein_accession>
          <name>DNA dC-&gt;dU-editing enzyme APOBEC-3G</name>
          <uniprot_id>Q9HC16</uniprot_id>
          <gene_name>APOBEC3G</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000015</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00015</accession>
      </secondary_accessions>
      <name>Cortexolone</name>
      <description>Cortexolone is the precursor of cortisol. Accumulation of cortexolone can happen in a defect known as congenital adrenal hyperplasia, which is due to 11-beta-hydroxylase deficiency, resulting in androgen excess, virilization, and hypertension (PMID: 2022736). Cortexolone is a 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities (PubChem).</description>
      <synonyms>
        <synonym>11-Desoxy-17-hydroxycorticosterone</synonym>
        <synonym>Cortodoxone</synonym>
        <synonym>Reichstein substance S</synonym>
        <synonym>Substance S, reichstein's</synonym>
        <synonym>11 Deoxycortisol</synonym>
        <synonym>11 Desoxycortisol</synonym>
        <synonym>11 Desoxycortisone</synonym>
        <synonym>S, Reichstein's substance</synonym>
        <synonym>11-Desoxycortisol</synonym>
        <synonym>11-Desoxycortisone</synonym>
        <synonym>Reichsteins substance S</synonym>
        <synonym>11-Deoxycortisol</synonym>
        <synonym>SK&amp;F 3050</synonym>
        <synonym>Reichstein's substance S</synonym>
        <synonym>11-Deoxy-17-hydroxycorticosterone</synonym>
        <synonym>11-Deoxyhydrocortisone</synonym>
        <synonym>11-Desoxyhydrocortisone</synonym>
        <synonym>17,21-Dihydroxy-4-pregnene-3,20-dione</synonym>
        <synonym>17,21-Dihydroxypregn-4-ene-3,20-dione</synonym>
        <synonym>17,21-Dihydroxyprogesterone</synonym>
        <synonym>17-Hydroxy-11-deoxycorticosterone</synonym>
        <synonym>17alpha-Hydroxycortexone</synonym>
        <synonym>20-Dione 17,21-dihydroxypregn-4-ene-3</synonym>
        <synonym>4-Pregnene-17alpha,21-diol-3,20-dione</synonym>
        <synonym>Compound S</synonym>
        <synonym>11-Deoxy-17-hydrocorticosterone</synonym>
        <synonym>11-Deoxycortisone</synonym>
        <synonym>11-Desoxy-17α-hydroxycorticosterone</synonym>
        <synonym>11-Desoxy-17alpha-hydroxycorticosterone</synonym>
        <synonym>17,21-Dihydroxypregn-4-en-3,20-dione</synonym>
        <synonym>17Α,21-dihydroxy-4-pregnen-3,20-dione</synonym>
        <synonym>17Α,21-dihydroxypregn-4-ene-3,20-dione</synonym>
        <synonym>17Α,21-dihydroxyprogesterone</synonym>
        <synonym>17Α-hydroxycortexone</synonym>
        <synonym>4-Pregnen-17α,21-diol-3,20-dione</synonym>
        <synonym>4-Pregnene-17α,21-diol-3,20-dione</synonym>
        <synonym>17alpha,21-Dihydroxy-4-pregnen-3,20-dione</synonym>
        <synonym>17alpha,21-Dihydroxypregn-4-ene-3,20-dione</synonym>
        <synonym>17alpha,21-Dihydroxyprogesterone</synonym>
        <synonym>4-Pregnen-17alpha,21-diol-3,20-dione</synonym>
        <synonym>Cortexolone</synonym>
      </synonyms>
      <chemical_formula>C21H30O4</chemical_formula>
      <average_molecular_weight>346.4605</average_molecular_weight>
      <monisotopic_molecular_weight>346.214409448</monisotopic_molecular_weight>
      <iupac_name>(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</iupac_name>
      <traditional_iupac>(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</traditional_iupac>
      <cas_registry_number>152-58-9</cas_registry_number>
      <smiles>[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</smiles>
      <inchi>InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1</inchi>
      <inchikey>WHBHBVVOGNECLV-OBQKJFGGSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone.</description>
        <direct_parent>21-hydroxysteroids</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Lipids and lipid-like molecules</super_class>
        <class>Steroids and steroid derivatives</class>
        <sub_class>Hydroxysteroids</sub_class>
        <molecular_framework>Aliphatic homopolycyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>17-hydroxysteroids</alternative_parent>
          <alternative_parent>20-oxosteroids</alternative_parent>
          <alternative_parent>3-oxo delta-4-steroids</alternative_parent>
          <alternative_parent>Alpha-hydroxy ketones</alternative_parent>
          <alternative_parent>Cyclic alcohols and derivatives</alternative_parent>
          <alternative_parent>Cyclohexenones</alternative_parent>
          <alternative_parent>Delta-4-steroids</alternative_parent>
          <alternative_parent>Gluco/mineralocorticoids, progestogins and derivatives</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Primary alcohols</alternative_parent>
          <alternative_parent>Tertiary alcohols</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>17-hydroxysteroid</substituent>
          <substituent>20-oxosteroid</substituent>
          <substituent>21-hydroxysteroid</substituent>
          <substituent>3-oxo-delta-4-steroid</substituent>
          <substituent>3-oxosteroid</substituent>
          <substituent>Alcohol</substituent>
          <substituent>Aliphatic homopolycyclic compound</substituent>
          <substituent>Alpha-hydroxy ketone</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Cyclic alcohol</substituent>
          <substituent>Cyclic ketone</substituent>
          <substituent>Cyclohexenone</substituent>
          <substituent>Delta-4-steroid</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Ketone</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Oxosteroid</substituent>
          <substituent>Pregnane-skeleton</substituent>
          <substituent>Primary alcohol</substituent>
          <substituent>Progestogin-skeleton</substituent>
          <substituent>Tertiary alcohol</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives</external_descriptor>
          <external_descriptor>C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives</external_descriptor>
          <external_descriptor>Glucocorticoids</external_descriptor>
          <external_descriptor>deoxycortisol</external_descriptor>
          <external_descriptor>glucocorticoid</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>All tissues</term>
                      <definition>All tissues in the body of the organism.</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Hepatic tissue</term>
                      <definition>The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes. (NCI Thesaurus).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Liver tissue</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Membrane</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Endoplasmic reticulum</term>
                      <definition>A network of tubular membranes within the cytoplasm of the cell, occurring either with a smooth surface (smooth endoplasmic reticulum) or studded with ribosomes (rough endoplasmic reticulum), involved in the transport of materials. (Infoplease Dictionary via NCI)</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Er</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell membrane</term>
                      <definition>A cellular compartment that separates a cellВ interiorВ from its exterior.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cellular membrane</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical process</term>
                      <definition>A biological process occurring at the subcellular level, involving biochemical reactions.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid transport</term>
                          <definition>A process in which a lipid molecules is translocated between cellular sites or compartments.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of lipids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Lipid metabolic process</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fatty acid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of fatty acids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Chemical reaction</term>
                      <definition>A defined chemical event that occurs within or between organism cells.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid peroxidation</term>
                          <definition>A chemical reaction involving oxidative attack from free radicals on a lipid molecule, resulting in its degradation. .</definition>
                          <parent_id>7663</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Cellular process</term>
                      <definition>A biological process occurring within a cell or its surroundings.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Cell signaling</term>
                          <definition>The process by which a cell responds to substances in its environment.</definition>
                          <parent_id>7665</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Signal transduction</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Acenocoumarol Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Alteplase Action Pathway</term>
                          <definition> it also produces limited conversion of plasminogen in the absence of fibrin.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Aminocaproic Acid Action Pathway</term>
                          <definition> it is a derivative of the amino acid lysine. the fibrinolysis-inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Anistreplase Action Pathway</term>
                          <definition> plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. this helps eliminate blood clots or arterial blockages that cause myocardial infarction.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Aprotinin Action Pathway</term>
                          <definition> its action on kallikrein leads to the inhibition of the formation of factor xiia. as a result, both the intrinsic pathway of coagulation and fibrinolysis are inhibited.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Ardeparin Action Pathway</term>
                          <definition> ardeparin also binds to heparin cofactor ii, inhibiting thrombin. ardeparin does not effect prothrombin time (pt) assays and may prolong activated partial thromboplastin time (aptt).</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Argatroban Action Pathway</term>
                          <definition> argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. argatroban does not require the co-factor antithrombin iii for antithrombotic activity.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Bivalirudin Action Pathway</term>
                          <definition> thrombin is a serine proteinase that plays a central role in the thrombotic process, acting to cleave fibrinogen into fibrin monomers and to activate factor xiii to factor xiiia, allowing fibrin to develop a covalently cross-linked framework which stabilizes the thrombus; thrombin also activates factors v and viii, promoting further thrombin generation, and activates platelets, stimulating aggregation and granule release.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH</term>
                          <definition> cholesterol side-chain cleavage enzyme convertes cholesterol to pregnenolone in adrenal cortisol synthesis of all steroid hormones. a defect in this enzyme results in in impaired synthesis of all three categories of adrenal steroids (cortisol, mineralocorticoids, sex steroids) and high levels of adrenocorticotropic hormone (acth).</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Dicoumarol Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Dicumarol Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Enoxaparin Action Pathway</term>
                          <definition> it acts mainly by accelerating the rate of the neutralization of certain activated coagulation factors by antithrombin, but other mechanisms may also be involved. the antithrombotic effect of enoxaparin is well correlated to the inhibition of factor xa.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fondaparinux Action Pathway</term>
                          <definition> by selectively binding to atiii, fondaparinux potentiates (about 300 times) the innate neutralization of factor xa by atiii. neutralization of factor xa interrupts the blood coagulation cascade and thus inhibits thrombin formation and thrombus development.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Heparin Action Pathway</term>
                          <definition> it acts mainly by accelerating the rate of the neutralization of certain activated coagulation factors by antithrombin, but other mechanisms may also be involved. the antithrombotic effect of heparin is well correlated to the inhibition of factor xa.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lepirudin Action Pathway</term>
                          <definition> it binds to thrombin and prevents thrombus or clot formation. it is a highly potent, selective, and essentially irreversible inhibitor of thrombin and clot-bond thrombin.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Phenindione Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Phenprocoumon Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Reteplase Action Pathway</term>
                          <definition> plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. this helps eliminate blood clots or arterial blockages that cause myocardial infarction.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Steroidogenesis</term>
                          <definition> products of steroidogenesis include androgens, testosterone, estrogens and progesterone, corticoids, cortisol and aldosterone. the first step in the synthesis of all steroid hormones is the synthesis of pregnenolone from cholesterol.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Streptokinase Action Pathway</term>
                          <definition> plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. this helps eliminate blood clots or arterial blockages that cause myocardial infarction.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Tenecteplase Action Pathway</term>
                          <definition> plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. this helps eliminate blood clots or arterial blockages that cause myocardial infarction.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Tranexamic Acid Action Pathway</term>
                          <definition> tranexamic acid also directly inhibits plasmin activity, but higher doses are required than are needed to reduce plasmin formation.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Urokinase Action Pathway</term>
                          <definition> it cleaves the arg-val bond in plasminogen to produce active plasmin. plasmin degrades fibrin clots as well as fibrinogen and other plasma proteins.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Warfarin Action Pathway</term>
                          <definition> this leads to the depletion of the reduced form of vitamin k (vitamin kh2). as vitamin k is a cofactor for the gamma-carboxylation and subsequent activation of the vitamin k-dependent coagulation factors (ii, vii, ix, and x), this ultimately results in reduced cleavage of fibrinogen into fibrin and decreased coagulability of the blood.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Ximelagatran Action Pathway</term>
                          <definition> it acts solely by inhibiting the actions of thrombin. ximelagatran is a prodrug, being converted in vivo to the active agent melagatran.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism pathway</term>
                          <definition>A cellular process that consists of synthesis or breakdown of lipid molecules for energy or storage.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Multicellular process</term>
                      <definition>A biological process occurring in multiple cells, of similar or different type.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Coagulation</term>
                          <definition>A process involving a cascade of events by which coagulation factors interact to form a fibrin clot.</definition>
                          <parent_id>7666</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Biological role</term>
              <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Membrane stabilizer</term>
                  <definition>A chemical substance that supports the formation and maintenance of a structurally-sound and functioning cell or organelle membrane. Phospholipids form a bilayer and maintain the stability of the membrane structure together with proteins, and other lipids (i.e. cholesterol) which further strengthen it and decrease its permeability. </definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Membrane stability agent</synonym>
                    <synonym>Membrane integrity agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy source</term>
                  <definition/>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy storage</term>
                  <definition>A chemical substance which can be utilized for production of energy in the organism.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Molecular messenger</term>
                  <definition> a chemical substance that is involved in transmission of biochemical signals.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hormone</term>
                      <definition>Substances produces in animals or plant that regulate the activity of certain organs or control processes in other parts of the plant.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Signaling molecule</term>
                      <definition>A chemical substance that particpiates in signal transduction processes in a living cell.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Signalling molecule</synonym>
                        <synonym>Signaling agent</synonym>
                        <synonym>Cell signaling agent</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Surfactant</term>
                  <definition>A chemical substance that has the ability to lower the surface tension of water or to reduce the interfacial tension between two immiscible substances. in the cspa consumer product ingredients dictionary, surfactants are classified on the basis of their ionic characteristics, as amphoteric, anionic, cationic, or nonionic; and functions, which are subdivided into the following major groups: surfactant - cleaning agent, surfactant - conditioning agent,  surfactant - emulsifying agent,  surfactant - foam booster , surfactant hydrotrop , surfactant - solubility agent, surfactant - suspending agent.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Surface-active agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Emulsifier</term>
                  <definition>Substances that promote the formation and stability of a suspension of fine particles of a liquid in another liquid.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>logp</kind>
          <value>3.08</value>
          <source>SANGSTER (1994)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>215 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>2.79</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-4.14</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>0.025 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>2.58</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>12.59</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-3.3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>346.4605</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>346.214409448</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C21H30O4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>WHBHBVVOGNECLV-OBQKJFGGSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>74.6</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>95.81</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>38.86</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>2953</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2249</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>374754</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>451422</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1304458</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1304459</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1304460</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1419007</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1419008</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>1419009</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Endoplasmic reticulum</cellular>
          <cellular>Extracellular</cellular>
          <cellular>Membrane</cellular>
          <cellular>Mitochondria</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>All Tissues</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>11-beta-hydroxylase deficiency (CYP11B1)</name>
            <smpdb_id>SMP00575</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>17-alpha-hydroxylase deficiency (CYP17)</name>
            <smpdb_id>SMP00566</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>21-hydroxylase deficiency (CYP21)</name>
            <smpdb_id>SMP00576</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Beta-Hydroxysteroid Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00718</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Acenocoumarol Action Pathway</name>
            <smpdb_id>SMP00269</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency</name>
            <smpdb_id>SMP00373</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency</name>
            <smpdb_id>SMP00372</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Alteplase Action Pathway</name>
            <smpdb_id>SMP00280</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Aminocaproic Acid Action Pathway</name>
            <smpdb_id>SMP00286</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Anistreplase Action Pathway</name>
            <smpdb_id>SMP00281</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Apparent mineralocorticoid excess syndrome</name>
            <smpdb_id>SMP00717</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Aprotinin Action Pathway</name>
            <smpdb_id>SMP00288</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Ardeparin Action Pathway</name>
            <smpdb_id>SMP00275</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Argatroban Action Pathway</name>
            <smpdb_id>SMP00276</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Bivalirudin Action Pathway</name>
            <smpdb_id>SMP00277</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Coagulation </name>
            <smpdb_id>SMP00586</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH</name>
            <smpdb_id>SMP00371</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Corticosterone methyl oxidase I deficiency (CMO I)</name>
            <smpdb_id>SMP00577</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Corticosterone methyl oxidase II deficiency - CMO II</name>
            <smpdb_id>SMP00578</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dicoumarol Action Pathway</name>
            <smpdb_id>SMP00656</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dicumarol Action Pathway</name>
            <smpdb_id>SMP00270</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Enoxaparin Action Pathway</name>
            <smpdb_id>SMP00272</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Fondaparinux Action Pathway</name>
            <smpdb_id>SMP00273</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Heparin Action Pathway</name>
            <smpdb_id>SMP00274</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Lepirudin Action Pathway</name>
            <smpdb_id>SMP00278</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Phenindione Action Pathway</name>
            <smpdb_id>SMP00655</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Phenprocoumon Action Pathway</name>
            <smpdb_id>SMP00271</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Reteplase Action Pathway</name>
            <smpdb_id>SMP00285</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Steroidogenesis</name>
            <smpdb_id>SMP00130</smpdb_id>
            <kegg_map_id>map00140</kegg_map_id>
          </pathway>
          <pathway>
            <name>Streptokinase Action Pathway</name>
            <smpdb_id>SMP00282</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tenecteplase Action Pathway</name>
            <smpdb_id>SMP00283</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tranexamic Acid Action Pathway</name>
            <smpdb_id>SMP00287</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Urokinase Action Pathway</name>
            <smpdb_id>SMP00284</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Warfarin Action Pathway</name>
            <smpdb_id>SMP00268</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Ximelagatran Action Pathway</name>
            <smpdb_id>SMP00279</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.0039 +/- 0.0004</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RP: Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma. Eur J Endocrinol. 1996 Sep;135(3):299-308.</reference_text>
              <pubmed_id>8890720</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;0.0250</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>&lt;0.0600</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Wet feces samples (n=10) were used in the study. Instrument: LC-MS. Technology specification: UPLC-MS/MS (Orbitrap) with polarity switching.</comment>
          <references>
            <reference>
              <reference_text>Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Fofanova T, Nelson A, Skeath T, Perry JD, Petrosino JF, Berrington JE, Cummings SP: Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls. Microbiome. 2017 Jul 12;5(1):75. doi: 10.1186/s40168-017-0295-1.</reference_text>
              <pubmed_id>28701177</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.017-178.9</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hughes IA, Arisaka O, Perry LA, Honour JW: Early diagnosis of 11 beta-hydroxylase deficiency in two siblings confirmed by analysis of a novel steroid metabolite in newborn urine. Acta Endocrinol (Copenh). 1986 Mar;111(3):349-54.</reference_text>
              <pubmed_id>3515819</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.02 (0.0091-0.032)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zachmann M, Tassinari D, Prader A: Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983 Feb;56(2):222-9.</reference_text>
              <pubmed_id>6296182</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1.3</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Newborn (0-30 days old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>11-beta-hydroxylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>1.84</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>11-beta-hydroxylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.00790-0.329</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>11-beta-hydroxylase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Newborn (0-30 days old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Sepsis</patient_information>
          <comment>Wet feces samples (n=4) were used in the study. p &lt; 0.043, higher than control (fold change = 250). Instrument: LC-MS. Technology specification: UPLC-MS/MS (Orbitrap) with polarity switching.</comment>
          <references>
            <reference>
              <reference_text>Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Fofanova T, Nelson A, Skeath T, Perry JD, Petrosino JF, Berrington JE, Cummings SP: Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls. Microbiome. 2017 Jul 12;5(1):75. doi: 10.1186/s40168-017-0295-1.</reference_text>
              <pubmed_id>28701177</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>11-beta-Hydroxylase deficiency</name>
          <omim_id>202010</omim_id>
          <references>
            <reference>
              <reference_text>Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE: Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006 Jun;91(6):2179-84. Epub 2006 Mar 21.</reference_text>
              <pubmed_id>16551734</pubmed_id>
            </reference>
            <reference>
              <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
              <pubmed_id>21359215</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810.  Epub 2008 Oct 25.</reference_text>
              <pubmed_id>18953024</pubmed_id>
            </reference>
            <reference>
              <reference_text>Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.</reference_text>
              <pubmed_id>17919531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Burren CP, Montalto J, Yong AB, Batch JA: CYP11 beta 1 (11-beta-hydroxylase) deficiency in congenital adrenal hyperplasia. J Paediatr Child Health. 1996 Oct;32(5):433-8.</reference_text>
              <pubmed_id>8933406</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Sepsis</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Pinna G, Meinhold H, Hiedra L, Thoma R, Hoell T, Graf KJ, Stoltenburg-Didinger G, Eravci M, Prengel H, Brodel O, Finke R, Baumgartner A: Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. J Clin Endocrinol Metab. 1997 May;82(5):1535-42.</reference_text>
              <pubmed_id>9141546</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M: A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med. 2009 Apr;35(4):717-21. doi: 10.1007/s00134-008-1358-3. Epub 2008 Nov 26.</reference_text>
              <pubmed_id>19034423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Fofanova T, Nelson A, Skeath T, Perry JD, Petrosino JF, Berrington JE, Cummings SP: Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls. Microbiome. 2017 Jul 12;5(1):75. doi: 10.1186/s40168-017-0295-1.</reference_text>
              <pubmed_id>28701177</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB021872</foodb_id>
      <pubchem_compound_id>440707</pubchem_compound_id>
      <chemspider_id>389582</chemspider_id>
      <chebi_id>28324</chebi_id>
      <kegg_id>C05488</kegg_id>
      <biocyc_id/>
      <drugbank_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id>45914</bigg_id>
      <wikipedia_id>Cortexolone</wikipedia_id>
      <metlin_id>5088</metlin_id>
      <pdb_id/>
      <synthesis_reference>Luu, Duc Huy.  New method for the synthesis of Reichstein's compound S from pregnene.    Tap Chi Duoc Hoc  (2002),   (9),  23-25. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Homma K, Hasegawa T, Masumoto M, Takeshita E, Watanabe K, Chiba H, Kurosawa T, Takahashi T, Matsuo N: Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring. Endocr J. 2003 Dec;50(6):783-92.</reference_text>
          <pubmed_id>14709852</pubmed_id>
        </reference>
        <reference>
          <reference_text>Trakakis E, Laggas D, Salamalekis E, Creatsas G: 21-Hydroxylase deficiency: from molecular genetics to clinical presentation. J Endocrinol Invest. 2005 Feb;28(2):187-92.</reference_text>
          <pubmed_id>15887869</pubmed_id>
        </reference>
        <reference>
          <reference_text>Krone N, Riepe FG, Gotze D, Korsch E, Rister M, Commentz J, Partsch CJ, Grotzinger J, Peter M, Sippell WG: Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene. J Clin Endocrinol Metab. 2005 Jun;90(6):3724-30. Epub 2005 Mar 8.</reference_text>
          <pubmed_id>15755848</pubmed_id>
        </reference>
        <reference>
          <reference_text>Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ: Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res. 2005 Apr;29(4):517-27.</reference_text>
          <pubmed_id>15834216</pubmed_id>
        </reference>
        <reference>
          <reference_text>Brown JR, Cavanaugh AH, Farnsworth WE: A simple radioimmunoassay for plasma cortisol and 11-deoxycortisol (17, 21-dihydroxy-4-pregnene-3, 20-dione). Steroids. 1976 Oct;28(4):487-98.</reference_text>
          <pubmed_id>1034356</pubmed_id>
        </reference>
        <reference>
          <reference_text>den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC: Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab. 2005 Sep;90(9):5110-7. Epub 2005 Jun 28.</reference_text>
          <pubmed_id>15985474</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee HH, Won GS, Chao HT, Lee YJ, Chung BC: Novel missense mutations, GCC [Ala306]- &gt; GTC [Val] and ACG [Thr318]- &gt; CCG [Pro], in the CYP11B1 gene cause steroid 11beta-hydroxylase deficiency in the Chinese. Clin Endocrinol (Oxf). 2005 Apr;62(4):418-22.</reference_text>
          <pubmed_id>15807871</pubmed_id>
        </reference>
        <reference>
          <reference_text>Zachmann M, Tassinari D, Prader A: Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983 Feb;56(2):222-9.</reference_text>
          <pubmed_id>6296182</pubmed_id>
        </reference>
        <reference>
          <reference_text>White PC, Tusie-Luna MT, New MI, Speiser PW: Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat. 1994;3(4):373-8.</reference_text>
          <pubmed_id>8081391</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bradshaw KD, Milewich L, Mason JI, Parker CR Jr, MacDonald PC, Carr BR: Steroid secretory characteristics of a virilizing adrenal adenoma in a woman. J Endocrinol. 1994 Feb;140(2):297-307.</reference_text>
          <pubmed_id>8169562</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bureik M, Bruck N, Hubel K, Bernhardt R: The human mineralocorticoid receptor only partially differentiates between different ligands after expression in fission yeast. FEMS Yeast Res. 2005 Apr;5(6-7):627-33.</reference_text>
          <pubmed_id>15780662</pubmed_id>
        </reference>
        <reference>
          <reference_text>Dragan CA, Zearo S, Hannemann F, Bernhardt R, Bureik M: Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast Schizosaccharomyces pombe. FEMS Yeast Res. 2005 Apr;5(6-7):621-5.</reference_text>
          <pubmed_id>15780661</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mellon SH, Miller WL: Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest. 1989 Nov;84(5):1497-502.</reference_text>
          <pubmed_id>2808702</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sakamoto N, Matsukura S, Tsuboi S, Tokumiya T, Imura H: Radioimmunoassay for 11-deoxycortisol using iodine-labeled tracer. Endocrinol Jpn. 1976 Aug;23(4):359-63.</reference_text>
          <pubmed_id>1024042</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tjeerdsma G, Sluiter WJ, Hew JM, Molenaar WM, de Lange WE, Dullaart RP: Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma. Eur J Endocrinol. 1996 Sep;135(3):299-308.</reference_text>
          <pubmed_id>8890720</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hughes IA, Arisaka O, Perry LA, Honour JW: Early diagnosis of 11 beta-hydroxylase deficiency in two siblings confirmed by analysis of a novel steroid metabolite in newborn urine. Acta Endocrinol (Copenh). 1986 Mar;111(3):349-54.</reference_text>
          <pubmed_id>3515819</pubmed_id>
        </reference>
        <reference>
          <reference_text>Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC: The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol. 1991 Oct;5(10):1513-22.</reference_text>
          <pubmed_id>1775135</pubmed_id>
        </reference>
        <reference>
          <reference_text>White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosler A: A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest. 1991 May;87(5):1664-7.</reference_text>
          <pubmed_id>2022736</pubmed_id>
        </reference>
        <reference>
          <reference_text>Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9.</reference_text>
          <pubmed_id>11413487</pubmed_id>
        </reference>
        <reference>
          <reference_text>Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10.</reference_text>
          <pubmed_id>16902246</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20.</reference_text>
          <pubmed_id>17374880</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621.</reference_text>
          <pubmed_id>20044567</pubmed_id>
        </reference>
        <reference>
          <reference_text>The lipid handbook with CD-ROM</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00445</protein_accession>
          <name>Cytochrome P450 11B1, mitochondrial</name>
          <uniprot_id>P15538</uniprot_id>
          <gene_name>CYP11B1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP02638</protein_accession>
          <name>Mineralocorticoid receptor</name>
          <uniprot_id>P08235</uniprot_id>
          <gene_name>NR3C2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP04403</protein_accession>
          <name>3 beta-hydroxysteroid dehydrogenase/Delta 5--&gt;4-isomerase type 1</name>
          <uniprot_id>P14060</uniprot_id>
          <gene_name>HSD3B1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP04404</protein_accession>
          <name>3 beta-hydroxysteroid dehydrogenase/Delta 5--&gt;4-isomerase type 2</name>
          <uniprot_id>P26439</uniprot_id>
          <gene_name>HSD3B2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP05268</protein_accession>
          <name>Cytochrome P450 11B2, mitochondrial</name>
          <uniprot_id>P19099</uniprot_id>
          <gene_name>CYP11B2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07366</protein_accession>
          <name>Cytochrome P450 21-hydroxylase</name>
          <uniprot_id>Q16874</uniprot_id>
          <gene_name>P450-CYP21B</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09242</protein_accession>
          <name>Cytochrome P450, family 21, subfamily A, polypeptide 2</name>
          <uniprot_id>Q08AG9</uniprot_id>
          <gene_name>CYP21A2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP11648</protein_accession>
          <name>Steroid 21-hydroxylase</name>
          <uniprot_id>P08686</uniprot_id>
          <gene_name>CYP21A2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000016</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00016</accession>
      </secondary_accessions>
      <name>Deoxycorticosterone</name>
      <description>11-Deoxycorticosterone (also called desoxycortone, 21-hydroxyprogesterone, DOC, or simply deoxycorticosterone) is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. It is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Deoxycorticosterone is very hydrophobic, practically insoluble (in water), and relatively neutral. Deoxycorticosterone can be synthesized from progesterone by 21-beta-hydroxylase and is then converted to corticosterone by 11-beta-hydroxylase. Corticosterone is then converted to aldosterone by aldosterone synthase. Deoxycorticosterone stimulates the collecting tubules in the kidney to continue to excrete potassium in much the same way that aldosterone does. Deoxycorticosterone has about 1/20 of the sodium retaining power of aldosterone and about 1/5 the potassium excreting power of aldosterone (Wikipedia). Deoxycorticosterone can be found throughout all human tissues and has been detected in amniotic fluid and blood. When present in sufficiently high levels, deoxycorticosterone can act as a hypertensive agent and a metabotoxin. A hypertensive agent increases blood pressure and causes the production of more urine. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels.  Chronically high levels of deoxycorticosterone are associated with congenital adrenal hyperplasia (CAH) and with adrenal tumors producing deoxycorticosterone (PMID: 20671982). High levels of this mineralocorticoid are associated with resistant hypertension, which can result in polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement. Deoxycorticosterone can be used to treat adrenal insufficiency. In particular, desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's disease.</description>
      <synonyms>
        <synonym>21-Hydroxy-4-pregnene-3,20-dione</synonym>
        <synonym>21-Hydroxyprogesterone</synonym>
        <synonym>4-Pregnen-21-ol-3,20-dione</synonym>
        <synonym>Cortexone</synonym>
        <synonym>DESOXYCORTICOSTERONE</synonym>
        <synonym>Desoxycortone</synonym>
        <synonym>DOC</synonym>
        <synonym>Kendall's desoxy compound b</synonym>
        <synonym>Reichstein's substance Q</synonym>
        <synonym>11-Dehydroxycorticosterone</synonym>
        <synonym>11-Deoxy-corticosterone</synonym>
        <synonym>11-Deoxycorticosterone</synonym>
        <synonym>11-Desoxycorticosterone</synonym>
        <synonym>21-Hydroxy-3,20-dioxopregn-4-ene</synonym>
        <synonym>21-Hydroxy-D4-pregnane-3,20-dione</synonym>
        <synonym>21-Hydroxy-D4-pregnene-3,20-dione</synonym>
        <synonym>21-Hydroxy-pregn-4-ene-3,20-dione</synonym>
        <synonym>21-Hydroxy-progesterone</synonym>
        <synonym>21-Hydroxypregn-4-ene-3,20-dione</synonym>
        <synonym>D4-Pregnene-21-ol-3,20-dione</synonym>
        <synonym>Deoxycortone</synonym>
        <synonym>Doca</synonym>
        <synonym>11-Decorticosterone</synonym>
        <synonym>21 Hydroxyprogesterone</synonym>
        <synonym>11 Decorticosterone</synonym>
        <synonym>21 Hydroxy 4 pregnene 3,20 dione</synonym>
        <synonym>Deoxycorticosterone</synonym>
      </synonyms>
      <chemical_formula>C21H30O3</chemical_formula>
      <average_molecular_weight>330.4611</average_molecular_weight>
      <monisotopic_molecular_weight>330.219494826</monisotopic_molecular_weight>
      <iupac_name>(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</iupac_name>
      <traditional_iupac>(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</traditional_iupac>
      <cas_registry_number>64-85-7</cas_registry_number>
      <smiles>[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</smiles>
      <inchi>InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1</inchi>
      <inchikey>ZESRJSPZRDMNHY-YFWFAHHUSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone.</description>
        <direct_parent>21-hydroxysteroids</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Lipids and lipid-like molecules</super_class>
        <class>Steroids and steroid derivatives</class>
        <sub_class>Hydroxysteroids</sub_class>
        <molecular_framework>Aliphatic homopolycyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>20-oxosteroids</alternative_parent>
          <alternative_parent>3-oxo delta-4-steroids</alternative_parent>
          <alternative_parent>Alpha-hydroxy ketones</alternative_parent>
          <alternative_parent>Cyclohexenones</alternative_parent>
          <alternative_parent>Delta-4-steroids</alternative_parent>
          <alternative_parent>Gluco/mineralocorticoids, progestogins and derivatives</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Primary alcohols</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>20-oxosteroid</substituent>
          <substituent>21-hydroxysteroid</substituent>
          <substituent>3-oxo-delta-4-steroid</substituent>
          <substituent>3-oxosteroid</substituent>
          <substituent>Alcohol</substituent>
          <substituent>Aliphatic homopolycyclic compound</substituent>
          <substituent>Alpha-hydroxy ketone</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Cyclic ketone</substituent>
          <substituent>Cyclohexenone</substituent>
          <substituent>Delta-4-steroid</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Ketone</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Oxosteroid</substituent>
          <substituent>Pregnane-skeleton</substituent>
          <substituent>Primary alcohol</substituent>
          <substituent>Progestogin-skeleton</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>20-oxo steroid</external_descriptor>
          <external_descriptor>21-hydroxy steroid</external_descriptor>
          <external_descriptor>3-oxo Delta(4)-steroid</external_descriptor>
          <external_descriptor>C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives</external_descriptor>
          <external_descriptor>C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives</external_descriptor>
          <external_descriptor>Mineralocorticoids</external_descriptor>
          <external_descriptor>Pregnane and derivatives [Fig]</external_descriptor>
          <external_descriptor>mineralocorticoid</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Congenital adrenal hyperplasia</term>
                      <definition>A steroid inherited metabolic disorder that is characterized by adrenal insufficiency and variable degrees of hyper or hypo androgeny manifestations resulting from steroidogenic enzyme deficiency. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>All tissues</term>
                      <definition>All tissues in the body of the organism.</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Hepatic tissue</term>
                      <definition>The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes. (NCI Thesaurus).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Liver tissue</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Membrane</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Endoplasmic reticulum</term>
                      <definition>A network of tubular membranes within the cytoplasm of the cell, occurring either with a smooth surface (smooth endoplasmic reticulum) or studded with ribosomes (rough endoplasmic reticulum), involved in the transport of materials. (Infoplease Dictionary via NCI)</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Er</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell membrane</term>
                      <definition>A cellular compartment that separates a cellВ interiorВ from its exterior.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cellular membrane</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical process</term>
                      <definition>A biological process occurring at the subcellular level, involving biochemical reactions.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid transport</term>
                          <definition>A process in which a lipid molecules is translocated between cellular sites or compartments.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of lipids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Lipid metabolic process</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fatty acid metabolism</term>
                          <definition>A process that involves catabolism or anabolism of fatty acids in an organism.</definition>
                          <parent_id>7664</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Chemical reaction</term>
                      <definition>A defined chemical event that occurs within or between organism cells.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lipid peroxidation</term>
                          <definition>A chemical reaction involving oxidative attack from free radicals on a lipid molecule, resulting in its degradation. .</definition>
                          <parent_id>7663</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Cellular process</term>
                      <definition>A biological process occurring within a cell or its surroundings.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Cell signaling</term>
                          <definition>The process by which a cell responds to substances in its environment.</definition>
                          <parent_id>7665</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Signal transduction</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH</term>
                          <definition> cholesterol side-chain cleavage enzyme convertes cholesterol to pregnenolone in adrenal cortisol synthesis of all steroid hormones. a defect in this enzyme results in in impaired synthesis of all three categories of adrenal steroids (cortisol, mineralocorticoids, sex steroids) and high levels of adrenocorticotropic hormone (acth).</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Steroidogenesis</term>
                          <definition> products of steroidogenesis include androgens, testosterone, estrogens and progesterone, corticoids, cortisol and aldosterone. the first step in the synthesis of all steroid hormones is the synthesis of pregnenolone from cholesterol.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Lipid metabolism pathway</term>
                          <definition>A cellular process that consists of synthesis or breakdown of lipid molecules for energy or storage.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Indirect biological role</term>
              <definition>An indirect function of a chemical which affect the physiological state of any organism (apart from the source organism, if of biological source).</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Metabotoxin</term>
                  <definition>An endogenous metabolite that causes adverse health effects at chronically high levels.</definition>
                  <parent_id>7691</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological role</term>
              <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Metabolite</term>
                  <definition>A chemical substance produced during metabolism process, as an intermediate or end-product.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Membrane stabilizer</term>
                  <definition>A chemical substance that supports the formation and maintenance of a structurally-sound and functioning cell or organelle membrane. Phospholipids form a bilayer and maintain the stability of the membrane structure together with proteins, and other lipids (i.e. cholesterol) which further strengthen it and decrease its permeability. </definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Membrane stability agent</synonym>
                    <synonym>Membrane integrity agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy source</term>
                  <definition/>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy storage</term>
                  <definition>A chemical substance which can be utilized for production of energy in the organism.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Hypertensive agent</term>
                  <definition>A chemical substance that increases blood pressure and causes the production of more urine.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Molecular messenger</term>
                  <definition> a chemical substance that is involved in transmission of biochemical signals.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Hormone</term>
                      <definition>Substances produces in animals or plant that regulate the activity of certain organs or control processes in other parts of the plant.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Signaling molecule</term>
                      <definition>A chemical substance that particpiates in signal transduction processes in a living cell.</definition>
                      <parent_id>7677</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Signalling molecule</synonym>
                        <synonym>Signaling agent</synonym>
                        <synonym>Cell signaling agent</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Surfactant</term>
                  <definition>A chemical substance that has the ability to lower the surface tension of water or to reduce the interfacial tension between two immiscible substances. in the cspa consumer product ingredients dictionary, surfactants are classified on the basis of their ionic characteristics, as amphoteric, anionic, cationic, or nonionic; and functions, which are subdivided into the following major groups: surfactant - cleaning agent, surfactant - conditioning agent,  surfactant - emulsifying agent,  surfactant - foam booster , surfactant hydrotrop , surfactant - solubility agent, surfactant - suspending agent.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Surface-active agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Emulsifier</term>
                  <definition>Substances that promote the formation and stability of a suspension of fine particles of a liquid in another liquid.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>0.0595 mg/mL at 37 °C</value>
          <source/>
        </property>
        <property>
          <kind>logp</kind>
          <value>2.88</value>
          <source>HANSCH,C ET AL. (1995)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>141 - 142 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>3.10</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-4.30</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>0.017 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>3.33</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>13.86</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-3.3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>330.4611</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>330.219494826</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C21H30O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>ZESRJSPZRDMNHY-YFWFAHHUSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>54.37</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>94.41</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>38.19</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::EiMs</type>
          <spectrum_id>660</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>924</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2248</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>22999</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>27996</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>29607</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30951</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37245</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1031</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>2561</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>3259</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>28</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>29</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>30</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2547</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2548</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317086</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317087</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>317088</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363487</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363488</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>363489</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>374770</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>451444</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Endoplasmic reticulum</cellular>
          <cellular>Extracellular</cellular>
          <cellular>Membrane</cellular>
          <cellular>Mitochondria</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Amniotic Fluid</biospecimen>
          <biospecimen>Blood</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>All Tissues</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>11-beta-hydroxylase deficiency (CYP11B1)</name>
            <smpdb_id>SMP00575</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>17-alpha-hydroxylase deficiency (CYP17)</name>
            <smpdb_id>SMP00566</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>21-hydroxylase deficiency (CYP21)</name>
            <smpdb_id>SMP00576</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Beta-Hydroxysteroid Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00718</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency</name>
            <smpdb_id>SMP00373</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency</name>
            <smpdb_id>SMP00372</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Apparent mineralocorticoid excess syndrome</name>
            <smpdb_id>SMP00717</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH</name>
            <smpdb_id>SMP00371</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Corticosterone methyl oxidase I deficiency (CMO I)</name>
            <smpdb_id>SMP00577</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Corticosterone methyl oxidase II deficiency - CMO II</name>
            <smpdb_id>SMP00578</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Steroidogenesis</name>
            <smpdb_id>SMP00130</smpdb_id>
            <kegg_map_id>map00140</kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Amniotic Fluid</biospecimen>
          <concentration_value>10.591 +/- 1.997</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Sippell WG, Muller-Holve W, Dorr HG, Bidlingmaier F, Knorr D: Concentrations of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation. J Clin Endocrinol Metab. 1981 Mar;52(3):385-92.</reference_text>
              <pubmed_id>7462398</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.073 (0.034-0.11)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Pakravan P, Kenny FM, Depp R, Allen AC: Familial congenital absence of adrenal glands; evaluation of glucocorticoid, mineralocorticoid, and estrogen metabolism in the perinatal period. J Pediatr. 1974 Jan;84(1):74-8.</reference_text>
              <pubmed_id>12119960</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.00009-0.000999</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Kim SM, Rhee JH: A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30.</reference_text>
              <pubmed_id>26161337</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.00118</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency</patient_information>
          <comment>n=1. Significantly higher than normal, but no p value</comment>
          <references>
            <reference>
              <reference_text>Kim SM, Rhee JH: A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30.</reference_text>
              <pubmed_id>26161337</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Congenital Adrenal Hyperplasia, due to 17-Hydroxylase-Deficiency</name>
          <omim_id>202110</omim_id>
          <references>
            <reference>
              <reference_text>Wong SL, Shu SG, Tsai CR: Seventeen alpha-hydroxylase deficiency. J Formos Med Assoc. 2006 Feb;105(2):177-81. doi: 10.1016/S0929-6646(09)60342-9.</reference_text>
              <pubmed_id>16477341</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kim SM, Rhee JH: A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015 Jun;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. Epub 2015 Jun 30.</reference_text>
              <pubmed_id>26161337</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB021873</foodb_id>
      <chemspider_id>5932</chemspider_id>
      <pubchem_compound_id>6166</pubchem_compound_id>
      <chebi_id>16973</chebi_id>
      <kegg_id>C03205</kegg_id>
      <pdb_id/>
      <drugbank_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id>41397</bigg_id>
      <wikipedia_id>Desoxycorticosterone</wikipedia_id>
      <metlin_id>5089</metlin_id>
      <biocyc_id>11-DEOXYCORTICOSTERONE</biocyc_id>
      <synthesis_reference>Mattox V R; Goodrich J E; Vrieze W D  Synthesis of C-21 glucosiduronates of cortisone and related corticosteroids.    Biochemistry  (1969),  8(3),  1188-99. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Muto S, Akai Y, Ono S, Kusano E, Asano Y: Selective hypoaldosteronism due to combined defects of the conversion from inactive renin to active renin and the aldosterone biosynthesis from corticosterone. Nephron. 2001 Jul;88(3):247-53.</reference_text>
          <pubmed_id>11423756</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bruynseels J, De Coster R, Van Rooy P, Wouters W, Coene MC, Snoeck E, Raeymaekers A, Freyne E, Sanz G, Vanden Bussche G, et al.: R 75251, a new inhibitor of steroid biosynthesis. Prostate. 1990;16(4):345-57.</reference_text>
          <pubmed_id>2164659</pubmed_id>
        </reference>
        <reference>
          <reference_text>Holmes NM, Miller WL, Baskin LS: Lack of defects in androgen production in children with hypospadias. J Clin Endocrinol Metab. 2004 Jun;89(6):2811-6.</reference_text>
          <pubmed_id>15181062</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sippell WG, Muller-Holve W, Dorr HG, Bidlingmaier F, Knorr D: Concentrations of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation. J Clin Endocrinol Metab. 1981 Mar;52(3):385-92.</reference_text>
          <pubmed_id>7462398</pubmed_id>
        </reference>
        <reference>
          <reference_text>Namiki M, Koh E, Meguro N, Kondoh N, Kiyohara H, Okuyama A, Sakoda S, Matsumoto K, Sonoda T: Extraadrenal expression of steroid 21-hydroxylase and 11 beta-hydroxylase by a benign testicular Leydig cell tumor. J Steroid Biochem Mol Biol. 1991 Dec;39(6):897-901.</reference_text>
          <pubmed_id>1751389</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wyss JM, Oparil S, Sripairojthikoon W: Neuronal control of the kidney: contribution to hypertension. Can J Physiol Pharmacol. 1992 May;70(5):759-70.</reference_text>
          <pubmed_id>1423019</pubmed_id>
        </reference>
        <reference>
          <reference_text>Pakravan P, Kenny FM, Depp R, Allen AC: Familial congenital absence of adrenal glands; evaluation of glucocorticoid, mineralocorticoid, and estrogen metabolism in the perinatal period. J Pediatr. 1974 Jan;84(1):74-8.</reference_text>
          <pubmed_id>12119960</pubmed_id>
        </reference>
        <reference>
          <reference_text>Krone N, Riepe FG, Grotzinger J, Partsch CJ, Sippell WG: Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2005 Jan;90(1):445-54. Epub 2004 Oct 13.</reference_text>
          <pubmed_id>15483094</pubmed_id>
        </reference>
        <reference>
          <reference_text>Deng PY, Li YJ: Calcitonin gene-related peptide and hypertension. Peptides. 2005 Sep;26(9):1676-85. Epub 2005 Mar 2.</reference_text>
          <pubmed_id>16112410</pubmed_id>
        </reference>
        <reference>
          <reference_text>Funder JW: Mineralocorticoid receptors: distribution and activation. Heart Fail Rev. 2005 Jan;10(1):15-22.</reference_text>
          <pubmed_id>15947887</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bassett MH, White PC, Rainey WE: The regulation of aldosterone synthase expression. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):67-74.</reference_text>
          <pubmed_id>15134803</pubmed_id>
        </reference>
        <reference>
          <reference_text>White PC, Tusie-Luna MT, New MI, Speiser PW: Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat. 1994;3(4):373-8.</reference_text>
          <pubmed_id>8081391</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ahmad N, Romero DG, Gomez-Sanchez EP, Gomez-Sanchez CE: Do human vascular endothelial cells produce aldosterone? Endocrinology. 2004 Aug;145(8):3626-9. Epub 2004 Apr 29.</reference_text>
          <pubmed_id>15117882</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mussig K, Wehrmann M, Horger M, Maser-Gluth C, Haring HU, Overkamp D: Adrenocortical carcinoma producing 11-deoxycorticosterone: a rare cause of mineralocorticoid hypertension. J Endocrinol Invest. 2005 Jan;28(1):61-5.</reference_text>
          <pubmed_id>15816373</pubmed_id>
        </reference>
        <reference>
          <reference_text>Azar ST, Melby JC: 19-Nor-deoxycorticosterone production from aldosterone-producing adenomas. Hypertension. 1992 Apr;19(4):362-4.</reference_text>
          <pubmed_id>1555868</pubmed_id>
        </reference>
        <reference>
          <reference_text>Bureik M, Bruck N, Hubel K, Bernhardt R: The human mineralocorticoid receptor only partially differentiates between different ligands after expression in fission yeast. FEMS Yeast Res. 2005 Apr;5(6-7):627-33.</reference_text>
          <pubmed_id>15780662</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mellon SH, Miller WL: Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest. 1989 Nov;84(5):1497-502.</reference_text>
          <pubmed_id>2808702</pubmed_id>
        </reference>
        <reference>
          <reference_text>Hogan MJ, Schambelan M, Biglieri EG: Concurrent hypercortisolism and hypermineralocorticoidism. Am J Med. 1977 May;62(5):777-82.</reference_text>
          <pubmed_id>871129</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW: The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol. 2004 Jun;43(6):770-81.</reference_text>
          <pubmed_id>15167270</pubmed_id>
        </reference>
        <reference>
          <reference_text>Campion J, Lahera V, Cachofeiro V, Maestro B, Davila N, Carranza MC, Calle C: In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess. Mol Cell Biochem. 1998 Aug;185(1-2):177-82.</reference_text>
          <pubmed_id>9746224</pubmed_id>
        </reference>
        <reference>
          <reference_text>Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9.</reference_text>
          <pubmed_id>11413487</pubmed_id>
        </reference>
        <reference>
          <reference_text>Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10.</reference_text>
          <pubmed_id>16902246</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20.</reference_text>
          <pubmed_id>17374880</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621.</reference_text>
          <pubmed_id>20044567</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gupta S, Melendez J, Khanna A: Deoxycorticosterone producing tumor as a cause of resistant hypertension. Case Rep Med. 2010;2010:372719. doi: 10.1155/2010/372719. Epub 2010 Jun 30.</reference_text>
          <pubmed_id>20671982</pubmed_id>
        </reference>
        <reference>
          <reference_text>The lipid handbook with CD-ROM</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00445</protein_accession>
          <name>Cytochrome P450 11B1, mitochondrial</name>
          <uniprot_id>P15538</uniprot_id>
          <gene_name>CYP11B1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP02638</protein_accession>
          <name>Mineralocorticoid receptor</name>
          <uniprot_id>P08235</uniprot_id>
          <gene_name>NR3C2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP04403</protein_accession>
          <name>3 beta-hydroxysteroid dehydrogenase/Delta 5--&gt;4-isomerase type 1</name>
          <uniprot_id>P14060</uniprot_id>
          <gene_name>HSD3B1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP04404</protein_accession>
          <name>3 beta-hydroxysteroid dehydrogenase/Delta 5--&gt;4-isomerase type 2</name>
          <uniprot_id>P26439</uniprot_id>
          <gene_name>HSD3B2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP05268</protein_accession>
          <name>Cytochrome P450 11B2, mitochondrial</name>
          <uniprot_id>P19099</uniprot_id>
          <gene_name>CYP11B2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP07366</protein_accession>
          <name>Cytochrome P450 21-hydroxylase</name>
          <uniprot_id>Q16874</uniprot_id>
          <gene_name>P450-CYP21B</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP09242</protein_accession>
          <name>Cytochrome P450, family 21, subfamily A, polypeptide 2</name>
          <uniprot_id>Q08AG9</uniprot_id>
          <gene_name>CYP21A2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP11648</protein_accession>
          <name>Steroid 21-hydroxylase</name>
          <uniprot_id>P08686</uniprot_id>
          <gene_name>CYP21A2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:47 UTC</update_date>
      <accession>HMDB0000017</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00017</accession>
      </secondary_accessions>
      <name>4-Pyridoxic acid</name>
      <description>4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) which is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced in persons with riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide as a cofactor.</description>
      <synonyms>
        <synonym>2-Methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid</synonym>
        <synonym>4-Pyridoxate</synonym>
        <synonym>4-Pyridoxinecarboxylic acid</synonym>
        <synonym>4-Pyridoxinic acid</synonym>
        <synonym>4-Pyridoxylic acid</synonym>
        <synonym>Pyridoxic acid</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinate</synonym>
        <synonym>4-Pyridoxinecarboxylate</synonym>
        <synonym>4-Pyridoxinate</synonym>
        <synonym>4-Pyridoxylate</synonym>
        <synonym>Pyridoxate</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylate</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinate</synonym>
        <synonym>3-Hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinic acid</synonym>
        <synonym>3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinate</synonym>
        <synonym>3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinic acid</synonym>
        <synonym>3-Hydroxy-5-hydroxymethyl-2-methyl-isonicotinsaeure</synonym>
        <synonym>4-Pyridoxinsaeure</synonym>
        <synonym>4 Pyridoxinic acid</synonym>
        <synonym>Pyridoxinecarboxylic acid</synonym>
        <synonym>4 Pyridoxylic acid</synonym>
        <synonym>4 Pyridoxic acid</synonym>
      </synonyms>
      <chemical_formula>C8H9NO4</chemical_formula>
      <average_molecular_weight>183.1614</average_molecular_weight>
      <monisotopic_molecular_weight>183.053157781</monisotopic_molecular_weight>
      <iupac_name>3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid</iupac_name>
      <traditional_iupac>pyridoxic acid</traditional_iupac>
      <cas_registry_number>82-82-6</cas_registry_number>
      <smiles>CC1=NC=C(CO)C(C(O)=O)=C1O</smiles>
      <inchi>InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)</inchi>
      <inchikey>HXACOUQIXZGNBF-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group.</description>
        <direct_parent>Pyridinecarboxylic acids</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organoheterocyclic compounds</super_class>
        <class>Pyridines and derivatives</class>
        <sub_class>Pyridinecarboxylic acids and derivatives</sub_class>
        <molecular_framework>Aromatic heteromonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Aromatic alcohols</alternative_parent>
          <alternative_parent>Azacyclic compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Heteroaromatic compounds</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Hydroxypyridines</alternative_parent>
          <alternative_parent>Methylpyridines</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Organonitrogen compounds</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
          <alternative_parent>Primary alcohols</alternative_parent>
          <alternative_parent>Vinylogous acids</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Alcohol</substituent>
          <substituent>Aromatic alcohol</substituent>
          <substituent>Aromatic heteromonocyclic compound</substituent>
          <substituent>Azacycle</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Heteroaromatic compound</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Hydroxypyridine</substituent>
          <substituent>Methylpyridine</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Primary alcohol</substituent>
          <substituent>Pyridine carboxylic acid</substituent>
          <substituent>Vinylogous acid</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>hydroxymethylpyridine</external_descriptor>
          <external_descriptor>methylpyridines</external_descriptor>
          <external_descriptor>monohydroxypyridine</external_descriptor>
          <external_descriptor>vitamin B6</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Liver</term>
                      <definition>An abdominal organ that has variable lobation which are composed mainly of hepatic lobules. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Bladder</term>
                      <definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Kidney</term>
                      <definition>The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Kidneys</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Hypophosphatasia</term>
                          <definition> it is an inborn error of metabolism characterized clinically by defective bone mineralization that can be fatal early in infancy.  three more or less distinct types can be identified: (1) type 1 with onset in utero or in early postnatal life, craniostenosis, severe skeletal abnormalities, hypercalcemia, and death in the first year or so of life; (2) type 2 with later, more gradual development of symptoms, moderately severe 'rachitic' skeletal changes and premature loss of teeth; (3) type 3 with no symptoms, the condition being determined on routine studies.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Phosphoethanolaminuria</synonym>
                            <synonym>Hops</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Vitamin B6 metabolism</term>
                          <definition> pyridoxal phosphate (plp) is the active form of vitamin b6 and is a cofactor in many reactions of amino acid metabolism, including transamination, deamination, and decarboxylation. seven forms of this vitamin are known: pyridoxine (pn), pyridoxine 5’-phosphate (pnp).</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>melting_point</kind>
          <value>247 - 248 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-0.08</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-1.32</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>8.71 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-0.75</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>2.55</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>4.09</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>183.1614</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>183.053157781</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>CC1=NC=C(CO)C(C(O)=O)=C1O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C8H9NO4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>HXACOUQIXZGNBF-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>90.65</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>44.55</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>17.19</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>5</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1032</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1679</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>18018</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30952</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>32212</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37246</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>925</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6154</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6155</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6156</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6157</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6158</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6159</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6160</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>6161</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>305956</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>305957</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>305958</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>349459</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>349460</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>349461</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438691</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439258</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>440067</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>446837</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>446838</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>446839</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>446840</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>446841</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>448196</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>448197</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>451897</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Extracellular</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Bladder</tissue>
          <tissue>Erythrocyte</tissue>
          <tissue>Kidney</tissue>
          <tissue>Liver</tissue>
          <tissue>Placenta</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Hypophosphatasia</name>
            <smpdb_id>SMP00503</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Vitamin B6 Metabolism</name>
            <smpdb_id>SMP00017</smpdb_id>
            <kegg_map_id>map00750</kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.027 (0.0062-3.14)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Rybak ME, Pfeiffer CM: Clinical analysis of vitamin B(6): determination of pyridoxal 5'-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem. 2004 Oct 15;333(2):336-44.</reference_text>
              <pubmed_id>15450810</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.040 +/- 0.007</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.0071 +/- 0.005</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Driskell JA, Giraud DW, Mitmesser SH: Vitamin B-6 intakes and plasma B-6 vitamer concentrations of men and women, 19-50 years of age. Int J Vitam Nutr Res. 2000 Sep;70(5):221-5.</reference_text>
              <pubmed_id>11068702</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.0097 +/- 0.00665</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Driskell JA, Giraud DW, Mitmesser SH: Vitamin B-6 intakes and plasma B-6 vitamer concentrations of men and women, 19-50 years of age. Int J Vitam Nutr Res. 2000 Sep;70(5):221-5.</reference_text>
              <pubmed_id>11068702</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With vitamin supplements. Health condition not specified. Assume they are healthy. They have no previous history of prostate, lung, colorectal, or ovarian cancer.</comment>
          <references>
            <reference>
              <reference_text>Guertin KA, Moore SC, Sampson JN, Huang WY, Xiao Q, Stolzenberg-Solomon RZ, Sinha R, Cross AJ: Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr. 2014 Jul;100(1):208-17. doi: 10.3945/ajcn.113.078758. Epub 2014 Apr 16.</reference_text>
              <pubmed_id>24740205</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With the consumption of high fiber breakfast cereals. Female twins. Healthy condition not specified, assume it is healthy</comment>
          <references>
            <reference>
              <reference_text>Pallister T, Jennings A, Mohney RP, Yarand D, Mangino M, Cassidy A, MacGregor A, Spector TD, Menni C: Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins. PLoS One. 2016 Jun 29;11(6):e0158568. doi: 10.1371/journal.pone.0158568. eCollection 2016.</reference_text>
              <pubmed_id>27355821</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.00009-0.00300</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Darin N, Reid E, Prunetti L, Samuelsson L, Husain RA, Wilson M, El Yacoubi B, Footitt E, Chong WK, Wilson LC, Prunty H, Pope S, Heales S, Lascelles K, Champion M, Wassmer E, Veggiotti P, de Crecy-Lagard V, Mills PB, Clayton PT: Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent Epilepsy. Am J Hum Genet. 2016 Dec 1;99(6):1325-1337. doi: 10.1016/j.ajhg.2016.10.011.</reference_text>
              <pubmed_id>27912044</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Children (6 - 18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Breast-fed</comment>
          <references>
            <reference>
              <reference_text>Chow J, Panasevich MR, Alexander D, Vester Boler BM, Rossoni Serao MC, Faber TA, Bauer LL, Fahey GC: Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res. 2014 May 2;13(5):2534-42. doi: 10.1021/pr500011w. Epub 2014 Mar 28.</reference_text>
              <pubmed_id>24628373</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>formula-fed</comment>
          <references>
            <reference>
              <reference_text>Chow J, Panasevich MR, Alexander D, Vester Boler BM, Rossoni Serao MC, Faber TA, Bauer LL, Fahey GC: Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res. 2014 May 2;13(5):2534-42. doi: 10.1021/pr500011w. Epub 2014 Mar 28.</reference_text>
              <pubmed_id>24628373</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Organic acid. By GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&gt; 0.33</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Fabian E, Majchrzak D, Dieminger B, Meyer E, Elmadfa I: Influence of probiotic and conventional yoghurt on the status of vitamins B1, B2 and B6 in young healthy women. Ann Nutr Metab. 2008;52(1):29-36. doi: 10.1159/000114408. Epub 2008 Jan 30.</reference_text>
              <pubmed_id>18230968</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.78 +/- 0.45</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Vitamin B6 intake was well below the recommended dietary allowance for men and woman</comment>
          <references>
            <reference>
              <reference_text>Schuster K, Bailey LB, Cerda JJ, Gregory JF 3rd: Urinary 4-pyridoxic acid excretion in 24-hour versus random urine samples as a measurement of vitamin B6 status in humans. Am J Clin Nutr. 1984 Mar;39(3):466-70.</reference_text>
              <pubmed_id>6695847</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>3.1 (0.4-7.5)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.975 +/- 2.873</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.157 +/- 0.0613</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tsuji T, Fukuwatari T, Sasaki S, Shibata K: Twenty-four-hour urinary water-soluble vitamin levels correlate with their intakes in free-living Japanese schoolchildren. Public Health Nutr. 2011 Feb;14(2):327-33. doi: 10.1017/S1368980010001904. Epub 2010 Jun 25.</reference_text>
              <pubmed_id>20576202</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.245 +/- 0.0873</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tsuji T, Fukuwatari T, Sasaki S, Shibata K: Twenty-four-hour urinary water-soluble vitamin levels correlate with their intakes in free-living Japanese university students. Eur J Clin Nutr. 2010 Aug;64(8):800-7. doi: 10.1038/ejcn.2010.72. Epub 2010 May 26.</reference_text>
              <pubmed_id>20502474</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.407 +/- 0.173</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Chang SJ, Hsiao LJ, Lee YC, Hsuen SY: Vitamin B6 status assessment in relation to dietary intake in high school students aged 16-18 years. Br J Nutr. 2007 Apr;97(4):764-9.</reference_text>
              <pubmed_id>17349090</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.420 +/- 0.187</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Chang SJ, Hsiao LJ, Lee YC, Hsuen SY: Vitamin B6 status assessment in relation to dietary intake in high school students aged 16-18 years. Br J Nutr. 2007 Apr;97(4):764-9.</reference_text>
              <pubmed_id>17349090</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&gt; 3.0</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Chang SJ, Huang YC, Hsiao LJ, Lee YC, Hsuen SY: Determination of vitamin B-6 estimated average requirement and recommended dietary allowance for children aged 7-12 years using vitamin B-6 intake, nutritional status and anthropometry. J Nutr. 2002 Oct;132(10):3130-4.</reference_text>
              <pubmed_id>12368406</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>2.99 +/- 5.25</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
              <pubmed_id>2026685</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal adenoma </patient_information>
          <comment>With vitamin supplements</comment>
          <references>
            <reference>
              <reference_text>Playdon MC, Sampson JN, Cross AJ, Sinha R, Guertin KA, Moy KA, Rothman N, Irwin ML, Mayne ST, Stolzenberg-Solomon R, Moore SC: Comparing metabolite profiles of habitual diet in serum and urine. Am J Clin Nutr. 2016 Sep;104(3):776-89. doi: 10.3945/ajcn.116.135301. Epub 2016 Aug 10.</reference_text>
              <pubmed_id>27510537</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Crohns disease</patient_information>
          <references>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value></concentration_value>
          <concentration_units></concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Iron deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Crohns disease</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Crohns disease</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Children (6 - 18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Unclassified IBD </patient_information>
          <references>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.701 +/- 3.878</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1414.9 +/- 737.8</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Critically ill</patient_information>
          <comment>After Vitamin B6 for 14 days. Disease is not specified in the reference. </comment>
          <references>
            <reference>
              <reference_text>Huang YC, Lan PH, Cheng CH, Lee BJ, Kan MN: Vitamin B6 intakes and status of mechanically ventilated critically ill patients in Taiwan. Eur J Clin Nutr. 2002 May;56(5):387-92.</reference_text>
              <pubmed_id>12001008</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal adenoma </patient_information>
          <comment>With vitamin supplements</comment>
          <references>
            <reference>
              <reference_text>Playdon MC, Sampson JN, Cross AJ, Sinha R, Guertin KA, Moy KA, Rothman N, Irwin ML, Mayne ST, Stolzenberg-Solomon R, Moore SC: Comparing metabolite profiles of habitual diet in serum and urine. Am J Clin Nutr. 2016 Sep;104(3):776-89. doi: 10.3945/ajcn.116.135301. Epub 2016 Aug 10.</reference_text>
              <pubmed_id>27510537</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Crohn's disease</name>
          <omim_id>266600</omim_id>
          <references>
            <reference>
              <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
              <pubmed_id>16440420</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
              <pubmed_id>8723414</pubmed_id>
            </reference>
            <reference>
              <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19491857</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Iron deficiency</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Canatan D, Akdeniz SK: Iron and ferritin levels in saliva of patients with thalassemia and iron deficiency anemia. Mediterr J Hematol Infect Dis. 2012;4(1):e2012051. doi: 10.4084/MJHID.2012.051. Epub 2012 Aug 9.</reference_text>
              <pubmed_id>22973495</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mishra OP, Agarwal KN, Agarwal RM: Salivary iron status in children with iron deficiency and iron overload. J Trop Pediatr. 1992 Apr;38(2):64-7.</reference_text>
              <pubmed_id>1569637</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ulcerative colitis</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
              <pubmed_id>21059682</pubmed_id>
            </reference>
            <reference>
              <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
              <pubmed_id>1740537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
              <pubmed_id>17314143</pubmed_id>
            </reference>
            <reference>
              <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
              <pubmed_id>21761941</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00847</kegg_id>
      <drugbank_id/>
      <foodb_id>FDB021874</foodb_id>
      <chemspider_id>6467</chemspider_id>
      <chebi_id>17405</chebi_id>
      <pubchem_compound_id>6723</pubchem_compound_id>
      <pdb_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id>36190</bigg_id>
      <wikipedia_id/>
      <metlin_id>239</metlin_id>
      <biocyc_id>CPD-1112</biocyc_id>
      <vmh_id>4PYRDX</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Senkuma, Masahiko; Imada, Katsumi; Sato, Masatada. Preparation of 4-pyridoxic acid. Jpn. Kokai Tokkyo Koho  (1992),  2 pp. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Huang YC, Lan PH, Cheng CH, Lee BJ, Kan MN: Vitamin B6 intakes and status of mechanically ventilated critically ill patients in Taiwan. Eur J Clin Nutr. 2002 May;56(5):387-92.</reference_text>
          <pubmed_id>12001008</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kodentsova VM, Vrzhesinskaia OA, Sokol'nikov AA, Beketova NA, Spirichev VB: [The effect of riboflavin supply on metabolism of water-soluble vitamins]. Vopr Med Khim. 1993 Sep-Oct;39(5):29-33.</reference_text>
          <pubmed_id>8279138</pubmed_id>
        </reference>
        <reference>
          <reference_text>Masse PG, Mahuren JD, Tranchant C, Dosy J: B-6 vitamers and 4-pyridoxic acid in the plasma, erythrocytes, and urine of postmenopausal women. Am J Clin Nutr. 2004 Oct;80(4):946-51.</reference_text>
          <pubmed_id>15447904</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang YC, Chang HH, Huang SC, Cheng CH, Lee BJ, Cheng SY, Su KH: Plasma pyridoxal 5'-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill. Nutrition. 2005 Jul-Aug;21(7-8):779-85.</reference_text>
          <pubmed_id>15975484</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ericson KL, Mahuren JD, Zubovic YM, Coburn SP: Use of chlorite to improve HPLC detection of pyridoxal 5'-phosphate. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 5;823(2):218-20.</reference_text>
          <pubmed_id>16054880</pubmed_id>
        </reference>
        <reference>
          <reference_text>Driskell JA, Chrisley BM: Plasma B-6 vitamer and plasma and urinary 4-pyridoxic acid concentrations in young women as determined using high performance liquid chromatography. Biomed Chromatogr. 1991 Sep;5(5):198-201.</reference_text>
          <pubmed_id>1742549</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, Roubenoff R: Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther. 2005;7(6):R1254-62. Epub 2005 Sep 13.</reference_text>
          <pubmed_id>16277678</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rybak ME, Pfeiffer CM: Clinical analysis of vitamin B(6): determination of pyridoxal 5'-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal Biochem. 2004 Oct 15;333(2):336-44.</reference_text>
          <pubmed_id>15450810</pubmed_id>
        </reference>
        <reference>
          <reference_text>Huang YC, Chang SJ, Chiu YT, Chang HH, Cheng CH: The status of plasma homocysteine and related B-vitamins in healthy young vegetarians and nonvegetarians. Eur J Nutr. 2003 Apr;42(2):84-90.</reference_text>
          <pubmed_id>12638029</pubmed_id>
        </reference>
        <reference>
          <reference_text>Midttun O, Hustad S, Solheim E, Schneede J, Ueland PM: Multianalyte quantification of vitamin B6 and B2 species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry. Clin Chem. 2005 Jul;51(7):1206-16.</reference_text>
          <pubmed_id>15976101</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chang SJ, Huang YC, Hsiao LJ, Lee YC, Hsuen SY: Determination of vitamin B-6 estimated average requirement and recommended dietary allowance for children aged 7-12 years using vitamin B-6 intake, nutritional status and anthropometry. J Nutr. 2002 Oct;132(10):3130-4.</reference_text>
          <pubmed_id>12368406</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00126</protein_accession>
          <name>Aldehyde oxidase</name>
          <uniprot_id>Q06278</uniprot_id>
          <gene_name>AOX1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-04-23 20:53:26 UTC</update_date>
      <accession>HMDB0000019</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00019</accession>
        <accession>HMDB0004260</accession>
        <accession>HMDB04260</accession>
      </secondary_accessions>
      <name>alpha-Ketoisovaleric acid</name>
      <description>alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development.</description>
      <synonyms>
        <synonym>2-Keto-3-methylbutyric acid</synonym>
        <synonym>2-Ketoisovaleric acid</synonym>
        <synonym>2-Ketovaline</synonym>
        <synonym>2-oxo-3-Methylbutanoic acid</synonym>
        <synonym>2-oxo-3-Methylbutyric acid</synonym>
        <synonym>2-Oxoisovaleric acid</synonym>
        <synonym>3-Methyl-2-oxobutanoate</synonym>
        <synonym>3-Methyl-2-oxobutyric acid</synonym>
        <synonym>alpha-Keto-isovaleric acid</synonym>
        <synonym>alpha-Ketovaline</synonym>
        <synonym>alpha-oxo-beta-Methylbutyricacid</synonym>
        <synonym>alpha-Oxoisovaleric acid</synonym>
        <synonym>Dimethylpyruvic acid</synonym>
        <synonym>Isopropylglyoxylic acid</synonym>
        <synonym>2-oxo-3-Methylbutanoate</synonym>
        <synonym>2-Oxoisovalerate</synonym>
        <synonym>2-Oxoisopentanoate</synonym>
        <synonym>2-Keto-3-methylbutyrate</synonym>
        <synonym>2-Ketoisovalerate</synonym>
        <synonym>2-oxo-3-Methylbutyrate</synonym>
        <synonym>3-Methyl-2-oxobutanoic acid</synonym>
        <synonym>3-Methyl-2-oxobutyrate</synonym>
        <synonym>a-Keto-isovalerate</synonym>
        <synonym>a-Keto-isovaleric acid</synonym>
        <synonym>alpha-Keto-isovalerate</synonym>
        <synonym>Α-keto-isovalerate</synonym>
        <synonym>Α-keto-isovaleric acid</synonym>
        <synonym>a-Ketovaline</synonym>
        <synonym>Α-ketovaline</synonym>
        <synonym>a-oxo-b-Methylbutyricacid</synonym>
        <synonym>Α-oxo-β-methylbutyricacid</synonym>
        <synonym>a-Oxoisovalerate</synonym>
        <synonym>a-Oxoisovaleric acid</synonym>
        <synonym>alpha-Oxoisovalerate</synonym>
        <synonym>Α-oxoisovalerate</synonym>
        <synonym>Α-oxoisovaleric acid</synonym>
        <synonym>Dimethylpyruvate</synonym>
        <synonym>Isopropylglyoxylate</synonym>
        <synonym>2-Oxoisopentanoic acid</synonym>
        <synonym>a-Ketoisovalerate</synonym>
        <synonym>a-Ketoisovaleric acid</synonym>
        <synonym>alpha-Ketoisovalerate</synonym>
        <synonym>Α-ketoisovalerate</synonym>
        <synonym>Α-ketoisovaleric acid</synonym>
        <synonym>2-Ketoisvaleric acid</synonym>
        <synonym>2-oxo-3-Methyl-butyrate</synonym>
        <synonym>3-Methyl-2-oxo-butanoate</synonym>
        <synonym>3-Methyl-2-oxo-butanoic acid</synonym>
        <synonym>3-Methyl-2-oxo-butyrate</synonym>
        <synonym>3-Methyl-2-oxo-butyric acid</synonym>
        <synonym>3-Methyl-2-oxobutinoate</synonym>
        <synonym>3-Methyl-2-oxobutinoic acid</synonym>
        <synonym>a-Keto-b-methylbutyrate</synonym>
        <synonym>a-Keto-b-methylbutyric acid</synonym>
        <synonym>a-oxo-b-Methylbutyrate</synonym>
        <synonym>a-oxo-b-Methylbutyric acid</synonym>
        <synonym>alpha-Keto-beta-methylbutyrate</synonym>
        <synonym>alpha-Keto-beta-methylbutyric acid</synonym>
        <synonym>alpha-oxo-beta-Methylbutyrate</synonym>
        <synonym>alpha-oxo-beta-Methylbutyric acid</synonym>
        <synonym>Ketovaline</synonym>
        <synonym>alpha-Ketoisopentanoic acid</synonym>
        <synonym>alpha-Ketoisovaleric acid</synonym>
      </synonyms>
      <chemical_formula>C5H8O3</chemical_formula>
      <average_molecular_weight>116.1152</average_molecular_weight>
      <monisotopic_molecular_weight>116.047344122</monisotopic_molecular_weight>
      <iupac_name>3-methyl-2-oxobutanoic acid</iupac_name>
      <traditional_iupac>α-ketoisovalerate</traditional_iupac>
      <cas_registry_number>759-05-7</cas_registry_number>
      <smiles>CC(C)C(=O)C(O)=O</smiles>
      <inchi>InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)</inchi>
      <inchikey>QHKABHOOEWYVLI-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms.</description>
        <direct_parent>Short-chain keto acids and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Keto acids and derivatives</class>
        <sub_class>Short-chain keto acids and derivatives</sub_class>
        <molecular_framework>Aliphatic acyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Alpha-hydroxy ketones</alternative_parent>
          <alternative_parent>Alpha-keto acids and derivatives</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Methyl-branched fatty acids</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>Aliphatic acyclic compound</substituent>
          <substituent>Alpha-hydroxy ketone</substituent>
          <substituent>Alpha-keto acid</substituent>
          <substituent>Branched fatty acid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Fatty acyl</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Ketone</substituent>
          <substituent>Methyl-branched fatty acid</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Short-chain keto acid</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>2-oxo monocarboxylic acid</external_descriptor>
          <external_descriptor>Branched fatty acids</external_descriptor>
          <external_descriptor>Branched fatty acids</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Animal</term>
                      <definition>A living organism belonging to the kingdom animalia. it feeds on organic matter, typically having specialized sense organs and nervous system and able to respond rapidly to stimuli.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fauna</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Fabaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Papilionoideae</synonym>
                            <synonym>Legume</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Glycine max</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Soy</synonym>
                            <synonym>Soya</synonym>
                            <synonym>Soybean</synonym>
                            <synonym>Soya bean</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Cucurbitaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Cucurbits</synonym>
                            <synonym>Gourds</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Placenta</term>
                      <definition>An organ present in some vertebrates during embryonic gestation that surrounds the fetus and provides it with nutrients and oxygen, facilitates gas and waste exchange between the fetus and mother, and provides parasitic cloaking from the mother's immune system by excretion of neurokinin b. (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Membrane</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Mitochondria</term>
                      <definition/>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cell membrane</term>
                      <definition>A cellular compartment that separates a cellВ interiorВ from its exterior.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cellular membrane</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cellular process</term>
                      <definition>A biological process occurring within a cell or its surroundings.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Cell signaling</term>
                          <definition>The process by which a cell responds to substances in its environment.</definition>
                          <parent_id>7665</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Signal transduction</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Valine, Leucine and Isoleucine Degradation</term>
                          <definition> because this arrangement of carbon atoms cannot be made by humans, these amino acids must be obtained from the diet. the catabolism of all three amino acids starts in muscle and yields nadh and fadh2 which can be utilized for atp generation.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Indirect biological role</term>
              <definition>An indirect function of a chemical which affect the physiological state of any organism (apart from the source organism, if of biological source).</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Neurotoxin</term>
                  <definition>A chemical substance that interferes with the normal functioning of the nervous system.</definition>
                  <parent_id>7691</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Neurotoxic</synonym>
                    <synonym>Neurotoxic agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Metabotoxin</term>
                  <definition>An endogenous metabolite that causes adverse health effects at chronically high levels.</definition>
                  <parent_id>7691</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Acidogen</term>
                  <definition>An acidic chemical substance that induces acidosis, which has multiple adverse effects on many organ systems.</definition>
                  <parent_id>7691</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological role</term>
              <definition>The biological function of a chemical.  the biological role answers the question how a chemical is involved in molecular processes in an organism. this can include biochemical effects of non-endogenous chemicals, which are also assigned an industrial application such as pharmaceuticals. the biological role is limited to cellular levls, and will not include role at system process level, such as a chemical which has a role in a disease.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Membrane stabilizer</term>
                  <definition>A chemical substance that supports the formation and maintenance of a structurally-sound and functioning cell or organelle membrane. Phospholipids form a bilayer and maintain the stability of the membrane structure together with proteins, and other lipids (i.e. cholesterol) which further strengthen it and decrease its permeability. </definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Membrane stability agent</synonym>
                    <synonym>Membrane integrity agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy source</term>
                  <definition/>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Energy storage</term>
                  <definition>A chemical substance which can be utilized for production of energy in the organism.</definition>
                  <parent_id>7672</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Food and nutrition</term>
                  <definition>A chemical purpose related to manufacturing of food and nutrition products.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Surfactant</term>
                  <definition>A chemical substance that has the ability to lower the surface tension of water or to reduce the interfacial tension between two immiscible substances. in the cspa consumer product ingredients dictionary, surfactants are classified on the basis of their ionic characteristics, as amphoteric, anionic, cationic, or nonionic; and functions, which are subdivided into the following major groups: surfactant - cleaning agent, surfactant - conditioning agent,  surfactant - emulsifying agent,  surfactant - foam booster , surfactant hydrotrop , surfactant - solubility agent, surfactant - suspending agent.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                    <synonym>Surface-active agent</synonym>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Emulsifier</term>
                  <definition>Substances that promote the formation and stability of a suspension of fine particles of a liquid in another liquid.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>melting_point</kind>
          <value>31.5 °C</value>
          <source></source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>0.49</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-0.59</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>30.2 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>1.31</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>3.37</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-9.7</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>3-methyl-2-oxobutanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>116.1152</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>116.047344122</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>CC(C)C(=O)C(O)=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C5H8O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>QHKABHOOEWYVLI-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>54.37</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>27.19</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>11.04</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1033</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4866</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>4867</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>926</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>935</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>282</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>283</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>938</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>966</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2985</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30050</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30051</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30583</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30584</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30953</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30954</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>31977</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>31978</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37247</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>31</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>32</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2549</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2550</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2551</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2552</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>7013</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>7014</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>7015</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>13685</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>13686</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>13687</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438056</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438057</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438058</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438059</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>438656</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Extracellular</cellular>
          <cellular>Membrane</cellular>
          <cellular>Mitochondria</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Placenta</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00137</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</name>
            <smpdb_id>SMP00138</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-hydroxyisobutyric acid dehydrogenase deficiency</name>
            <smpdb_id>SMP00521</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-hydroxyisobutyric aciduria</name>
            <smpdb_id>SMP00522</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Methylcrotonyl Coa Carboxylase Deficiency Type I</name>
            <smpdb_id>SMP00237</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Methylglutaconic Aciduria Type I</name>
            <smpdb_id>SMP00139</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Methylglutaconic Aciduria Type III</name>
            <smpdb_id>SMP00140</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>3-Methylglutaconic Aciduria Type IV</name>
            <smpdb_id>SMP00141</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Beta-Ketothiolase Deficiency</name>
            <smpdb_id>SMP00173</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Isobutyryl-coa dehydrogenase deficiency</name>
            <smpdb_id>SMP00523</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Isovaleric acidemia</name>
            <smpdb_id>SMP00524</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Isovaleric Aciduria</name>
            <smpdb_id>SMP00238</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Maple Syrup Urine Disease</name>
            <smpdb_id>SMP00199</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methylmalonate Semialdehyde Dehydrogenase Deficiency</name>
            <smpdb_id>SMP00384</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Methylmalonic Aciduria</name>
            <smpdb_id>SMP00200</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Propionic Acidemia</name>
            <smpdb_id>SMP00236</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Valine, Leucine and Isoleucine Degradation</name>
            <smpdb_id>SMP00032</smpdb_id>
            <kegg_map_id>map00280</kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>14.0 (0.0-28.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>11.0 +/- 1.7</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With wine consumption. Female twins. Healthy condition not specified, assume it is healthy</comment>
          <references>
            <reference>
              <reference_text>Pallister T, Jennings A, Mohney RP, Yarand D, Mangino M, Cassidy A, MacGregor A, Spector TD, Menni C: Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins. PLoS One. 2016 Jun 29;11(6):e0158568. doi: 10.1371/journal.pone.0158568. eCollection 2016.</reference_text>
              <pubmed_id>27355821</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>6 +/- 3</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):164-73. doi: 10.1016/j.jchromb.2008.05.001. Epub 2008 May 8.</reference_text>
              <pubmed_id>18502700</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>8.2 +/- 6.8 </concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.</reference_text>
              <pubmed_id>8412012</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>1H NMR on fecal extract</comment>
          <references>
            <reference>
              <reference_text>Saric J, Wang Y, Li J, Coen M, Utzinger J, Marchesi JR, Keiser J, Veselkov K, Lindon JC, Nicholson JK, Holmes E: Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res. 2008 Jan;7(1):352-60. Epub 2007 Dec 1.</reference_text>
              <pubmed_id>18052033</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.679 +/- 0.369</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=24)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.752 +/- 0.287</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI ≥ 21.00 kg/m2 (n=22)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>1.06 +/- 0.436</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>BMI &lt; 21.00 kg/m2 (n=45)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.345 +/- 0.858</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=27)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.434 +/- 0.382</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Possive drool method (n=18)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>0.656 +/- 0.399</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Salivettes (n=18)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.78-1.2 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.16 +/- 0.48</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
              <pubmed_id>2026685</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.5 (0.2-1.1)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.13 (0.00-0.54)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
              <pubmed_id>9869358</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.07 (0.01-0.45)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Gallina DL, Dominguez JM, Hoschoian JC, Barrio JR: Maintenance of nitrogen balance in a young woman by substitution of -ketoisovaleric acid for valine. J Nutr. 1971 Sep;101(9):1165-7.</reference_text>
              <pubmed_id>5096137</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.79-1.1 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.07 (0.01-0.45)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
              <pubmed_id>9869358</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>10.7 +/- 5.5</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Heart Transplant</patient_information>
          <references>
            <reference>
              <reference_text>Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, Krishnamurthy R, Eisner R, Gautam B, Young N, Xia J, Knox C, Dong E, Huang P, Hollander Z, Pedersen TL, Smith SR, Bamforth F, Greiner R, McManus B, Newman JW, Goodfriend T, Wishart DS: The human serum metabolome. PLoS One. 2011 Feb 16;6(2):e16957. doi: 10.1371/journal.pone.0016957.</reference_text>
              <pubmed_id>21359215</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>237</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Maple syrup urine disease</patient_information>
          <comment>n=1. While patient was in coma.</comment>
          <references>
            <reference>
              <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>189</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Maple syrup urine disease</patient_information>
          <comment>n=1. While patient was in coma.</comment>
          <references>
            <reference>
              <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Bladder cancer</patient_information>
          <references>
            <reference>
              <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
              <pubmed_id>28157703</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>550.00 (300.00-800.00)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Maple syrup urine disease (MSUD). When treated, the concentrations are 1-2 uM/mM.</patient_information>
          <references>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>550.00 (300.00-800.00)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Maple syrup urine disease (MSUD). When treated, the concentrations are 1-2 uM/mM.</patient_information>
          <references>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Maple syrup urine disease</name>
          <omim_id>248600</omim_id>
          <references>
            <reference>
              <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
              <pubmed_id>12101068</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U: Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem. 1999 Oct;45(10):1734-40.</reference_text>
              <pubmed_id>10508118</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schadewaldt P, Hammen HW, Ott AC, Wendel U: Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease. J Inherit Metab Dis. 1999 Aug;22(6):706-22.</reference_text>
              <pubmed_id>10472531</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kumps A, Duez P, Mardens Y: Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem. 2002 May;48(5):708-17.</reference_text>
              <pubmed_id>11978597</pubmed_id>
            </reference>
            <reference>
              <reference_text>Podebrad F, Heil M, Reichert S, Mosandl A, Sewell AC, Bohles H: 4,5-dimethyl-3-hydroxy-2[5H]-furanone (sotolone)--the odour of maple syrup urine disease. J Inherit Metab Dis. 1999 Apr;22(2):107-14.</reference_text>
              <pubmed_id>10234605</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.</reference_text>
              <pubmed_id>6422161</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yunus ZM, Kamaludin DA, Mamat M, Choy YS, Ngu L: Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep. 2012;5:99-107. doi: 10.1007/8904_2011_105. Epub 2011 Dec 11.</reference_text>
              <pubmed_id>23430924</pubmed_id>
            </reference>
            <reference>
              <reference_text>Barschak AG, Marchesan C, Sitta A, Deon M, Giugliani R, Wajner M, Vargas CR: Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008 Mar;41(4-5):317-24. Epub 2007 Dec 5.</reference_text>
              <pubmed_id>18088602</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids. Eur J Pediatr (1980) 134: 57. https://doi.org/10.1007/BF00442404</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C00141</kegg_id>
      <drugbank_id>DB04074</drugbank_id>
      <foodb_id>FDB012250</foodb_id>
      <chemspider_id>48</chemspider_id>
      <chebi_id>16530</chebi_id>
      <pubchem_compound_id>49</pubchem_compound_id>
      <pdb_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id>C00007623</knapsack_id>
      <bigg_id>34011</bigg_id>
      <wikipedia_id>Alpha-Ketoisovaleric acid</wikipedia_id>
      <metlin_id>5091</metlin_id>
      <biocyc_id>2-KETO-ISOVALERATE</biocyc_id>
      <vmh_id>3MOB</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Pirrung, Michael C.; Ha, Hyun Joon; Holmes, Christopher P. Purification and inhibition of spinach a,b-dihydroxyacid dehydratase . Journal of Organic Chemistry  (1989),  54(7),  1543-8. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Schaefer K, von Herrath D, Erley CM, Asmus G: Calcium ketovaline as new therapy for uremic hyperphosphatemia. Miner Electrolyte Metab. 1990;16(6):362-4.</reference_text>
          <pubmed_id>2089249</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.</reference_text>
          <pubmed_id>2026685</pubmed_id>
        </reference>
        <reference>
          <reference_text>Livesey G, Lund P: Binding of branched-chain 2-oxo acids to bovine serum albumin. Biochem J. 1982 Apr 15;204(1):265-72.</reference_text>
          <pubmed_id>7115325</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shigematsu Y, Kikuchi K, Momoi T, Sudo M, Kikawa Y, Nosaka K, Kuriyama M, Haruki S, Sanada K, Hamano N, et al.: Organic acids and branched-chain amino acids in body fluids before and after multiple exchange transfusions in maple syrup urine disease. J Inherit Metab Dis. 1983;6(4):183-9.</reference_text>
          <pubmed_id>6422161</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chuang DT, Niu WL, Cox RP: Activities of branched-chain 2-oxo acid dehydrogenase and its components in skin fibroblasts from normal and classical-maple-syrup-urine-disease subjects. Biochem J. 1981 Oct 15;200(1):59-67.</reference_text>
          <pubmed_id>6895847</pubmed_id>
        </reference>
        <reference>
          <reference_text>Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.</reference_text>
          <pubmed_id>9869358</pubmed_id>
        </reference>
        <reference>
          <reference_text>Gallina DL, Dominguez JM, Hoschoian JC, Barrio JR: Maintenance of nitrogen balance in a young woman by substitution of -ketoisovaleric acid for valine. J Nutr. 1971 Sep;101(9):1165-7.</reference_text>
          <pubmed_id>5096137</pubmed_id>
        </reference>
        <reference>
          <reference_text>Schauder P, Schroder K, Langenbeck U: Serum branched-chain amino and keto acid response to a protein-rich meal in man. Ann Nutr Metab. 1984;28(6):350-6.</reference_text>
          <pubmed_id>6393856</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tsuchiya H, Hashizume I, Tokunaga T, Tatsumi M, Takagi N, Hayashi T: High-performance liquid chromatography of alpha-keto acids in human saliva. Arch Oral Biol. 1983;28(11):989-92.</reference_text>
          <pubmed_id>6581765</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yudkoff M, Daikhin Y, Nissim I, Horyn O, Luhovyy B, Lazarow A, Nissim I: Brain amino acid requirements and toxicity: the example of leucine. J Nutr. 2005 Jun;135(6 Suppl):1531S-8S.</reference_text>
          <pubmed_id>15930465</pubmed_id>
        </reference>
        <reference>
          <reference_text>Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043.</reference_text>
          <pubmed_id>32033212</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00012</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit beta, mitochondrial</name>
          <uniprot_id>P11177</uniprot_id>
          <gene_name>PDHB</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00046</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial</name>
          <uniprot_id>P08559</uniprot_id>
          <gene_name>PDHA1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00050</protein_accession>
          <name>Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial</name>
          <uniprot_id>P29803</uniprot_id>
          <gene_name>PDHA2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00055</protein_accession>
          <name>Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial</name>
          <uniprot_id>P10515</uniprot_id>
          <gene_name>DLAT</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00299</protein_accession>
          <name>2-oxoisovalerate dehydrogenase subunit beta, mitochondrial</name>
          <uniprot_id>P21953</uniprot_id>
          <gene_name>BCKDHB</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00300</protein_accession>
          <name>2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial</name>
          <uniprot_id>P12694</uniprot_id>
          <gene_name>BCKDHA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00301</protein_accession>
          <name>Branched-chain-amino-acid aminotransferase, cytosolic</name>
          <uniprot_id>P54687</uniprot_id>
          <gene_name>BCAT1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00516</protein_accession>
          <name>Branched-chain-amino-acid aminotransferase, mitochondrial</name>
          <uniprot_id>O15382</uniprot_id>
          <gene_name>BCAT2</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01109</protein_accession>
          <name>Monocarboxylate transporter 4</name>
          <uniprot_id>O15427</uniprot_id>
          <gene_name>SLC16A3</gene_name>
          <protein_type>Transporter</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01111</protein_accession>
          <name>Monocarboxylate transporter 1</name>
          <uniprot_id>P53985</uniprot_id>
          <gene_name>SLC16A1</gene_name>
          <protein_type>Transporter</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP01115</protein_accession>
          <name>Monocarboxylate transporter 2</name>
          <uniprot_id>O60669</uniprot_id>
          <gene_name>SLC16A7</gene_name>
          <protein_type>Transporter</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-27 20:29:42 UTC</update_date>
      <accession>HMDB0000020</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00020</accession>
      </secondary_accessions>
      <name>p-Hydroxyphenylacetic acid</name>
      <description>p-Hydroxyphenylacetic acid, also known as 4-hydroxybenzeneacetate, is classified as a member of the 1-hydroxy-2-unsubstituted benzenoids. 1-Hydroxy-2-unsubstituted benzenoids are phenols that are unsubstituted at the 2-position. p-Hydroxyphenylacetic acid is considered to be slightly soluble (in water) and acidic.  p-Hydroxyphenylacetic acid can be synthesized from acetic acid. It is also a parent compound for other transformation products, including but not limited to, methyl 2-(4-hydroxyphenyl)acetate, ixerochinolide, and lactucopicrin 15-oxalate.  p-Hydroxyphenylacetic acid can be found in numerous foods such as olives, cocoa beans, oats, and mushrooms. p-Hydroxyphenylacetic acid can be found throughout all human tissues and in all biofluids. Within a cell, p-hydroxyphenylacetic acid is primarily located in the cytoplasm and in the extracellular space. p-Hydroxyphenylacetic acid is also a microbial metabolite produced by Acinetobacter, Clostridium, Klebsiella, Pseudomonas, and Proteus. Higher levels of this metabolite are associated with an overgrowth of small intestinal bacteria from Clostridia species including C. difficile, C. stricklandii, C. lituseburense, C. subterminale, C. putrefaciens, and C. propionicum (PMID: 476929, 12173102). p-Hydroxyphenylacetic acid is detected after the consumption of whole grain.</description>
      <synonyms>
        <synonym>(p-Hydroxyphenyl)acetic acid</synonym>
        <synonym>4-Carboxymethylphenol</synonym>
        <synonym>4-Hydroxybenzeneacetic acid</synonym>
        <synonym>4-Hydroxyphenylacetate</synonym>
        <synonym>4-Hydroxyphenylacetic acid</synonym>
        <synonym>(p-Hydroxyphenyl)acetate</synonym>
        <synonym>4-Hydroxybenzeneacetate</synonym>
        <synonym>p-Hydroxyphenylacetate</synonym>
        <synonym>(4-Hydroxy-phenyl)-acetate</synonym>
        <synonym>(4-Hydroxy-phenyl)-acetic acid</synonym>
        <synonym>(4-Hydroxy-phenyl)-essigsaeure</synonym>
        <synonym>(4-Hydroxyphenyl)acetate</synonym>
        <synonym>(4-Hydroxyphenyl)acetic acid</synonym>
        <synonym>(p-Hydroxyphenyl)-acetate</synonym>
        <synonym>(p-Hydroxyphenyl)-acetic acid</synonym>
        <synonym>4-Hydroxy-benzeneacetate</synonym>
        <synonym>4-Hydroxy-benzeneacetic acid</synonym>
        <synonym>4-Hydroxyphenyl-acetic acid</synonym>
        <synonym>Parahydroxy phenylacetate</synonym>
        <synonym>Parahydroxy phenylacetic acid</synonym>
        <synonym>Parahydroxyphenylacetate</synonym>
        <synonym>Para-hydroxyphenylacetic acid</synonym>
        <synonym>p-Hydroxyphenylacetic acid</synonym>
      </synonyms>
      <chemical_formula>C8H8O3</chemical_formula>
      <average_molecular_weight>152.1473</average_molecular_weight>
      <monisotopic_molecular_weight>152.047344122</monisotopic_molecular_weight>
      <iupac_name>2-(4-hydroxyphenyl)acetic acid</iupac_name>
      <traditional_iupac>4-hydroxyphenylacetic acid</traditional_iupac>
      <cas_registry_number>156-38-7</cas_registry_number>
      <smiles>OC(=O)CC1=CC=C(O)C=C1</smiles>
      <inchi>InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)</inchi>
      <inchikey>XQXPVVBIMDBYFF-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that are unsubstituted at the 2-position.</description>
        <direct_parent>1-hydroxy-2-unsubstituted benzenoids</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Benzenoids</super_class>
        <class>Phenols</class>
        <sub_class>1-hydroxy-2-unsubstituted benzenoids</sub_class>
        <molecular_framework>Aromatic homomonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>Benzene and substituted derivatives</alternative_parent>
          <alternative_parent>Carbonyl compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
          <substituent>Aromatic homomonocyclic compound</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Carboxylic acid derivative</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Monocyclic benzene moiety</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organooxygen compound</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>monocarboxylic acid</external_descriptor>
          <external_descriptor>phenols</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Schizophrenia</term>
                      <definition>A psychotic disorder that is characterized by a disintegration of thought processes and of emotional responsiveness. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Epilepsy</term>
                      <definition>A brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions. (do).</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Epileptic spasms</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Spina bifida</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Spina bifida cystica</synonym>
                        <synonym>Myelomeningocele</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cancer</term>
                      <definition>A group of disorders characterized by the presense of malignant neoplasm.</definition>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Lung cancer</term>
                          <definition>A respiratory system cancer that is located in the lung. (do).</definition>
                          <parent_id>7696</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Carcinoma of the lung</synonym>
                            <synonym>Lung carcinoma</synonym>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Route of exposure</term>
              <definition>A mean by which a chemical agent comes in contact with an organism, either under intended or unintended circumstances.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Enteral</term>
                  <definition>Chemical exposure via the alimentary canal (mouth to anus).</definition>
                  <parent_id>7743</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Ingestion</term>
                      <definition>Chemical exposure facilitated by entry through the mouth.</definition>
                      <parent_id>7744</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Digestion</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Food</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
                <descendant>
                  <term>Biological</term>
                  <definition>A living organism (species or a higher taxonomy rank), in which a chemical can be found.</definition>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Microbe</term>
                      <definition>A living organism that is of a microscopic scale, either single-celled or a cluster of cells.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Pseudomonas</term>
                          <definition/>
                          <parent_id>7739</parent_id>
                          <level>5</level>
                          <type>parent</type>
                          <synonyms>
                          </synonyms>
                          <descendants>
                            <descendant>
                              <term>Pseudomonas aeruginosa</term>
                              <definition/>
                              <parent_id>11365</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                          </descendants>
                        </descendant>
                        <descendant>
                          <term>Klebsiella</term>
                          <definition/>
                          <parent_id>7739</parent_id>
                          <level>5</level>
                          <type>parent</type>
                          <synonyms>
                          </synonyms>
                          <descendants>
                            <descendant>
                              <term>Klebsiella pneumoniae</term>
                              <definition/>
                              <parent_id>11316</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                          </descendants>
                        </descendant>
                        <descendant>
                          <term>Acinetobacter</term>
                          <definition/>
                          <parent_id>7739</parent_id>
                          <level>5</level>
                          <type>parent</type>
                          <synonyms>
                          </synonyms>
                          <descendants>
                            <descendant>
                              <term>Acinetobacter baumannii</term>
                              <definition/>
                              <parent_id>11240</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                          </descendants>
                        </descendant>
                        <descendant>
                          <term>Clostridium</term>
                          <definition/>
                          <parent_id>7739</parent_id>
                          <level>5</level>
                          <type>parent</type>
                          <synonyms>
                          </synonyms>
                          <descendants>
                            <descendant>
                              <term>Clostridium difficile</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                            <descendant>
                              <term>Clostridium lituseburense</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                            <descendant>
                              <term>Clostridium propionicum</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                            <descendant>
                              <term>Clostridium putrefaciens</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                            <descendant>
                              <term>Clostridium stricklandii</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                            <descendant>
                              <term>Clostridium subterminale</term>
                              <definition/>
                              <parent_id>11279</parent_id>
                              <level>6</level>
                              <type>child</type>
                              <synonyms>
                              </synonyms>
                            </descendant>
                          </descendants>
                        </descendant>
                      </descendants>
                    </descendant>
                    <descendant>
                      <term>Plant</term>
                      <definition>A living organism belonging to the kingdom plantea. typically, it grows in a permanent site, absorbs water and inorganic substances through its roots, and synthesizes nutrients in its leaves by photosynthesis using the green pigment chlorophyll. examples incude trees, shrubs, herbs, grasses, ferns, and mosses.</definition>
                      <parent_id>7736</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                        <synonym>Flora</synonym>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Poaceae</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                            <synonym>Gramineae</synonym>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Theobroma cacao</term>
                          <definition/>
                          <parent_id>7738</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Tissue and substructures</term>
                  <definition>An anatomical organizational level including multiple cells yet not comprising a complete organ .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Epidermis</term>
                      <definition>The epithelial portion of the skin (cutis). it consists of the following layers: stratum corneum (horny layer), stratum granulosum (granular layer), stratum spinosum (prickle cell layer), and stratum basale (basal cell layer). (nci).</definition>
                      <parent_id>7729</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Prostate</term>
                      <definition>The male reproductive accessory gland that produces prostatic fluid and is located adjacent to or around the urethra distal to the urinary bladder in mammals. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Prostate gland</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Bladder</term>
                      <definition>The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Kidney</term>
                      <definition>The organs of the urinary tract located in the retroperitoneal cavity adjacent to the spine and composed of the renal cortex and the renal medulla. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Kidneys</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Saliva</term>
                      <definition>The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Feces</term>
                      <definition>The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Fecal</synonym>
                        <synonym>Stool</synonym>
                        <synonym>Faecal</synonym>
                        <synonym>Faeces</synonym>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Cell and elements</term>
                  <definition>An anatomical organizational level comprising of a single cell (or a fragment in some exceptions). a cell is defined by its type or function. it is the smallest unit of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Extracellular</term>
                      <definition>The space external to the outermost structure of a cell.</definition>
                      <parent_id>7732</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Extracellular region</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Disulfiram Action Pathway</term>
                          <definition> with regards to cocaine addiction, cocaine inhibits dopamine reuptake by blocking dopamine transporter 1 (dat1). this increases dopamine concentrations in the synapse and dopamine binding to its receptors induces euphoria.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Tyrosine Metabolism</term>
                          <definition> half of the phenylalanine required goes into the production of tyrosine; if the diet is rich in tyrosine itself, the requirements for phenylalanine are reduced by about 50%. phenylalanine hydroxylase is a mixed-function oxygenase: one atom of oxygen is incorporated into water and the other into the hydroxyl of tyrosine.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>60.7 mg/mL</value>
          <source/>
        </property>
        <property>
          <kind>logp</kind>
          <value>0.75</value>
          <source>HANSCH,C ET AL. (1995)</source>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>148 - 150 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>0.93</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-1.33</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>7.12 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>1.31</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>-6</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>2-(4-hydroxyphenyl)acetic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>152.1473</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>152.047344122</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>OC(=O)CC1=CC=C(O)C=C1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C8H8O3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>XQXPVVBIMDBYFF-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>57.53</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>39.35</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>14.83</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>-1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::EiMs</type>
          <spectrum_id>234</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>927</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>33</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>34</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>35</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2555</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2556</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2557</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2558</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2559</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2560</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2561</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>178116</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>178117</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>178118</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>180432</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>180433</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>180434</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437776</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437777</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437778</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437779</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>437780</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439738</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>439739</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>449840</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>449841</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1034</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1121</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>2255</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>5047</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>5048</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>284</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>285</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>286</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>287</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1313</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>2422</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>27534</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>28712</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30037</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30169</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30258</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30455</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30749</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30955</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>31842</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37248</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
          <cellular>Extracellular</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Feces</biospecimen>
          <biospecimen>Saliva</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Bladder</tissue>
          <tissue>Epidermis</tissue>
          <tissue>Kidney</tissue>
          <tissue>Prostate</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Alkaptonuria</name>
            <smpdb_id>SMP00169</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Disulfiram Action Pathway</name>
            <smpdb_id>SMP00429</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dopamine beta-hydroxylase deficiency</name>
            <smpdb_id>SMP00498</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Hawkinsinuria</name>
            <smpdb_id>SMP00190</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Monoamine oxidase-a deficiency (MAO-A)</name>
            <smpdb_id>SMP00533</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tyrosine Metabolism</name>
            <smpdb_id>SMP00006</smpdb_id>
            <kegg_map_id>map00350</kegg_map_id>
          </pathway>
          <pathway>
            <name>Tyrosinemia Type I</name>
            <smpdb_id>SMP00218</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tyrosinemia, transient, of the newborn</name>
            <smpdb_id>SMP00494</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>6.346 +/- 0.518</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Before ingestion of water</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>6.695 +/- 0.555</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>2 h after ingestion of water</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>6.387 +/- 0.586</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Before ingestion of quercetin</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>7.911 +/- 1</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>2 h after ingestion of 200 mg of quercetin</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>6.5 +/- 0.432</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Before ingestion of (-)-epicathechin</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>6.661 +/- 0.692</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>2 h after ingestion of 200 mg of (-)-epicathechin</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>5.791 +/- 0.609</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Before ingestion of epigallocatechin gallate</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>42.412 +/- 35.919</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>2 h after ingestion of 200 mg of epigallocatechin gallate</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.230 (0.070-0.390)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.05 +/- 0.007</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>GC-MS on fecal extract sample collected after raspberry supplementation</comment>
          <references>
            <reference>
              <reference_text>Gill CI, McDougall GJ, Glidewell S, Stewart D, Shen Q, Tuohy K, Dobbin A, Boyd A, Brown E, Haldar S, Rowland IR: Profiling of phenols in human fecal water after raspberry supplementation. J Agric Food Chem. 2010 Oct 13;58(19):10389-95. doi: 10.1021/jf1017143.</reference_text>
              <pubmed_id>20809621</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>GC-MS on fecal extract sample collected before raspberry supplementation</comment>
          <references>
            <reference>
              <reference_text>Gill CI, McDougall GJ, Glidewell S, Stewart D, Shen Q, Tuohy K, Dobbin A, Boyd A, Brown E, Haldar S, Rowland IR: Profiling of phenols in human fecal water after raspberry supplementation. J Agric Food Chem. 2010 Oct 13;58(19):10389-95. doi: 10.1021/jf1017143.</reference_text>
              <pubmed_id>20809621</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=102) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Lyophilized feces samples (n=18) were used in the study.  Instrument: LC-MS. Technology specification: UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Loftfield E, Vogtmann E, Sampson JN, Moore SC, Nelson H, Knight R, Chia N, Sinha R: Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490. doi: 10.1158/1055-9965.EPI-16-0409. Epub 2016 Aug 19.</reference_text>
              <pubmed_id>27543620</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-TOFMS on lyophilized fecal samples</comment>
          <references>
            <reference>
              <reference_text>Phua LC, Koh PK, Cheah PY, Ho HK, Chan EC: Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:103-13. doi: 10.1016/j.jchromb.2013.08.025. Epub 2013 Aug 26.</reference_text>
              <pubmed_id>24029555</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>23.530 +/- 21.821</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>After wine intake study. By UPLC-ESI-MS/MS on fecal extracts</comment>
          <references>
            <reference>
              <reference_text>Munoz-Gonzalez I, Jimenez-Giron A, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV: Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. J Agric Food Chem. 2013 Oct 2;61(39):9470-9. doi: 10.1021/jf4025135. Epub 2013 Sep 19.</reference_text>
              <pubmed_id>24010549</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Wet feces sample (n=1) were used in the study.  Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Grun CH, van Dorsten FA, Jacobs DM, Le Belleguic M, van Velzen EJ, Bingham MO, Janssen HG, van Duynhoven JP: GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Aug 15;871(2):212-9. doi: 10.1016/j.jchromb.2008.04.039. Epub 2008 May 3.</reference_text>
              <pubmed_id>18502705</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>26.882 +/- 32.797</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Intervention group. After wine intake study. By UPLC-ESI-MS/MS on fecal extracts.</comment>
          <references>
            <reference>
              <reference_text>Munoz-Gonzalez I, Jimenez-Giron A, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV: Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. J Agric Food Chem. 2013 Oct 2;61(39):9470-9. doi: 10.1021/jf4025135. Epub 2013 Sep 19.</reference_text>
              <pubmed_id>24010549</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>31.0226 +/- 50.0830</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Intervention group. Before wine intake study. By UPLC-ESI-MS/MS on fecal extracts.</comment>
          <references>
            <reference>
              <reference_text>Munoz-Gonzalez I, Jimenez-Giron A, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV: Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. J Agric Food Chem. 2013 Oct 2;61(39):9470-9. doi: 10.1021/jf4025135. Epub 2013 Sep 19.</reference_text>
              <pubmed_id>24010549</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>63.228 +/- 88.730</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Before wine intake study. By UPLC-ESI-MS/MS on fecal extracts</comment>
          <references>
            <reference>
              <reference_text>Munoz-Gonzalez I, Jimenez-Giron A, Martin-Alvarez PJ, Bartolome B, Moreno-Arribas MV: Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. J Agric Food Chem. 2013 Oct 2;61(39):9470-9. doi: 10.1021/jf4025135. Epub 2013 Sep 19.</reference_text>
              <pubmed_id>24010549</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>GC MS on fecal extract</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL: Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem. 2009 Oct 15;393(2):163-75. doi: 10.1016/j.ab.2009.06.036. Epub 2009 Jun 30.</reference_text>
              <pubmed_id>19573517</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex/>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Chow J, Panasevich MR, Alexander D, Vester Boler BM, Rossoni Serao MC, Faber TA, Bauer LL, Fahey GC: Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res. 2014 May 2;13(5):2534-42. doi: 10.1021/pr500011w. Epub 2014 Mar 28.</reference_text>
              <pubmed_id>24628373</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>21.821 +/- 8.939</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC MS on fecal extract. The original unit of the concentration was reported as ug/mL. The concentration has been converted to nmol/g using the assumption that 1 mL = 1 g of feces.</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, Sebedio JL: Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem. 2009 Oct 15;393(2):163-75. doi: 10.1016/j.ab.2009.06.036. Epub 2009 Jun 30.</reference_text>
              <pubmed_id>19573517</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>1H NMR on lyopholized feces</comment>
          <references>
            <reference>
              <reference_text>Jacobs DM, Deltimple N, van Velzen E, van Dorsten FA, Bingham M, Vaughan EE, van Duynhoven J: (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 2008 Jul;21(6):615-26.</reference_text>
              <pubmed_id>18085514</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>3.714 (0.513-31.226)</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Wet feces samples (n=74) were used in the study.  Instrument: LC-MS. Technology specification: RP-UPLC-TQD-MS/MS, with use of authentic standards of phenolic compounds. The original concentration was reported as 0.565(0.078-4.751) ug/mL of wet feces, assuming 1mL= 1g feces.</comment>
          <references>
            <reference>
              <reference_text>Gutierrez-Diaz I, Fernandez-Navarro T, Salazar N, Bartolome B, Moreno-Arribas MV, de Andres-Galiana EJ, Fernandez-Martinez JL, de Los Reyes-Gavilan CG, Gueimonde M, Gonzalez S: Adherence to a Mediterranean Diet Influences the Fecal Metabolic Profile of Microbial-Derived Phenolics in a Spanish Cohort of Middle-Age and Older People. J Agric Food Chem. 2017 Jan 25;65(3):586-595. doi: 10.1021/acs.jafc.6b04408. Epub 2017 Jan 11.</reference_text>
              <pubmed_id>28029051</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal water. Metabolite detected using 1H NMR spectroscopy</comment>
          <references>
            <reference>
              <reference_text>Gratton J, Phetcharaburanin J, Mullish BH, Williams HR, Thursz M, Nicholson JK, Holmes E, Marchesi JR, Li JV: Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces. Anal Chem. 2016 May 3;88(9):4661-8. doi: 10.1021/acs.analchem.5b04159. Epub 2016  Apr 21.</reference_text>
              <pubmed_id>27065191</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value>57.181 +/- 44.0363</concentration_value>
          <concentration_units>nmol/g wet feces</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-MS on fecal extract. The original unit of the concentration was reported as ug/mL. The concentration has been converted to nmol/g using the assumption that 1 mL = 1 g of feces.</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
              <pubmed_id>20669995</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Wet feces samples (n=183) were used in the study.  Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>GC-MS on fecal extract</comment>
          <references>
            <reference>
              <reference_text>Gao X, Pujos-Guillot E, Sebedio JL: Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. Anal Chem. 2010 Aug 1;82(15):6447-56. doi: 10.1021/ac1006552.</reference_text>
              <pubmed_id>20669995</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Fecal samples of 786 predominantly female twins of the TwinsUK cohort, aged 65.2 (+/-7.6), with an average BMI of 26.1 (+/-4.7) </comment>
          <references>
            <reference>
              <reference_text>Zierer J, Jackson MA, Kastenmuller G, Mangino M, Long T, Telenti A, Mohney RP, Small KS, Bell JT, Steves CJ, Valdes AM, Spector TD, Menni C: The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018 Jun;50(6):790-795. doi: 10.1038/s41588-018-0135-7. Epub 2018 May  28.</reference_text>
              <pubmed_id>29808030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Breast-fed</comment>
          <references>
            <reference>
              <reference_text>Chow J, Panasevich MR, Alexander D, Vester Boler BM, Rossoni Serao MC, Faber TA, Bauer LL, Fahey GC: Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res. 2014 May 2;13(5):2534-42. doi: 10.1021/pr500011w. Epub 2014 Mar 28.</reference_text>
              <pubmed_id>24628373</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>formula-fed</comment>
          <references>
            <reference>
              <reference_text>Chow J, Panasevich MR, Alexander D, Vester Boler BM, Rossoni Serao MC, Faber TA, Bauer LL, Fahey GC: Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J Proteome Res. 2014 May 2;13(5):2534-42. doi: 10.1021/pr500011w. Epub 2014 Mar 28.</reference_text>
              <pubmed_id>24628373</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Yen S, McDonald JA, Schroeter K, Oliphant K, Sokolenko S, Blondeel EJ, Allen-Vercoe E, Aucoin MG: Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. J Proteome Res. 2015 Mar 6;14(3):1472-82. doi: 10.1021/pr5011247. Epub 2015 Feb 25.</reference_text>
              <pubmed_id>25670064</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>8.18 +/- 11.0</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=27)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Unstimulated human saliva </comment>
          <references>
            <reference>
              <reference_text>Ward ME, Politzer IR, Laseter JL, Alam SQ: Gas chromatographic mass spectrometric evaluation of free organic acids in human saliva. Biomed Mass Spectrom. 1976 Apr;3(2):77-80.</reference_text>
              <pubmed_id>1268322</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 1 hour of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 13 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 17 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 21 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 25 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 29 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 33 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 37 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 5 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected after 9 hours of wakefulness</comment>
          <references>
            <reference>
              <reference_text>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA: The human circadian metabolome. Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2625-9. doi: 10.1073/pnas.1114410109. Epub 2012 Jan 31.</reference_text>
              <pubmed_id>22308371</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>7.0 (2.0-10.0)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Takahama U, Oniki T, Murata H: The presence of 4-hydroxyphenylacetic acid in human saliva and the possibility of its nitration by salivary nitrite in the stomach. FEBS Lett. 2002 May 8;518(1-3):116-8.</reference_text>
              <pubmed_id>11997029</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>2.70 +/- 4.48</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Saliva samples were collected at 16:00 (n=24)</comment>
          <references>
            <reference>
              <reference_text>Sugimoto et al. (2013) Physiological and environmental parameters associated with mass spectrometry-based salivary metabolomic profiles. </reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Alvarez-Sanchez B, Priego-Capote F, Luque de Castro MD: Study of sample preparation for metabolomic profiling of human saliva by liquid chromatography-time of flight/mass spectrometry. J Chromatogr A. 2012 Jul 27;1248:178-81. doi: 10.1016/j.chroma.2012.05.029. Epub  2012 May 12.</reference_text>
              <pubmed_id>22727327</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value>25.11 +/- 14.59</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Zerihun T. Dame, Farid Aziat, Rupasri Mandal, Ram Krishnamurthy, Souhaila Bouatra, Shima Borzouie, An Chi Guo, Tanvir Sajed, Lu Deng, Hong Lin, Philip Liu, Edison Dong, David S. Wishart "The human saliva metabolome" Metabolomics (2015) DOI 10.1007/s11306-015-0840-5</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>6.0 (2.4-9.7)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>by GC-MS</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>25.268 +/- 17.653</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.</reference_text>
              <pubmed_id>21389975</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.8-12 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Urine compound detected by GC-MS</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;185.774</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>44.586 +/- 28.981</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>56.475 +/- 36.412</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>4-24 hours after phenylalanine load.</comment>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>69.108 +/- 70.594</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>0-4 hours after phenylalanine load.</comment>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.5 (1.4-14.6)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>urine by NMR</comment>
          <references>
            <reference>
              <reference_text>Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS: The human urine metabolome. PLoS One. 2013 Sep 4;8(9):e73076. doi: 10.1371/journal.pone.0073076. eCollection  2013.</reference_text>
              <pubmed_id>24023812</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>17.772 +/- 12.817</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 13 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>9.68</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Based on one measurement</comment>
          <references>
            <reference>
              <reference_text>Shaykhutdinov RA, MacInnis GD, Dowlatabadi R, Weljie AM, Vogel HJ.  Quantitative analysis of metabolite concentrations in human urine samples using 13C{1H} NMR spectroscopy.  Metabolomics.  2009</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex/>
          <subject_condition>Consuming polyphenols described by Phenol-Explorer entry 573</subject_condition>
          <references>
            <reference>
              <reference_text>Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB: Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr. 2003 Jun;133(6):1806-14.</reference_text>
              <pubmed_id>12771321</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex/>
          <subject_condition>Consuming polyphenols described by Phenol-Explorer entry 573</subject_condition>
          <references>
            <reference>
              <reference_text>Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F: Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition. 2010 Nov-Dec;26(11-12):1110-6. doi: 10.1016/j.nut.2009.09.021. Epub 2010 Jan 15.</reference_text>
              <pubmed_id>20080030</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex/>
          <subject_condition>Consuming polyphenols described by Phenol-Explorer entry 573</subject_condition>
          <references>
            <reference>
              <reference_text>Roowi S, Mullen W, Edwards CA, Crozier A: Yoghurt impacts on the excretion of phenolic acids derived from colonic breakdown of orange juice flavanones in humans. Mol Nutr Food Res. 2009 May;53 Suppl 1:S68-75. doi: 10.1002/mnfr.200800287.</reference_text>
              <pubmed_id>19415668</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age/>
          <subject_sex/>
          <subject_condition>Consuming polyphenols described by Phenol-Explorer entry 573</subject_condition>
          <references>
            <reference>
              <reference_text>Zhang K, Zuo Y: GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juice. J Agric Food Chem. 2004 Jan 28;52(2):222-7.</reference_text>
              <pubmed_id>14733499</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>917.00 +/- 341.8</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoehn T, Janssen S, Mani AR, Brauers G, Moore KP, Schadewaldt P, Mayatepek E: Urinary excretion of the nitrotyrosine metabolite 3-nitro-4-hydroxyphenylacetic acid in preterm and term infants. Neonatology. 2008;93(2):73-6. Epub 2007 Aug 6.</reference_text>
              <pubmed_id>17684421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>11 (3.5-22)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L: Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem. 1989 Apr;35(4):587-95.</reference_text>
              <pubmed_id>2702744</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>7.0 (2.8-11.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>McKibbin B, O'Gorman L, Duckworth T: Catecholamine metabolite excretion in spina bifida. J Clin Pathol. 1969 Nov;22(6):687-9.</reference_text>
              <pubmed_id>4903899</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>24.2</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
              <pubmed_id>14708889</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>36.7</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
              <pubmed_id>14708889</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>20.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
              <pubmed_id>14708889</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>31.4</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
              <pubmed_id>14708889</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
              <pubmed_id>14708889</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>24.2 (8.6-73.2)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>10.455</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By LC-MS/MS (24h urine) with the consumption of red wine</comment>
          <references>
            <reference>
              <reference_text>Zamora-Ros R, Achaintre D, Rothwell JA, Rinaldi S, Assi N, Ferrari P, Leitzmann M, Boutron-Ruault MC, Fagherazzi G, Auffret A, Kuhn T, Katzke V, Boeing H, Trichopoulou A, Naska A, Vasilopoulou E, Palli D, Grioni S, Mattiello A, Tumino R, Ricceri F, Slimani N, Romieu I, Scalbert A: Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study. Sci Rep. 2016 Jun 7;6:26905. doi: 10.1038/srep26905.</reference_text>
              <pubmed_id>27273479</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>7.4 +/- 4.4</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Jones MG, Cooper E, Amjad S, Goodwin CS, Barron JL, Chalmers RA: Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. Clin Chim Acta. 2005 Nov;361(1-2):150-8.</reference_text>
              <pubmed_id>15992788</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>36.7 (8.4-142.0)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Infant (0-1 year old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>1.680-101.700</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>With polyphenol-rich meal (by LC-MS/MS with spot urine &amp; 24h urine)</comment>
          <references>
            <reference>
              <reference_text>Achaintre D, Bulete A, Cren-Olive C, Li L, Rinaldi S, Scalbert A: Differential Isotope Labeling of 38 Dietary Polyphenols and Their Quantification in Urine by Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry. Anal Chem. 2016 Mar 1;88(5):2637-44. doi: 10.1021/acs.analchem.5b03609. Epub 2016 Feb 11.</reference_text>
              <pubmed_id>26814424</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>20.3</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>31.4 (9.7-187.4)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>15.3 (3.2-180.2)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adolescent (13-18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
              <pubmed_id>8087979</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>5.2-12 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>&lt;109.33</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1 - 18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By GCMS.</comment>
          <references>
            <reference>
              <reference_text>BC Children's Hospital Biochemical Genetics Lab</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>12.024 +/- 1.428</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>5-h after ingestion of 200 mg of quercetin, quercetin, (-)-epicatechin and epigallocatechin gallate</comment>
          <references>
            <reference>
              <reference_text>Loke WM, Jenner AM, Proudfoot JM, McKinley AJ, Hodgson JM, Halliwell B, Croft KD: A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009 Dec;139(12):2309-14. doi: 10.3945/jn.109.113613. Epub 2009 Oct 7.</reference_text>
              <pubmed_id>19812218</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>36-69</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Newborn (0-30 days old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>By H-NMR 600 MHz BRUKER spectrometers</comment>
          <references>
            <reference>
              <reference_text>Embade N, Cannet C, Diercks T, Gil-Redondo R, Bruzzone C, Anso S, Echevarria LR, Ayucar MMM, Collazos L, Lodoso B, Guerra E, Elorriaga IA, Kortajarena MA, Legorburu AP, Fang F, Astigarraga I, Schafer H, Spraul M, Millet O: NMR-based newborn urine screening for optimized detection of inherited errors of metabolism. Sci Rep. 2019 Sep 10;9(1):13067. doi: 10.1038/s41598-019-49685-x.</reference_text>
              <pubmed_id>31506554</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <comment>Under vegetarian diet</comment>
          <references>
            <reference>
              <reference_text>Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. 2006 Oct;5(10):2780-8.</reference_text>
              <pubmed_id>17022649</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Jacobs DM, Spiesser L, Garnier M, de Roo N, van Dorsten F, Hollebrands B, van Velzen E, Draijer R, van Duynhoven J: SPE-NMR metabolite sub-profiling of urine. Anal Bioanal Chem. 2012 Nov;404(8):2349-61. doi: 10.1007/s00216-012-6339-2. Epub  2012 Aug 31.</reference_text>
              <pubmed_id>22932811</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Breast cancer</patient_information>
          <comment>By GC-MS </comment>
          <references>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.31 +/- 0.0.03</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Schizophrenia</patient_information>
          <references>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.038 +/- 0.005</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Epilepsy</patient_information>
          <references>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Breast cancer</patient_information>
          <comment>By GC-MS </comment>
          <references>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=131) were used in the study. Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Ulcerative colitis</patient_information>
          <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.01, higher than control. Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Crohn disease</patient_information>
          <comment>Wet feces samples (n=183) were used in the study. p &lt; 0.05, higher than control. Instrument: GC-MS.</comment>
          <references>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal cancer</patient_information>
          <comment>Lyophilized feces samples (n=48) were used in the study.  Instrument: GC-MS; LC-MS. Technology specification: GC-MS/MS and UPLC-MS/MS in multiple conditions; authentic standards (metabolon).</comment>
          <references>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Feces</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Colorectal Cancer</patient_information>
          <references>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Saliva</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Breast cancer</patient_information>
          <comment>By GC-MS </comment>
          <references>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>30.103 +/- 31.073</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>34.998 +/- 55.908</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Gastroesophageal reflux disease</patient_information>
          <comment>By GC-MS</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Bladder cancer</patient_information>
          <references>
            <reference>
              <reference_text>Zhou Y, Song R, Ma C, Zhou L, Liu X, Yin P, Zhang Z, Sun Y, Xu C, Lu X, Xu G: Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Oncotarget. 2017 Mar 28;8(13):20719-20728. doi: 10.18632/oncotarget.14988.</reference_text>
              <pubmed_id>28157703</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>24.522</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Fumarase deficiency</patient_information>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>44.586 +/- 66.136</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Phenylketonuria</patient_information>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>46.0719 +/- 45.329</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Phenylketonuria</patient_information>
          <comment>4-24 hours after phenylalanine load.</comment>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>47.558 +/- 69.108</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1-13 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Phenylketonuria</patient_information>
          <comment>0-4 hours after phenylalanine load.</comment>
          <references>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>18.772 +/- 21.602</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Children (1 - 13 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Eosinophilic esophagitis</patient_information>
          <comment>By NMR</comment>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Hypertension (mild)</patient_information>
          <comment>After 4-wk comsumption of polyphenol-rich MIX. MIX consists of 2:1 mixture of red wine extract (ProvinolsTM, Seppic, France) and Rubired GJX (Mega- NaturalTM, Polyphenolics, USA). The total polyphenol dose of both the MIX and the GJX supplements was 800 mg gallic acid equivalents (GAEs) per day.</comment>
          <references>
            <reference>
              <reference_text>van Dorsten FA, Grun CH, van Velzen EJ, Jacobs DM, Draijer R, van Duynhoven JP: The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Mol Nutr Food Res. 2010 Jul;54(7):897-908. doi: 10.1002/mnfr.200900212.</reference_text>
              <pubmed_id>20013882</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Hypertension (mild)</patient_information>
          <comment>After 4-wk comsumption of polyphenol-rich GJX (Mega- NaturalTM, Polyphenolics, USA). The total polyphenol dose of the GJX supplements was 800 mg gallic acid equivalents (GAEs) per day.</comment>
          <references>
            <reference>
              <reference_text>van Dorsten FA, Grun CH, van Velzen EJ, Jacobs DM, Draijer R, van Duynhoven JP: The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Mol Nutr Food Res. 2010 Jul;54(7):897-908. doi: 10.1002/mnfr.200900212.</reference_text>
              <pubmed_id>20013882</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>428.00 +/- 164.00</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Infant (0-1 year old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Preterm infants</patient_information>
          <references>
            <reference>
              <reference_text>Hoehn T, Janssen S, Mani AR, Brauers G, Moore KP, Schadewaldt P, Mayatepek E: Urinary excretion of the nitrotyrosine metabolite 3-nitro-4-hydroxyphenylacetic acid in preterm and term infants. Neonatology. 2008;93(2):73-6. Epub 2007 Aug 6.</reference_text>
              <pubmed_id>17684421</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>25.0 (7.0-50.5)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Meningomyelocoele</patient_information>
          <references>
            <reference>
              <reference_text>McKibbin B, O'Gorman L, Duckworth T: Catecholamine metabolite excretion in spina bifida. J Clin Pathol. 1969 Nov;22(6):687-9.</reference_text>
              <pubmed_id>4903899</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>16.0 +/- 15.0</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Not Specified</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Lung cancer</patient_information>
          <references>
            <reference>
              <reference_text>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810.  Epub 2008 Oct 25.</reference_text>
              <pubmed_id>18953024</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Cardiosvacular risk</patient_information>
          <comment>With wine consumption</comment>
          <references>
            <reference>
              <reference_text>Vazquez-Fresno R, Llorach R, Alcaro F, Rodriguez MA, Vinaixa M, Chiva-Blanch G, Estruch R, Correig X, Andres-Lacueva C: (1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors. Electrophoresis. 2012 Aug;33(15):2345-54. doi: 10.1002/elps.201100646.</reference_text>
              <pubmed_id>22887155</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value/>
          <concentration_units/>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Female</patient_sex>
          <patient_information>Breast cancer</patient_information>
          <comment>By GC-MS </comment>
          <references>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Schizophrenia</name>
          <omim_id>181500</omim_id>
          <references>
            <reference>
              <reference_text>Harnryd C, Bjerkenstedt L, Grimm VE, Sedvall G: Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology (Berl). 1979 Aug 8;64(2):131-4.</reference_text>
              <pubmed_id>115032</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
            <reference>
              <reference_text>Alfredsson G, Wiesel FA: Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment. Psychopharmacology (Berl). 1989;99(3):322-7.</reference_text>
              <pubmed_id>2480613</pubmed_id>
            </reference>
            <reference>
              <reference_text>Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2.</reference_text>
              <pubmed_id>17276036</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walker EF, Bonsall R, Walder DJ: Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Mar;15(1):10-7.</reference_text>
              <pubmed_id>11877547</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003 Jun;60(6):572-6.</reference_text>
              <pubmed_id>12796220</pubmed_id>
            </reference>
            <reference>
              <reference_text>Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.</reference_text>
              <pubmed_id>7595563</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathe AA: Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.</reference_text>
              <pubmed_id>20814316</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.</reference_text>
              <pubmed_id>25004141</pubmed_id>
            </reference>
            <reference>
              <reference_text>Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K: A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry. 2014 Apr 8;4:e379. doi: 10.1038/tp.2014.19.</reference_text>
              <pubmed_id>24713860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ballesteros A, Summerfelt A, Du X, Jiang P, Chiappelli J, Tagamets M, O'Donnell P, Kochunov P, Hong LE: Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia. Clin Neurophysiol. 2013 Nov;124(11):2209-15. doi: 10.1016/j.clinph.2013.05.021. Epub 2013 Jun 30.</reference_text>
              <pubmed_id>23823132</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA: Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry. 1985 Sep;147:276-82.</reference_text>
              <pubmed_id>2415198</pubmed_id>
            </reference>
            <reference>
              <reference_text>Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ: Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul;47(7):641-8.</reference_text>
              <pubmed_id>1694425</pubmed_id>
            </reference>
            <reference>
              <reference_text>Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104.</reference_text>
              <pubmed_id>7711000</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kim YK, Myint AM, Verkerk R, Scharpe S, Steinbusch H, Leonard B: Cytokine changes and tryptophan metabolites in medication-naive and medication-free schizophrenic patients. Neuropsychobiology. 2009;59(2):123-9. doi: 10.1159/000213565. Epub 2009 Apr 22.</reference_text>
              <pubmed_id>19390223</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25.</reference_text>
              <pubmed_id>22024767</pubmed_id>
            </reference>
            <reference>
              <reference_text>Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y, Chen J, Feng G, Fang Y, Jia W, Xing Q, He L: Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res. 2011 Dec 2;10(12):5433-43. doi: 10.1021/pr2006796. Epub 2011 Nov  8.</reference_text>
              <pubmed_id>22007635</pubmed_id>
            </reference>
            <reference>
              <reference_text>Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM, Rothermundt M, Bogerts B, Koethe D, Kranaster L, Ohrmann P, Suslow T, McAllister G, Spain M, Barnes A, van Beveren NJ, Baron-Cohen S, Steiner J, Torrey FE, Yolken RH, Bahn S: Identification of a biological signature for schizophrenia in serum. Mol Psychiatry. 2012 May;17(5):494-502. doi: 10.1038/mp.2011.42. Epub 2011 Apr 12.</reference_text>
              <pubmed_id>21483431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Mathe AA, Eberhard G, Saaf J, Wetterberg L: Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder. Biol Psychiatry. 1986 Sep;21(11):1024-30.</reference_text>
              <pubmed_id>3741918</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct. 2002 Jun;20(2):171-5.</reference_text>
              <pubmed_id>11979513</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zumarraga M, Davila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, Gonzalez-Torres MA, Guimon J: Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4.</reference_text>
              <pubmed_id>20206656</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
              <pubmed_id>436860</pubmed_id>
            </reference>
            <reference>
              <reference_text>Yao JK, Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R: Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry. 2010 Sep;15(9):938-53. doi: 10.1038/mp.2009.33. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19401681</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gattaz WF, Waldmeier P, Beckmann H: CSF monoamine metabolites in schizophrenic patients. Acta Psychiatr Scand. 1982 Nov;66(5):350-60.</reference_text>
              <pubmed_id>6184954</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nilsson-Todd LK, Nordin C, Jonsson EG, Skogh E, Erhardt S: Cerebrospinal fluid kynurenic acid in male patients with schizophrenia - correlation with monoamine metabolites. Acta Neuropsychiatr. 2007 Feb;19(1):45-52. doi: 10.1111/j.1601-5215.2006.00170.x.</reference_text>
              <pubmed_id>26952797</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cai HL, Li HD, Yan XZ, Sun B, Zhang Q, Yan M, Zhang WY, Jiang P, Zhu RH, Liu YP, Fang PF, Xu P, Yuan HY, Zhang XH, Hu L, Yang W, Ye HS: Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone. J Proteome Res. 2012 Aug 3;11(8):4338-50. doi: 10.1021/pr300459d. Epub 2012 Jul 26.</reference_text>
              <pubmed_id>22800120</pubmed_id>
            </reference>
            <reference>
              <reference_text>Al Awam K, Haussleiter IS, Dudley E, Donev R, Brune M, Juckel G, Thome J: Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia. J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S111-22. doi: 10.1007/s00702-014-1224-0. Epub 2014 May 1.</reference_text>
              <pubmed_id>24789758</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bicikova M, Hill M, Ripova D, Mohr P, Hampl R: Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013 Jan;133:77-83. doi: 10.1016/j.jsbmb.2012.08.009. Epub 2012 Aug 24.</reference_text>
              <pubmed_id>22944140</pubmed_id>
            </reference>
            <reference>
              <reference_text>He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D: Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012 Aug 14;2:e149. doi: 10.1038/tp.2012.76.</reference_text>
              <pubmed_id>22892715</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):934-45. Epub 2007 Apr 17.</reference_text>
              <pubmed_id>17440431</pubmed_id>
            </reference>
            <reference>
              <reference_text>Fryar-Williams S, Strobel JE: Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis. Biomark Res. 2015 Feb 6;3:3. doi: 10.1186/s40364-015-0028-1. eCollection 2015.</reference_text>
              <pubmed_id>25729574</pubmed_id>
            </reference>
            <reference>
              <reference_text>Oresic M, Seppanen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyotylainen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lonnqvist J, Cannon TD: Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.</reference_text>
              <pubmed_id>22257447</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Epilepsy</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.</reference_text>
              <pubmed_id>14992292</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cady EB, Lorek A, Penrice J, Reynolds EO, Iles RA, Burns SP, Coutts GA, Cowan FM: Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med. 1994 Dec;32(6):764-7.</reference_text>
              <pubmed_id>7869898</pubmed_id>
            </reference>
            <reference>
              <reference_text>Perosa SR, Porcionatto MA, Cukiert A, Martins JR, Amado D, Nader HB, Cavalheiro EA, Leite JP, Naffah-Mazzacoratti MG: Extracellular matrix components are altered in the hippocampus, cortex, and cerebrospinal fluid of patients with mesial temporal lobe epilepsy. Epilepsia. 2002;43 Suppl 5:159-61.</reference_text>
              <pubmed_id>12121313</pubmed_id>
            </reference>
            <reference>
              <reference_text>Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH: The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Neurology. 1999 Oct 22;53(7):1518-22.</reference_text>
              <pubmed_id>10534261</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rating D, Siemes H, Loscher W: Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis. J Neurol. 1983;230(4):217-25.</reference_text>
              <pubmed_id>6198481</pubmed_id>
            </reference>
            <reference>
              <reference_text>Botez MI, Young SN: Effects of anticonvulsant treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain. 1991 Feb;114 ( Pt 1A):333-48.</reference_text>
              <pubmed_id>1705463</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kobayashi K, Koide Y, Yoshino K, Shohmori T: [P-hydroxyphenylacetic acid concentrations in cerebrospinal fluid]. No To Shinkei. 1982 Aug;34(8):769-74.</reference_text>
              <pubmed_id>7126379</pubmed_id>
            </reference>
            <reference>
              <reference_text>Czarnecka J, Cieslak M, Michal K: Application of solid phase extraction and high-performance liquid chromatography to qualitative and quantitative analysis of nucleotides and nucleosides in human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 5;822(1-2):85-90.</reference_text>
              <pubmed_id>15993662</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shaywitz BA, Cohen DJ, Bowers MB: Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology. 1975 Jan;25(1):72-9.</reference_text>
              <pubmed_id>803305</pubmed_id>
            </reference>
            <reference>
              <reference_text>Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C: Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 Jun;99(6):387-92.</reference_text>
              <pubmed_id>10577274</pubmed_id>
            </reference>
            <reference>
              <reference_text>Romigi A, Bari M, Placidi F, Marciani MG, Malaponti M, Torelli F, Izzi F, Prosperetti C, Zannino S, Corte F, Chiaramonte C, Maccarrone M: Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. Epilepsia. 2010 May;51(5):768-72. doi: 10.1111/j.1528-1167.2009.02334.x. Epub 2009 Oct 8.</reference_text>
              <pubmed_id>19817812</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hirai K, Seki T: Cerebrospinal fluid somatostatin levels in febrile seizures and epilepsy in children. Neuropeptides. 2000 Feb;34(1):18-24.</reference_text>
              <pubmed_id>10688964</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peters JG: Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. Eur Neurol. 1979;18(1):15-8.</reference_text>
              <pubmed_id>436860</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Colorectal cancer</name>
          <omim_id>114500</omim_id>
          <references>
            <reference>
              <reference_text>Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.</reference_text>
              <pubmed_id>7482520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.</reference_text>
              <pubmed_id>19006102</pubmed_id>
            </reference>
            <reference>
              <reference_text>Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.</reference_text>
              <pubmed_id>23940645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.</reference_text>
              <pubmed_id>24424155</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.</reference_text>
              <pubmed_id>20156336</pubmed_id>
            </reference>
            <reference>
              <reference_text>Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.</reference_text>
              <pubmed_id>19678709</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.</reference_text>
              <pubmed_id>22148915</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.</reference_text>
              <pubmed_id>25105552</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.</reference_text>
              <pubmed_id>21773981</pubmed_id>
            </reference>
            <reference>
              <reference_text>Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.</reference_text>
              <pubmed_id>25037050</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.</reference_text>
              <pubmed_id>27015276</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.</reference_text>
              <pubmed_id>27107423</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.</reference_text>
              <pubmed_id>27275383</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.</reference_text>
              <pubmed_id>28587349</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science &amp; Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984</reference_text>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Ulcerative colitis</name>
          <omim_id></omim_id>
          <references>
            <reference>
              <reference_text>Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41. doi: 10.1093/nar/gkq1126. Epub 2010 Nov 8.</reference_text>
              <pubmed_id>21059682</pubmed_id>
            </reference>
            <reference>
              <reference_text>Almer S, Andersson T, Strom M: Pharmacokinetics of tranexamic acid in patients with ulcerative colitis and in healthy volunteers after the single instillation of 2 g rectally. J Clin Pharmacol. 1992 Jan;32(1):49-54.</reference_text>
              <pubmed_id>1740537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Garner CE, Smith S, de Lacy Costello B, White P, Spencer R, Probert CS, Ratcliffe NM: Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 2007 Jun;21(8):1675-88. Epub 2007 Feb 21.</reference_text>
              <pubmed_id>17314143</pubmed_id>
            </reference>
            <reference>
              <reference_text>Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8.</reference_text>
              <pubmed_id>21761941</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Crohn's disease</name>
          <omim_id>266600</omim_id>
          <references>
            <reference>
              <reference_text>Lapidus A, Akerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn 's disease. World J Gastroenterol. 2006 Jan 7;12(1):70-4.</reference_text>
              <pubmed_id>16440420</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ehrenpreis ED, Salvino M, Craig RM: Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. J Clin Gastroenterol. 2001 Jul;33(1):36-40.</reference_text>
              <pubmed_id>11418788</pubmed_id>
            </reference>
            <reference>
              <reference_text>Brydon WG, Nyhlin H, Eastwood MA, Merrick MV: Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur J Gastroenterol Hepatol. 1996 Feb;8(2):117-23.</reference_text>
              <pubmed_id>8723414</pubmed_id>
            </reference>
            <reference>
              <reference_text>Williams HR, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, Jewell DP, Ghosh S, Thomas HJ, Teare JP, Jakobovits S, Zeki S, Welsh KI, Taylor-Robinson SD, Orchard TR: Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009 Jun;104(6):1435-44. doi: 10.1038/ajg.2009.175. Epub 2009 Apr 28.</reference_text>
              <pubmed_id>19491857</pubmed_id>
            </reference>
            <reference>
              <reference_text>Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51.</reference_text>
              <pubmed_id>17269711</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello Bde L, Ratcliffe NM, Probert CS: An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One. 2013;8(3):e58204. doi: 10.1371/journal.pone.0058204. Epub 2013 Mar 13.</reference_text>
              <pubmed_id>23516449</pubmed_id>
            </reference>
            <reference>
              <reference_text>Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA, Cauchi M, Bessant C, Hunter JO: Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013 Sep;19(10):2069-78. doi: 10.1097/MIB.0b013e31829a91f6.</reference_text>
              <pubmed_id>23867873</pubmed_id>
            </reference>
            <reference>
              <reference_text>De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015 Mar;64(3):447-58. doi: 10.1136/gutjnl-2013-306423. Epub 2014 May 8.</reference_text>
              <pubmed_id>24811995</pubmed_id>
            </reference>
            <reference>
              <reference_text>Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Gunther U, Nielsen OH: Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics. 2015;11:122-133. Epub 2014 Jun 1.</reference_text>
              <pubmed_id>25598765</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ahmed I, Greenwood R, Costello B, Ratcliffe N, Probert CS: Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Aliment Pharmacol Ther. 2016 Mar;43(5):596-611. doi: 10.1111/apt.13522. Epub 2016 Jan 25.</reference_text>
              <pubmed_id>26806034</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4.</reference_text>
              <pubmed_id>26848182</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158.</reference_text>
              <pubmed_id>27609529</pubmed_id>
            </reference>
            <reference>
              <reference_text>Azario I, Pievani A, Del Priore F, Antolini L, Santi L, Corsi A, Cardinale L, Sawamoto K, Kubaski F, Gentner B, Bernardo ME, Valsecchi MG, Riminucci M, Tomatsu S, Aiuti A, Biondi A, Serafini M: Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I. Sci Rep. 2017 Aug 25;7(1):9473. doi: 10.1038/s41598-017-09958-9.</reference_text>
              <pubmed_id>28842642</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Lung Cancer</name>
          <omim_id>211980</omim_id>
          <references>
            <reference>
              <reference_text>Stretch C, Eastman T, Mandal R, Eisner R, Wishart DS, Mourtzakis M, Prado CM, Damaraju S, Ball RO, Greiner R, Baracos VE: Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach. J Nutr. 2012 Jan;142(1):14-21. doi: 10.3945/jn.111.147751. Epub 2011 Dec 7.</reference_text>
              <pubmed_id>22157537</pubmed_id>
            </reference>
            <reference>
              <reference_text>Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009 Jan;37(Database issue):D603-10. doi: 10.1093/nar/gkn810.  Epub 2008 Oct 25.</reference_text>
              <pubmed_id>18953024</pubmed_id>
            </reference>
            <reference>
              <reference_text>Chen Y, Ma Z, Min L, Li H, Wang B, Zhong J, Dai L: Biomarker identification and pathway analysis by serum metabolomics of lung cancer. Biomed Res Int. 2015;2015:183624. doi: 10.1155/2015/183624. Epub 2015 Apr 16.</reference_text>
              <pubmed_id>25961003</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Spina Bifida</name>
          <omim_id>182940</omim_id>
          <references>
            <reference>
              <reference_text>Pal K, Sharma U, Gupta DK, Pratap A, Jagannathan NR: Metabolite profile of cerebrospinal fluid in patients with spina bifida: a proton magnetic resonance spectroscopy study. Spine (Phila Pa 1976). 2005 Feb 1;30(3):E68-72.</reference_text>
              <pubmed_id>15681999</pubmed_id>
            </reference>
            <reference>
              <reference_text>McKibbin B, O'Gorman L, Duckworth T: Catecholamine metabolite excretion in spina bifida. J Clin Pathol. 1969 Nov;22(6):687-9.</reference_text>
              <pubmed_id>4903899</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tam PK, Lister J: Elevation of cerebrospinal fluid substance P concentrations in spina bifida. Z Kinderchir. 1984 Dec;39 Suppl 2:89-90.</reference_text>
              <pubmed_id>6084371</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Eosinophilic esophagitis</name>
          <omim_id>610247</omim_id>
          <references>
            <reference>
              <reference_text>Mordechai, Hien, and David S. Wishart</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Perillyl alcohol administration for cancer treatment</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Byun JA, Lee SH, Jung BH, Choi MH, Moon MH, Chung BC: Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2008 Jan;22(1):73-80.</reference_text>
              <pubmed_id>17668437</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW: Clinical significance and prognostic value of urinary nucleosides in breast cancer patients. Clin Biochem. 2005 Jan;38(1):24-30.</reference_text>
              <pubmed_id>15607313</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cauley JA, Zmuda JM, Danielson ME, Ljung BM, Bauer DC, Cummings SR, Kuller LH: Estrogen metabolites and the risk of breast cancer in older women. Epidemiology. 2003 Nov;14(6):740-4.</reference_text>
              <pubmed_id>14569192</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang Z, Chen H, Chan KK, Budd T, Ganapathi R: Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma. J Chromatogr B Biomed Sci Appl. 1999 May 14;728(1):85-95.</reference_text>
              <pubmed_id>10379660</pubmed_id>
            </reference>
            <reference>
              <reference_text>Grace PB, Mistry NS, Carter MH, Leathem AJ, Teale P: High throughput quantification of phytoestrogens in human urine and serum using liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 15;853(1-2):138-46. Epub  2007 Mar 18.</reference_text>
              <pubmed_id>17403619</pubmed_id>
            </reference>
            <reference>
              <reference_text>Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec  22.</reference_text>
              <pubmed_id>22284503</pubmed_id>
            </reference>
            <reference>
              <reference_text>Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10.</reference_text>
              <pubmed_id>20300169</pubmed_id>
            </reference>
            <reference>
              <reference_text>Lv W, Yang T: Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem. 2012 Jan;45(1-2):127-33. doi: 10.1016/j.clinbiochem.2011.10.011. Epub 2011 Oct 26.</reference_text>
              <pubmed_id>22061338</pubmed_id>
            </reference>
            <reference>
              <reference_text>Nam H, Chung BC, Kim Y, Lee K, Lee D: Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics. 2009 Dec 1;25(23):3151-7. doi: 10.1093/bioinformatics/btp558. Epub 2009 Sep 25.</reference_text>
              <pubmed_id>19783829</pubmed_id>
            </reference>
            <reference>
              <reference_text>Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC: Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta. 2009 Feb;400(1-2):63-9. doi: 10.1016/j.cca.2008.10.014. Epub 2008 Oct 30.</reference_text>
              <pubmed_id>19010317</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Fumarase deficiency</name>
          <omim_id>606812</omim_id>
          <references>
            <reference>
              <reference_text>Bastug O, Kardas F, Ozturk MA, Halis H, Memur S, Korkmaz L, Tag Z, Gunes T: A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey. Turk Pediatri Ars. 2014 Mar 1;49(1):74-6. doi: 10.5152/tpa.2014.442. eCollection  2014 Mar.</reference_text>
              <pubmed_id>26078636</pubmed_id>
            </reference>
            <reference>
              <reference_text>Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15.</reference_text>
              <pubmed_id>20549362</pubmed_id>
            </reference>
            <reference>
              <reference_text>Tregoning S, Salter W, Thorburn DR, Durkie M, Panayi M, Wu JY, Easterbrook A, Coman DJ: Fumarase deficiency in dichorionic diamniotic twins. Twin Res Hum Genet. 2013 Dec;16(6):1117-20. doi: 10.1017/thg.2013.72. Epub 2013 Nov 4.</reference_text>
              <pubmed_id>24182348</pubmed_id>
            </reference>
            <reference>
              <reference_text>Whelan DT, Hill RE, McClorry S: Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983 Aug 31;132(3):301-8.</reference_text>
              <pubmed_id>6616883</pubmed_id>
            </reference>
            <reference>
              <reference_text>Maradin M, Fumic K, Hansikova H, Tesarova M, Wenchich L, Dorner S, Sarnavka V, Zeman J, Baric I: Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis. 2006 Oct;29(5):683. Epub 2006 Aug 5.</reference_text>
              <pubmed_id>16972175</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Phenylketonuria</name>
          <omim_id>261600</omim_id>
          <references>
            <reference>
              <reference_text>Perry TL, Hansen S: Cystinylglycine in plasma: diagnostic relevance for pyroglutamic acidemia, homocystinuria, and phenylketonuria. Clin Chim Acta. 1981 Nov 25;117(1):7-12.</reference_text>
              <pubmed_id>7333014</pubmed_id>
            </reference>
            <reference>
              <reference_text>Monch E, Kneer J, Jakobs C, Arnold M, Diehl H, Batzler U: Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age--Part 1. Eur J Pediatr. 1990;149 Suppl 1:S17-24.</reference_text>
              <pubmed_id>2091926</pubmed_id>
            </reference>
            <reference>
              <reference_text>Deng C, Shang C, Hu Y, Zhang X: Rapid diagnosis of phenylketonuria and other aminoacidemias by quantitative analysis of amino acids in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jul 25;775(1):115-20.</reference_text>
              <pubmed_id>12101068</pubmed_id>
            </reference>
            <reference>
              <reference_text>Elvers LH, Loeber JG, Dhondt JL, Fukushi M, Hannon WH, Torresani T, Webster D: First ISNS Reference Preparation for Neonatal Screening for thyrotropin, phenylalanine and 17alpha-hydroxyprogesterone in blood spots. J Inherit Metab Dis. 2007 Aug;30(4):609. Epub 2007 Jun 14.</reference_text>
              <pubmed_id>17574536</pubmed_id>
            </reference>
            <reference>
              <reference_text>Langenbeck U, Behbehani A, Luthe H: Renal transport of aromatic acids in patients with phenylketonuria. J Inherit Metab Dis. 1981;4(2):69-70.</reference_text>
              <pubmed_id>6790852</pubmed_id>
            </reference>
            <reference>
              <reference_text>Peck H, Pollitt RJ: The occurrence of gamma-glutamylphenylalanine in the urine of newborn phenylketonurics. Clin Chim Acta. 1979 Jun 15;94(3):237-40.</reference_text>
              <pubmed_id>466810</pubmed_id>
            </reference>
            <reference>
              <reference_text>Clemens PC, Schunemann MH, Hoffmann GF, Kohlschutter A: Plasma concentrations of phenyllactic acid in phenylketonuria. J Inherit Metab Dis. 1990;13(2):227-8.</reference_text>
              <pubmed_id>2116554</pubmed_id>
            </reference>
            <reference>
              <reference_text>Gronwald W, Klein MS, Kaspar H, Fagerer SR, Nurnberger N, Dettmer K, Bertsch T, Oefner PJ: Urinary metabolite quantification employing 2D NMR spectroscopy. Anal Chem. 2008 Dec 1;80(23):9288-97. doi: 10.1021/ac801627c.</reference_text>
              <pubmed_id>19551947</pubmed_id>
            </reference>
            <reference>
              <reference_text>Jansen RS, Addie R, Merkx R, Fish A, Mahakena S, Bleijerveld OB, Altelaar M, IJlst L, Wanders RJ, Borst P, van de Wetering K: N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc Natl Acad Sci U S A. 2015 May 26;112(21):6601-6. doi: 10.1073/pnas.1424638112. Epub 2015 May 11.</reference_text>
              <pubmed_id>25964343</pubmed_id>
            </reference>
            <reference>
              <reference_text>Swarna M, Jyothy A, Usha Rani P, Reddy PP: Amino acid disorders in mental retardation: a two-decade study from Andhra Pradesh. Biochem Genet. 2004 Apr;42(3-4):85-98.</reference_text>
              <pubmed_id>15168722</pubmed_id>
            </reference>
            <reference>
              <reference_text>Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9.</reference_text>
              <pubmed_id>4837567</pubmed_id>
            </reference>
            <reference>
              <reference_text>MetaGene: Metabolic &amp; Genetic Information Center (MIC: http://www.metagene.de)</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB010534</foodb_id>
      <pubchem_compound_id>127</pubchem_compound_id>
      <chemspider_id>124</chemspider_id>
      <drugbank_id/>
      <phenol_explorer_compound_id>573</phenol_explorer_compound_id>
      <knapsack_id/>
      <kegg_id>C00642</kegg_id>
      <bigg_id>35599</bigg_id>
      <wikipedia_id>4-hydroxyphenylacetic_acid</wikipedia_id>
      <metlin_id>130</metlin_id>
      <chebi_id>18101</chebi_id>
      <pdb_id/>
      <biocyc_id>4-HYDROXYPHENYLACETATE</biocyc_id>
      <synthesis_reference>Qiao, Xi-long; Tian, Hui; Li, Wen; Zhao, Xiu-yun; Zhang, Jin-fang.  Study of 4-hydroxyphenylacetic acid synthesis from glyoxalic acid.    Hebei Gongye Keji  (2005),  22(5),  264-266. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Hirota S, Takahama U, Ly TN, Yamauchi R: Quercetin-dependent inhibition of nitration induced by peroxidase/H2O2/nitrite systems in human saliva and characterization of an oxidation product of quercetin formed during the inhibition. J Agric Food Chem. 2005 May 4;53(9):3265-72.</reference_text>
          <pubmed_id>15853358</pubmed_id>
        </reference>
        <reference>
          <reference_text>Takahama U, Oniki T, Murata H: The presence of 4-hydroxyphenylacetic acid in human saliva and the possibility of its nitration by salivary nitrite in the stomach. FEBS Lett. 2002 May 8;518(1-3):116-8.</reference_text>
          <pubmed_id>11997029</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kobayashi K, Koide Y, Shohmori T: Determination of p-hydroxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection. Clin Chim Acta. 1982 Aug 4;123(1-2):161-8.</reference_text>
          <pubmed_id>7116636</pubmed_id>
        </reference>
        <reference>
          <reference_text>Tyce GM, Stockard J, Sharpless NS, Muenter MD: Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa. Clin Pharmacol Ther. 1983 Sep;34(3):390-8.</reference_text>
          <pubmed_id>6883916</pubmed_id>
        </reference>
        <reference>
          <reference_text>Young SN, Davis BA, Gauthier S: Precursors and metabolites of phenylethylamine, m and p-tyramine and tryptamine in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):633-9.</reference_text>
          <pubmed_id>6181210</pubmed_id>
        </reference>
        <reference>
          <reference_text>Boulat O, Gradwohl M, Matos V, Guignard JP, Bachmann C: Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin Chem Lab Med. 2003 Dec;41(12):1642-58.</reference_text>
          <pubmed_id>14708889</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muskiet FA, Groen A: Urinary excretion of conjugated homovanillic acid, 3,4-dihydroxyphenylacetic acid, p-hydroxyphenylacetic acid, and vanillic acid by persons on their usual diet and patients with neuroblastoma. Clin Chem. 1979 Jul;25(7):1281-4.</reference_text>
          <pubmed_id>455649</pubmed_id>
        </reference>
        <reference>
          <reference_text>Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.</reference_text>
          <pubmed_id>8087979</pubmed_id>
        </reference>
        <reference>
          <reference_text>McKibbin B, O'Gorman L, Duckworth T: Catecholamine metabolite excretion in spina bifida. J Clin Pathol. 1969 Nov;22(6):687-9.</reference_text>
          <pubmed_id>4903899</pubmed_id>
        </reference>
        <reference>
          <reference_text>Mani AR, Pannala AS, Orie NN, Ollosson R, Harry D, Rice-Evans CA, Moore KP: Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine. Biochem J. 2003 Sep 1;374(Pt 2):521-7.</reference_text>
          <pubmed_id>12797864</pubmed_id>
        </reference>
        <reference>
          <reference_text>Takahama U, Hirota S, Nishioka T, Oniki T: Human salivary peroxidase-catalyzed oxidation of nitrite and nitration of salivary components 4-hydroxyphenylacetic acid and proteins. Arch Oral Biol. 2003 Oct;48(10):679-90.</reference_text>
          <pubmed_id>12971945</pubmed_id>
        </reference>
        <reference>
          <reference_text>Quijano C, Hernandez-Saavedra D, Castro L, McCord JM, Freeman BA, Radi R: Reaction of peroxynitrite with Mn-superoxide dismutase. Role of the metal center in decomposition kinetics and nitration. J Biol Chem. 2001 Apr 13;276(15):11631-8. Epub 2001 Jan 4.</reference_text>
          <pubmed_id>11152462</pubmed_id>
        </reference>
        <reference>
          <reference_text>Raw I, Schmidt BJ, Merzel J: Catecholamines and congenital pain insensitivity. Braz J Med Biol Res. 1984;17(3-4):271-9.</reference_text>
          <pubmed_id>6085021</pubmed_id>
        </reference>
        <reference>
          <reference_text>Jenner AM, Rafter J, Halliwell B: Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic Biol Med. 2005 Mar 15;38(6):763-72.</reference_text>
          <pubmed_id>15721987</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762.</reference_text>
          <pubmed_id>19212411</pubmed_id>
        </reference>
        <reference>
          <reference_text>Chalmers RA, Valman HB, Liberman MM: Measurement of 4-hydroxyphenylacetic aciduria as a screening test for small-bowel disease. Clin Chem. 1979 Oct;25(10):1791-4.</reference_text>
          <pubmed_id>476929</pubmed_id>
        </reference>
        <reference>
          <reference_text>Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A: Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S6-S16. doi: 10.1086/341914.</reference_text>
          <pubmed_id>12173102</pubmed_id>
        </reference>
        <reference>
          <reference_text>Publications of the University of Eastern Finland. Dissertations in Health Sciences., no 510</reference_text>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00292</protein_accession>
          <name>Aldehyde dehydrogenase, dimeric NADP-preferring</name>
          <uniprot_id>P30838</uniprot_id>
          <gene_name>ALDH3A1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00294</protein_accession>
          <name>Aldehyde dehydrogenase family 1 member A3</name>
          <uniprot_id>P47895</uniprot_id>
          <gene_name>ALDH1A3</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00483</protein_accession>
          <name>UDP-glucuronosyltransferase 1-1</name>
          <uniprot_id>P22309</uniprot_id>
          <gene_name>UGT1A1</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00541</protein_accession>
          <name>Aldehyde dehydrogenase family 3 member B2</name>
          <uniprot_id>P48448</uniprot_id>
          <gene_name>ALDH3B2</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00542</protein_accession>
          <name>Aldehyde dehydrogenase family 3 member B1</name>
          <uniprot_id>P43353</uniprot_id>
          <gene_name>ALDH3B1</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP12057</protein_accession>
          <name>Sulfotransferase 1A3</name>
          <uniprot_id>P0DMM9</uniprot_id>
          <gene_name>SULT1A3</gene_name>
          <protein_type>Enzyme</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-02-26 21:21:48 UTC</update_date>
      <accession>HMDB0000021</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00021</accession>
      </secondary_accessions>
      <name>Iodotyrosine</name>
      <description>Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3.</description>
      <synonyms>
        <synonym>(2S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoic acid</synonym>
        <synonym>3-IODO-tyrosine</synonym>
        <synonym>MIT</synonym>
        <synonym>(2S)-2-Amino-3-(4-hydroxy-3-iodophenyl)propanoate</synonym>
        <synonym>3-Iodo-4-hydroxyphenylalanine</synonym>
        <synonym>3-Iodo-L-tyrosine</synonym>
        <synonym>3-Iodotyrosine</synonym>
        <synonym>3-Monoiodo-L-tyrosine</synonym>
        <synonym>4-Hydroxy-3-iodophenylalanine</synonym>
        <synonym>IYR</synonym>
        <synonym>L-Tyrosine-3-iodo</synonym>
        <synonym>Monoiodotyrosine</synonym>
      </synonyms>
      <chemical_formula>C9H10INO3</chemical_formula>
      <average_molecular_weight>307.0851</average_molecular_weight>
      <monisotopic_molecular_weight>306.970536611</monisotopic_molecular_weight>
      <iupac_name>(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid</iupac_name>
      <traditional_iupac>iodotyrosine</traditional_iupac>
      <cas_registry_number>70-78-0</cas_registry_number>
      <smiles>N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O</smiles>
      <inchi>InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1</inchi>
      <inchikey>UQTZMGFTRHFAAM-ZETCQYMHSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as tyrosine and derivatives. Tyrosine and derivatives are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
        <direct_parent>Tyrosine and derivatives</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Organic acids and derivatives</super_class>
        <class>Carboxylic acids and derivatives</class>
        <sub_class>Amino acids, peptides, and analogues</sub_class>
        <molecular_framework>Aromatic homomonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>1-hydroxy-2-unsubstituted benzenoids</alternative_parent>
          <alternative_parent>Amino acids</alternative_parent>
          <alternative_parent>Amphetamines and derivatives</alternative_parent>
          <alternative_parent>Aralkylamines</alternative_parent>
          <alternative_parent>Aryl iodides</alternative_parent>
          <alternative_parent>Carbonyl compounds</alternative_parent>
          <alternative_parent>Carboxylic acids</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Iodobenzenes</alternative_parent>
          <alternative_parent>L-alpha-amino acids</alternative_parent>
          <alternative_parent>Monoalkylamines</alternative_parent>
          <alternative_parent>Monocarboxylic acids and derivatives</alternative_parent>
          <alternative_parent>O-iodophenols</alternative_parent>
          <alternative_parent>Organic oxides</alternative_parent>
          <alternative_parent>Organoiodides</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
          <alternative_parent>Phenylalanine and derivatives</alternative_parent>
          <alternative_parent>Phenylpropanoic acids</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
          <substituent>2-halophenol</substituent>
          <substituent>2-iodophenol</substituent>
          <substituent>3-phenylpropanoic-acid</substituent>
          <substituent>Alpha-amino acid</substituent>
          <substituent>Amine</substituent>
          <substituent>Amino acid</substituent>
          <substituent>Amphetamine or derivatives</substituent>
          <substituent>Aralkylamine</substituent>
          <substituent>Aromatic homomonocyclic compound</substituent>
          <substituent>Aryl halide</substituent>
          <substituent>Aryl iodide</substituent>
          <substituent>Benzenoid</substituent>
          <substituent>Carbonyl group</substituent>
          <substituent>Carboxylic acid</substituent>
          <substituent>Halobenzene</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Iodobenzene</substituent>
          <substituent>L-alpha-amino acid</substituent>
          <substituent>Monocarboxylic acid or derivatives</substituent>
          <substituent>Monocyclic benzene moiety</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxide</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organohalogen compound</substituent>
          <substituent>Organoiodide</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Phenol</substituent>
          <substituent>Phenylalanine or derivatives</substituent>
          <substituent>Primary aliphatic amine</substituent>
          <substituent>Primary amine</substituent>
          <substituent>Tyrosine or derivatives</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>L-tyrosine derivative</external_descriptor>
          <external_descriptor>Other amino acids</external_descriptor>
          <external_descriptor>monoiodotyrosine</external_descriptor>
          <external_descriptor>non-proteinogenic L-alpha-amino acid</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Physiological effect</term>
          <definition>The effect on an organism physiology, resulting from its exposure to a chemical.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Health effect</term>
              <definition>A health condition or observation associated with a stimuli or with a biological activity of a chemical.</definition>
              <parent_id>7693</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Health condition</term>
                  <definition>A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.</definition>
                  <parent_id>7694</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Athyreosis</term>
                      <definition/>
                      <parent_id>7695</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Athyreotic patients</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Endocrine gland</term>
                      <definition/>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Thyroid gland</term>
                          <definition>Endocrine gland(s) adjacent to the trachea in mammals that produce thyroxine and other hormones. (nci).</definition>
                          <parent_id>7728</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Thyroid hormone synthesis</term>
                          <definition> iodine is necessary for the production of t3 and t4. a deficiency of iodine leads to decreased production of t3 and t4, enlarges the thyroid tissue and will cause the disease known as goitre.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Tyrosine Metabolism</term>
                          <definition> half of the phenylalanine required goes into the production of tyrosine; if the diet is rich in tyrosine itself, the requirements for phenylalanine are reduced by about 50%. phenylalanine hydroxylase is a mixed-function oxygenase: one atom of oxygen is incorporated into water and the other into the hydroxyl of tyrosine.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Role</term>
          <definition>The purpose or function assumed by a chemical, either naturally or as intended by humans .</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Industrial application</term>
              <definition>The assumed function of a chemical utilized by human.</definition>
              <parent_id>7671</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Pharmaceutical industry</term>
                  <definition>A pharmacologic activity for which a chemical substance is utilized owing to its biological role.</definition>
                  <parent_id>7678</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Pharmaceutical</term>
                      <definition/>
                      <parent_id>7679</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>water_solubility</kind>
          <value>3 mg/mL</value>
          <source/>
        </property>
        <property>
          <kind>melting_point</kind>
          <value>205 °C</value>
          <source/>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-1.51</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-2.52</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>0.94 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>-0.56</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>0.99</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>9.5</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>307.0851</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>306.970536611</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C9H10INO3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>UQTZMGFTRHFAAM-ZETCQYMHSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>83.55</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>60.46</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>23.54</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>4</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>928</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1035</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1887</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1890</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>9065</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30956</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30957</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37249</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>36</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>37</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>38</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2566</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2567</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2568</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2569</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2570</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2571</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2572</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2573</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2574</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2575</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2576</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2577</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2578</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2579</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2580</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2581</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2582</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>2583</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>263550</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>263551</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>263552</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>283479</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Thyroid Gland</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Thyroid hormone synthesis</name>
            <smpdb_id>SMP00716</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tyrosine Metabolism</name>
            <smpdb_id>SMP00006</smpdb_id>
            <kegg_map_id>map00350</kegg_map_id>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.00069 +/- 0.00020</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Tan SA, Lewis JE, Berk LS, Wilcox RB: Extrathyroidal physiology of monoiodotyrosine in humans. Clin Physiol Biochem. 1990;8(3):109-15.</reference_text>
              <pubmed_id>2225717</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.00032 +/- 0.00008</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Both</patient_sex>
          <patient_information>Athyroic patients </patient_information>
          <references>
            <reference>
              <reference_text>Tan SA, Lewis JE, Berk LS, Wilcox RB: Extrathyroidal physiology of monoiodotyrosine in humans. Clin Physiol Biochem. 1990;8(3):109-15.</reference_text>
              <pubmed_id>2225717</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Athyreosis</name>
          <omim_id/>
          <references>
            <reference>
              <reference_text>Tan SA, Lewis JE, Berk LS, Wilcox RB: Extrathyroidal physiology of monoiodotyrosine in humans. Clin Physiol Biochem. 1990;8(3):109-15.</reference_text>
              <pubmed_id>2225717</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <kegg_id>C02515</kegg_id>
      <drugbank_id>DB01758</drugbank_id>
      <foodb_id>FDB021875</foodb_id>
      <chemspider_id>388804</chemspider_id>
      <chebi_id>27847</chebi_id>
      <pubchem_compound_id>439744</pubchem_compound_id>
      <pdb_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id/>
      <bigg_id>39998</bigg_id>
      <wikipedia_id>3-Iodotyrosine</wikipedia_id>
      <metlin_id/>
      <biocyc_id>CPD-12288</biocyc_id>
      <vmh_id>3ITYR_L</vmh_id>
      <fbonto_id/>
      <synthesis_reference>Hillmann, Gunther; Hillmann-Elies, Anneliese.  Synthesis of 3-iodo-L-tyrosine.    Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie  (1956),  305  177-81. </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Sakamoto K, Hayashi A, Sakamoto A, Kiga D, Nakayama H, Soma A, Kobayashi T, Kitabatake M, Takio K, Saito K, Shirouzu M, Hirao I, Yokoyama S: Site-specific incorporation of an unnatural amino acid into proteins in mammalian cells. Nucleic Acids Res. 2002 Nov 1;30(21):4692-9.</reference_text>
          <pubmed_id>12409460</pubmed_id>
        </reference>
        <reference>
          <reference_text>Painter K, Vader CR: Interference of iodine-125 ligands in radioimmunoassay: evidence implicating thyroxine-binding globulin. Clin Chem. 1979 May;25(5):797-9.</reference_text>
          <pubmed_id>108034</pubmed_id>
        </reference>
        <reference>
          <reference_text>Ismail-Beigi F, Rahimifar M: A variant of iodotyrosine-dehalogenase deficiency. J Clin Endocrinol Metab. 1977 Mar;44(3):499-506.</reference_text>
          <pubmed_id>838849</pubmed_id>
        </reference>
        <reference>
          <reference_text>Smythe GA, Compton PJ, Lazarus L: The stimulation of human prolactin secretion by 3-Iodo-L-tyrosine. J Clin Endocrinol Metab. 1975 Apr;40(4):714-6.</reference_text>
          <pubmed_id>1127080</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muller EE, Locatelli V, Cella S, Penalva A, Novelli A, Cocchi D: Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications. Drugs. 1983 Apr;25(4):399-432.</reference_text>
          <pubmed_id>6133737</pubmed_id>
        </reference>
        <reference>
          <reference_text>Kucerova Z, Ticha M: Aromatic amino acids and their derivatives as ligands for the isolation of aspartic proteinases. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Apr 25;770(1-2):121-8.</reference_text>
          <pubmed_id>12013218</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00276</protein_accession>
          <name>Thyroid peroxidase</name>
          <uniprot_id>P07202</uniprot_id>
          <gene_name>TPO</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
    <metabolite>
      <version>4.0</version>
      <creation_date>2005-11-16 15:48:42 UTC</creation_date>
      <update_date>2020-04-23 20:53:27 UTC</update_date>
      <accession>HMDB0000022</accession>
      <status>quantified</status>
      <secondary_accessions>
        <accession>HMDB00022</accession>
        <accession>HMDB0006022</accession>
        <accession>HMDB06022</accession>
      </secondary_accessions>
      <name>3-Methoxytyramine</name>
      <description>3-methoxytyramine, also known as 4-(2-amino-Ethyl)-2-methoxy-phenol or 3-O-Methyldopamine, is classified as a member of the Methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 3-methoxytyramine is considered to be slightly soluble (in water) and acidic.  3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm</description>
      <synonyms>
        <synonym>3-Methoxy-4-hydroxyphenylethyl amine</synonym>
        <synonym>3-O-Methyldopamine</synonym>
        <synonym>4-(2-Amino-ethyl)-2-methoxy-phenol</synonym>
        <synonym>4-(2-Aminoethyl)-2-methoxy-phenol</synonym>
        <synonym>4-(2-Aminoethyl)-2-methoxyphenol</synonym>
        <synonym>5-(2-Aminoethyl)guaiacol</synonym>
        <synonym>Methoxytyramine</synonym>
        <synonym>3-Methoxytyramine hydrochloride</synonym>
      </synonyms>
      <chemical_formula>C9H13NO2</chemical_formula>
      <average_molecular_weight>167.205</average_molecular_weight>
      <monisotopic_molecular_weight>167.094628665</monisotopic_molecular_weight>
      <iupac_name>4-(2-aminoethyl)-2-methoxyphenol</iupac_name>
      <traditional_iupac>methoxytyramine</traditional_iupac>
      <cas_registry_number>554-52-9</cas_registry_number>
      <smiles>COC1=C(O)C=CC(CCN)=C1</smiles>
      <inchi>InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3</inchi>
      <inchikey>DIVQKHQLANKJQO-UHFFFAOYSA-N</inchikey>
      <taxonomy>
        <description> belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety.</description>
        <direct_parent>Methoxyphenols</direct_parent>
        <kingdom>Organic compounds</kingdom>
        <super_class>Benzenoids</super_class>
        <class>Phenols</class>
        <sub_class>Methoxyphenols</sub_class>
        <molecular_framework>Aromatic homomonocyclic compounds</molecular_framework>
        <alternative_parents>
          <alternative_parent>1-hydroxy-2-unsubstituted benzenoids</alternative_parent>
          <alternative_parent>2-arylethylamines</alternative_parent>
          <alternative_parent>Alkyl aryl ethers</alternative_parent>
          <alternative_parent>Anisoles</alternative_parent>
          <alternative_parent>Aralkylamines</alternative_parent>
          <alternative_parent>Hydrocarbon derivatives</alternative_parent>
          <alternative_parent>Methoxybenzenes</alternative_parent>
          <alternative_parent>Monoalkylamines</alternative_parent>
          <alternative_parent>Organopnictogen compounds</alternative_parent>
          <alternative_parent>Phenethylamines</alternative_parent>
          <alternative_parent>Phenoxy compounds</alternative_parent>
        </alternative_parents>
        <substituents>
          <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
          <substituent>2-arylethylamine</substituent>
          <substituent>Alkyl aryl ether</substituent>
          <substituent>Amine</substituent>
          <substituent>Anisole</substituent>
          <substituent>Aralkylamine</substituent>
          <substituent>Aromatic homomonocyclic compound</substituent>
          <substituent>Ether</substituent>
          <substituent>Hydrocarbon derivative</substituent>
          <substituent>Methoxybenzene</substituent>
          <substituent>Methoxyphenol</substituent>
          <substituent>Monocyclic benzene moiety</substituent>
          <substituent>Organic nitrogen compound</substituent>
          <substituent>Organic oxygen compound</substituent>
          <substituent>Organonitrogen compound</substituent>
          <substituent>Organooxygen compound</substituent>
          <substituent>Organopnictogen compound</substituent>
          <substituent>Phenethylamine</substituent>
          <substituent>Phenol ether</substituent>
          <substituent>Phenoxy compound</substituent>
          <substituent>Primary aliphatic amine</substituent>
          <substituent>Primary amine</substituent>
        </substituents>
        <external_descriptors>
          <external_descriptor>methoxybenzene</external_descriptor>
          <external_descriptor>phenols</external_descriptor>
        </external_descriptors>
      </taxonomy>
      <ontology>
        <root>
          <term>Disposition</term>
          <definition>A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Source</term>
              <definition>Natural or synthetic origin of a chemical.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Endogenous</term>
                  <definition/>
                  <parent_id>7735</parent_id>
                  <level>3</level>
                  <type>child</type>
                  <synonyms>
                  </synonyms>
                </descendant>
              </descendants>
            </descendant>
            <descendant>
              <term>Biological location</term>
              <definition>The physiological origin within an organism, including anatomical compnents, biofluids and excreta.</definition>
              <parent_id>7724</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Organ and components</term>
                  <definition>An anatomical organizational level including multiple tissues or substructures, which enables a common biological function.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Brain</term>
                      <definition>An organ composed of grey and white matter that is the center for intelligence and reasoning. it is protected by the bony cranium. (nci).</definition>
                      <parent_id>7727</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Biofluid and excreta</term>
                  <definition>A liquid, semi-solid or solid material originating in the body.</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Urine</term>
                      <definition>Excretion in liquid state processed by the kidney.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Blood</term>
                      <definition>A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                      </synonyms>
                    </descendant>
                    <descendant>
                      <term>Cerebrospinal fluid</term>
                      <definition>The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).</definition>
                      <parent_id>7731</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Csf</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
                <descendant>
                  <term>Subcellular</term>
                  <definition>An anatomical organizational level including a component within a biological cell .</definition>
                  <parent_id>7725</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Cytoplasm</term>
                      <definition>The portion of the cell contained within the plasma membrane but excluding the nucleus.</definition>
                      <parent_id>7730</parent_id>
                      <level>4</level>
                      <type>child</type>
                      <synonyms>
                        <synonym>Cytoplasma</synonym>
                      </synonyms>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
        <root>
          <term>Process</term>
          <definition>Biological or chemical events, or a series thereof, leading to a known function or end-product.</definition>
          <parent_id/>
          <level>1</level>
          <type>parent</type>
          <descendants>
            <descendant>
              <term>Naturally occurring process</term>
              <definition>Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.</definition>
              <parent_id>7659</parent_id>
              <level>2</level>
              <type>parent</type>
              <synonyms>
              </synonyms>
              <descendants>
                <descendant>
                  <term>Biological process</term>
                  <definition>Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.</definition>
                  <parent_id>7660</parent_id>
                  <level>3</level>
                  <type>parent</type>
                  <synonyms>
                  </synonyms>
                  <descendants>
                    <descendant>
                      <term>Biochemical pathway</term>
                      <definition>A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.</definition>
                      <parent_id>7661</parent_id>
                      <level>4</level>
                      <type>parent</type>
                      <synonyms>
                      </synonyms>
                      <descendants>
                        <descendant>
                          <term>Disulfiram Action Pathway</term>
                          <definition> with regards to cocaine addiction, cocaine inhibits dopamine reuptake by blocking dopamine transporter 1 (dat1). this increases dopamine concentrations in the synapse and dopamine binding to its receptors induces euphoria.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                        <descendant>
                          <term>Tyrosine Metabolism</term>
                          <definition> half of the phenylalanine required goes into the production of tyrosine; if the diet is rich in tyrosine itself, the requirements for phenylalanine are reduced by about 50%. phenylalanine hydroxylase is a mixed-function oxygenase: one atom of oxygen is incorporated into water and the other into the hydroxyl of tyrosine.</definition>
                          <parent_id>7662</parent_id>
                          <level>5</level>
                          <type>child</type>
                          <synonyms>
                          </synonyms>
                        </descendant>
                      </descendants>
                    </descendant>
                  </descendants>
                </descendant>
              </descendants>
            </descendant>
          </descendants>
        </root>
      </ontology>
      <state>Solid</state>
      <experimental_properties>
        <property>
          <kind>logp</kind>
          <value>-0.08</value>
          <source>SANGSTER (1994)</source>
        </property>
      </experimental_properties>
      <predicted_properties>
        <property>
          <kind>logp</kind>
          <value>-0.04</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logs</kind>
          <value>-1.49</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>solubility</kind>
          <value>5.36 g/L</value>
          <source>ALOGPS</source>
        </property>
        <property>
          <kind>logp</kind>
          <value>0.53</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_acidic</kind>
          <value>10.39</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>pka_strongest_basic</kind>
          <value>9.64</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>iupac</kind>
          <value>4-(2-aminoethyl)-2-methoxyphenol</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>average_mass</kind>
          <value>167.205</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mono_mass</kind>
          <value>167.094628665</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>smiles</kind>
          <value>COC1=C(O)C=CC(CCN)=C1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formula</kind>
          <value>C9H13NO2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchi</kind>
          <value>InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>inchikey</kind>
          <value>DIVQKHQLANKJQO-UHFFFAOYSA-N</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polar_surface_area</kind>
          <value>55.48</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>refractivity</kind>
          <value>47.73</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>polarizability</kind>
          <value>18.21</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rotatable_bond_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>acceptor_count</kind>
          <value>3</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>donor_count</kind>
          <value>2</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>physiological_charge</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>formal_charge</kind>
          <value>0</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>number_of_rings</kind>
          <value>1</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>bioavailability</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>rule_of_five</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>ghose_filter</kind>
          <value>Yes</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>veber_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
        <property>
          <kind>mddr_like_rule</kind>
          <value>No</value>
          <source>ChemAxon</source>
        </property>
      </predicted_properties>
      <spectra>
        <spectrum>
          <type>Specdb::NmrTwoD</type>
          <spectrum_id>929</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::NmrOneD</type>
          <spectrum_id>1036</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>1749</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>25307</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>30958</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::CMs</type>
          <spectrum_id>37250</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>39</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>40</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>41</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>322024</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>322025</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>322026</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>369811</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>369812</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>369813</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>440152</spectrum_id>
        </spectrum>
        <spectrum>
          <type>Specdb::MsMs</type>
          <spectrum_id>451979</spectrum_id>
        </spectrum>
      </spectra>
      <biological_properties>
        <cellular_locations>
          <cellular>Cytoplasm</cellular>
        </cellular_locations>
        <biospecimen_locations>
          <biospecimen>Blood</biospecimen>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <biospecimen>Urine</biospecimen>
        </biospecimen_locations>
        <tissue_locations>
          <tissue>Brain</tissue>
        </tissue_locations>
        <pathways>
          <pathway>
            <name>Alkaptonuria</name>
            <smpdb_id>SMP00169</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Disulfiram Action Pathway</name>
            <smpdb_id>SMP00429</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Dopamine beta-hydroxylase deficiency</name>
            <smpdb_id>SMP00498</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Hawkinsinuria</name>
            <smpdb_id>SMP00190</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Monoamine oxidase-a deficiency (MAO-A)</name>
            <smpdb_id>SMP00533</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tyrosine Metabolism</name>
            <smpdb_id>SMP00006</smpdb_id>
            <kegg_map_id>map00350</kegg_map_id>
          </pathway>
          <pathway>
            <name>Tyrosinemia Type I</name>
            <smpdb_id>SMP00218</smpdb_id>
            <kegg_map_id/>
          </pathway>
          <pathway>
            <name>Tyrosinemia, transient, of the newborn</name>
            <smpdb_id>SMP00494</smpdb_id>
            <kegg_map_id/>
          </pathway>
        </pathways>
      </biological_properties>
      <normal_concentrations>
        <concentration>
          <biospecimen>Blood</biospecimen>
          <concentration_value>0.0025 (0.0016-0.0029)</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.00377</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Not Specified</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Beck O, Faull KF: Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid. Anal Biochem. 1985 Sep;149(2):492-500.</reference_text>
              <pubmed_id>4073504</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.0014 +/- 0.0002</concentration_value>
          <concentration_units>uM</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Not Specified</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Loeffler DA, LeWitt PA, DeMaggio AJ, Juneau PL, Milbury PE, Matson WR: Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1995;9(1):45-53.</reference_text>
              <pubmed_id>7605589</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.31-0.55 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Female</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.6</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Guo K, Li L: Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem. 2009 May 15;81(10):3919-32. doi: 10.1021/ac900166a.</reference_text>
              <pubmed_id>19309105</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.014 (0.0052-0.028)</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Children (1-13 years old)</subject_age>
          <subject_sex>Both</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.</reference_text>
              <pubmed_id/>
            </reference>
            <reference>
              <reference_text>Basel, Switzerland c1981-1992.</reference_text>
              <pubmed_id/>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.29-0.54 </concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Husek P, Svagera Z, Hanzlikova D, Rimnacova L, Zahradnickova H, Opekarova I, Simek P: Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry. J Chromatogr A. 2016 Apr 22;1443:211-32. doi: 10.1016/j.chroma.2016.03.019. Epub  2016 Mar 10.</reference_text>
              <pubmed_id>27012787</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.0370-0.118</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9.</reference_text>
              <pubmed_id>8503438</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.0130-0.0290</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <subject_age>Adult (&gt;18 years old)</subject_age>
          <subject_sex>Male</subject_sex>
          <subject_condition>Normal</subject_condition>
          <references>
            <reference>
              <reference_text>Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9.</reference_text>
              <pubmed_id>8503438</pubmed_id>
            </reference>
          </references>
        </concentration>
      </normal_concentrations>
      <abnormal_concentrations>
        <concentration>
          <biospecimen>Cerebrospinal Fluid (CSF)</biospecimen>
          <concentration_value>0.0005 +/- 0.0003</concentration_value>
          <concentration_units>uM</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Not Specified</patient_sex>
          <patient_information>Parkinson's Disease</patient_information>
          <references>
            <reference>
              <reference_text>Loeffler DA, LeWitt PA, DeMaggio AJ, Juneau PL, Milbury PE, Matson WR: Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1995;9(1):45-53.</reference_text>
              <pubmed_id>7605589</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.217-0.318</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Brunner Syndrome</patient_information>
          <references>
            <reference>
              <reference_text>Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9.</reference_text>
              <pubmed_id>8503438</pubmed_id>
            </reference>
          </references>
        </concentration>
        <concentration>
          <biospecimen>Urine</biospecimen>
          <concentration_value>0.0140-0.0340</concentration_value>
          <concentration_units>umol/mmol creatinine</concentration_units>
          <patient_age>Adult (&gt;18 years old)</patient_age>
          <patient_sex>Male</patient_sex>
          <patient_information>Brunner Syndrome</patient_information>
          <references>
            <reference>
              <reference_text>Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9.</reference_text>
              <pubmed_id>8503438</pubmed_id>
            </reference>
          </references>
        </concentration>
      </abnormal_concentrations>
      <diseases>
        <disease>
          <name>Parkinson's disease</name>
          <omim_id>168600</omim_id>
          <references>
            <reference>
              <reference_text>Loeffler DA, LeWitt PA, DeMaggio AJ, Juneau PL, Milbury PE, Matson WR: Markers of dopamine depletion and compensatory response in striatum and cerebrospinal fluid. J Neural Transm Park Dis Dement Sect. 1995;9(1):45-53.</reference_text>
              <pubmed_id>7605589</pubmed_id>
            </reference>
            <reference>
              <reference_text>Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.</reference_text>
              <pubmed_id>12834252</pubmed_id>
            </reference>
            <reference>
              <reference_text>Cheng H, Gomes-Trolin C, Aquilonius SM, Steinberg A, Lofberg C, Ekblom J, Oreland L: Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol. 1997 Jun;145(2 Pt 1):580-5.</reference_text>
              <pubmed_id>9217094</pubmed_id>
            </reference>
            <reference>
              <reference_text>Selley ML: (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med. 1998 Jul 15;25(2):169-74.</reference_text>
              <pubmed_id>9667492</pubmed_id>
            </reference>
            <reference>
              <reference_text>Zhang W, Xie Y, Gu J, Ai S, Wang J, Yamamoto K, Jin L: Liquid chromatography with amperometric detection at a nano crystalline Ce-doped lead dioxide film modified electrode for determination of (R)-Salsolinol, (R)-N-methylsalsolinol and monoamine neurotransmitters in Parkinsonian patients' cerebrospinal fluid. Analyst. 2004 Mar;129(3):229-34. Epub 2004 Feb 6.</reference_text>
              <pubmed_id>14978525</pubmed_id>
            </reference>
            <reference>
              <reference_text>Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M: 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem. 1995 Dec;65(6):2633-8.</reference_text>
              <pubmed_id>7595560</pubmed_id>
            </reference>
            <reference>
              <reference_text>Naoi M, Maruyama W: Cell death of dopamine neurons in aging and Parkinson's disease. Mech Ageing Dev. 1999 Nov;111(2-3):175-88.</reference_text>
              <pubmed_id>10656535</pubmed_id>
            </reference>
            <reference>
              <reference_text>Moser A, Scholz J, Nobbe F, Vieregge P, Bohme V, Bamberg H: Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease. J Neurol Sci. 1995 Aug;131(2):183-9.</reference_text>
              <pubmed_id>7595645</pubmed_id>
            </reference>
            <reference>
              <reference_text>Abe T, Isobe C, Murata T, Sato C, Tohgi H: Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neurosci Lett. 2003 Jan 16;336(2):105-8.</reference_text>
              <pubmed_id>12499051</pubmed_id>
            </reference>
            <reference>
              <reference_text>Pappert EJ, Tangney CC, Goetz CG, Ling ZD, Lipton JW, Stebbins GT, Carvey PM: Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct;47(4):1037-42.</reference_text>
              <pubmed_id>8857741</pubmed_id>
            </reference>
            <reference>
              <reference_text>LeWitt PA, Galloway MP, Matson W, Milbury P, McDermott M, Srivastava DK, Oakes D: Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. Neurology. 1992 Nov;42(11):2111-7.</reference_text>
              <pubmed_id>1436520</pubmed_id>
            </reference>
            <reference>
              <reference_text>Shukla R, Rajani M, Srivastava N, Barthwal MK, Dikshit M: Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease. Int J Neurosci. 2006 Dec;116(12):1391-402.</reference_text>
              <pubmed_id>17145675</pubmed_id>
            </reference>
            <reference>
              <reference_text>Miura Y: Plasma beta-phenylethylamine in Parkinson's disease. Kurume Med J. 2000;47(4):267-72.</reference_text>
              <pubmed_id>11197147</pubmed_id>
            </reference>
            <reference>
              <reference_text>Forte G, Alimonti A, Pino A, Stanzione P, Brescianini S, Brusa L, Sancesario G, Violante N, Bocca B: Metals and oxidative stress in patients with Parkinson's disease. Ann Ist Super Sanita. 2005;41(2):189-95.</reference_text>
              <pubmed_id>16244392</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ishimitsu T, Hirose S, Asahara K, Imaizumi M: The formation of 3-hydroxy-4-methoxyphenylalanine and 3-hydroxy-4-methoxyphenethylamine in plasma during L-DOPA therapy in patients with Parkinson's disease. Chem Pharm Bull (Tokyo). 1984 Aug;32(8):3320-2.</reference_text>
              <pubmed_id>6518609</pubmed_id>
            </reference>
            <reference>
              <reference_text>Levin J, Botzel K, Giese A, Vogeser M, Lorenzl S: Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dement Geriatr Cogn Disord. 2010;29(6):553-9. doi: 10.1159/000314841. Epub 2010 Jul 3.</reference_text>
              <pubmed_id>20606437</pubmed_id>
            </reference>
            <reference>
              <reference_text>Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T: Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011 Apr 15;303(1-2):95-9. doi: 10.1016/j.jns.2011.01.003. Epub 2011 Feb 2.</reference_text>
              <pubmed_id>21292280</pubmed_id>
            </reference>
            <reference>
              <reference_text>Dizdar N, Kagedal B, Lindvall B: Treatment of Parkinson's disease with NADH. Acta Neurol Scand. 1994 Nov;90(5):345-7.</reference_text>
              <pubmed_id>7887134</pubmed_id>
            </reference>
            <reference>
              <reference_text>Furukawa Y, Nishi K, Mizuno Y, Narabayashi H: [Significance of CSF biopterin and neopterin in hereditary progressive dystonia with marked diurnal fluctuation (HPD)--a clue to pathogenesis]. No To Shinkei. 1995 Mar;47(3):261-8.</reference_text>
              <pubmed_id>7669428</pubmed_id>
            </reference>
            <reference>
              <reference_text>Ebinger G, Adriaenssens K: Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease. Clin Chim Acta. 1973 Nov 15;48(4):427-31.</reference_text>
              <pubmed_id>4761590</pubmed_id>
            </reference>
          </references>
        </disease>
        <disease>
          <name>Brunner Syndrome</name>
          <omim_id>300615</omim_id>
          <references>
            <reference>
              <reference_text>Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9.</reference_text>
              <pubmed_id>8503438</pubmed_id>
            </reference>
          </references>
        </disease>
      </diseases>
      <foodb_id>FDB021876</foodb_id>
      <chemspider_id>1606</chemspider_id>
      <pubchem_compound_id>1669</pubchem_compound_id>
      <chebi_id>742324</chebi_id>
      <drugbank_id/>
      <phenol_explorer_compound_id/>
      <knapsack_id>C00042132</knapsack_id>
      <kegg_id>C05587</kegg_id>
      <bigg_id>46076</bigg_id>
      <wikipedia_id>3-Methoxytyramine</wikipedia_id>
      <metlin_id>5094</metlin_id>
      <biocyc_id/>
      <pdb_id/>
      <synthesis_reference>Kametani, Tetsuji; Takano, Seiichi; Karibe, Etsuo.  Syntheses of heterocyclic compounds. LXXXVII. Simplified synthesis of 3-methoxy-4-hydroxy- and 3-methoxy-4-tosyloxyphenethylamine.    Yakugaku Zasshi  (1963),  83(11),  1035-9.  </synthesis_reference>
      <general_references>
        <reference>
          <reference_text>Leysen JE, Wynants J, Eens A, Janssen PA: Ketanserin reduces a particular monoamine pool in peripheral tissues. Mol Pharmacol. 1989 Mar;35(3):375-80.</reference_text>
          <pubmed_id>2927387</pubmed_id>
        </reference>
        <reference>
          <reference_text>Faraj BA, Lawson DH, Nixon DW, Murray DR, Camp VM, Ali FM, Black M, Stacciarini W, Tarcan Y: Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine. Clin Chem. 1981 Jan;27(1):108-12.</reference_text>
          <pubmed_id>7004664</pubmed_id>
        </reference>
        <reference>
          <reference_text>Muskiet FA, Thomasson CG, Gerding AM, Fremouw-Ottevangers DC, Nagel GT, Wolthers BG: Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards. Clin Chem. 1979 Mar;25(3):453-60.</reference_text>
          <pubmed_id>262188</pubmed_id>
        </reference>
        <reference>
          <reference_text>Sparks DL, Hunsaker JC 3rd, Slevin JT: Postmortem accumulation of 3-methoxytyramine in the brain. N Engl J Med. 1984 Aug 23;311(8):540.</reference_text>
          <pubmed_id>6749220</pubmed_id>
        </reference>
        <reference>
          <reference_text>Peterson ZD, Collins DC, Bowerbank CR, Lee ML, Graves SW: Determination of catecholamines and metanephrines in urine by capillary electrophoresis-electrospray ionization-time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 5;776(2):221-9.</reference_text>
          <pubmed_id>12138004</pubmed_id>
        </reference>
        <reference>
          <reference_text>Beck O, Faull KF: Extractive acylation and mass spectrometric assay of 3-methoxytyramine, normetanephrine, and metanephrine in cerebrospinal fluid. Anal Biochem. 1985 Sep;149(2):492-500.</reference_text>
          <pubmed_id>4073504</pubmed_id>
        </reference>
        <reference>
          <reference_text>Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11. Epub 2003 Mar 20.</reference_text>
          <pubmed_id>12649306</pubmed_id>
        </reference>
        <reference>
          <reference_text>Oeltmann T, Carson R, Shannon JR, Ketch T, Robertson D: Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders. Auton Neurosci. 2004 Nov 30;116(1-2):1-10.</reference_text>
          <pubmed_id>15556832</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yui K, Ikemoto S, Goto K: Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Ann N Y Acad Sci. 2002 Jun;965:292-304.</reference_text>
          <pubmed_id>12105105</pubmed_id>
        </reference>
        <reference>
          <reference_text>Uchikura K, Horikawa R, Tanimura T, Kabasawa Y: Determination of catecholamines by radioenzymatic assay using ion-pair liquid chromatography. J Chromatogr. 1981 Apr 10;223(1):41-50.</reference_text>
          <pubmed_id>7251775</pubmed_id>
        </reference>
        <reference>
          <reference_text>Carlsson A, Lindqvist M, Kehr W: Postmortal accumulation of 3-methoxytyramine in brain. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(4):365-72.</reference_text>
          <pubmed_id>4281061</pubmed_id>
        </reference>
        <reference>
          <reference_text>Shoup RE, Kissinger PT: Determination of urinary normetanephrine, metanephrine, and 3-methoxytyramine by liquid chromatography, with amperometric detection. Clin Chem. 1977 Jul;23(7):1268-74.</reference_text>
          <pubmed_id>872373</pubmed_id>
        </reference>
        <reference>
          <reference_text>Wester P, Puu G, Reiz S, Winblad B, Wester PO: Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke. Acta Neurol Scand. 1987 Dec;76(6):473-9.</reference_text>
          <pubmed_id>3434205</pubmed_id>
        </reference>
        <reference>
          <reference_text>Yui K, Goto K, Ikemoto S: The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence. Ann N Y Acad Sci. 2004 Oct;1025:296-306.</reference_text>
          <pubmed_id>15542730</pubmed_id>
        </reference>
        <reference>
          <reference_text>Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O: Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism Relat Disord. 2004 Jun;10(4):221-6.</reference_text>
          <pubmed_id>15120096</pubmed_id>
        </reference>
      </general_references>
      <protein_associations>
        <protein>
          <protein_accession>HMDBP00161</protein_accession>
          <name>Amine oxidase [flavin-containing] B</name>
          <uniprot_id>P27338</uniprot_id>
          <gene_name>MAOB</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00169</protein_accession>
          <name>Amine oxidase [flavin-containing] A</name>
          <uniprot_id>P21397</uniprot_id>
          <gene_name>MAOA</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
        <protein>
          <protein_accession>HMDBP00272</protein_accession>
          <name>Catechol O-methyltransferase</name>
          <uniprot_id>P21964</uniprot_id>
          <gene_name>COMT</gene_name>
          <protein_type>Unknown</protein_type>
        </protein>
      </protein_associations>
    </metabolite>
</hmdb>